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ABSTRACT 
Maize is not only one of the world’s most important crops, but it is also the first field-
grown plant-based recombinant expression system developed for commercial purposes. With 
advantages of low cost, high yield, high protein stability, and well-developed transformation 
technology over other plant systems, maize is considered to be an ideal recombinant 
production system. However, there are three major challenges limiting the use of maize for 
producing recombinant proteins: 1) maize lacks mammalian-like post-translational 
modification ability that may be required for pharmaceutical and industrial proteins; 2) 
transgenic pollen containment in open-field production; and 3) low expression of 
recombinant products. The aim of the present study was to develop strategies to safely 
produce recombinant proteins with high yield and adequate modification in maize seeds.  
Firstly, we showed that the recombinant human collagen type I alpha 1 (rCIα1) with 
high ratio of hydroxylated prolines (Hyp) similar to native human collagen was expressed in 
maize seeds co-expressing a recombinant human prolyl 4-hydroxylase (rP4H). The 
hydroxylated rCIα1 had a markedly enhanced thermal stability compared to non-
hydroxylated rCIα1.   
Secondly, we demonstrated that a cytoplasmic male-sterile maize system could be 
used for open-field production of maize-derived recombinant protein to minimize 
contamination risk caused by pollen drift. Two strategies were presented: the transgene was 
directly transformed into a male-sterile line via biolistic- or Agrobacterium-mediated 
methods, or introgressed from male-fertile to male-sterile germplasm by conventional 
breeding. The male-sterile transgenic maize seed from the second strategy can be used for 
vii 
 
open-field production by using a non-transgenic maize pollen donor to produce 100% 
transgenic seeds after six seasons of breeding. 
Thirdly, we examined the feasibility of producing a small peptide in maize seeds. A 
designed 22 amino acid peptide biosurfactant GAM1 was fused to the C-terminus of a 
fluoresce protein, the red fluorescent protein (RFP), or a maize seed storage protein, the 22-
kDa α-zein, to avoid proteolytic degradation in the cell. While red fluorescence could be 
detected in seeds carrying RFP fusion construct, we failed to detect the presence of GAM1 
despite using various protein concentration and detection methods. Strategies for producing 
this peptide in maize will need to be redesigned.   
Lastly, we evaluated two strategies for enhancing recombinant protein expression in 
maize seeds. In the first strategy, we generated a line with reduced seed storage protein γ-
zein by RNA interference (γRNAi). Then we crossed this line with a transgenic line 
expressing green fluorescent protein (γGFP). The GFP levels in subsequent generations were 
decreased in the γGFP/γRNAi seeds, which was opposite to what we expected. In the second 
strategy, we generated a line (oxPBF) constitutively overexpressing the transcription factor 
prolamin-box binding factor (PBF) that plays regulatory roles to the 27-kDa γ-zein promoter. 
We intend to cross the oxPBF line with transgenic lines expressing the GFP or recombinant 
proteins driven by the 27-kDa γ-zein promoter. It is hoped that the PBF overexpression may 
enhance the production of foreign protein under the γ-zein promoter control.  
This work indicated that maize has the potential to produce recombinant proteins with 
mammalian-like post-translational modifications and can be used for open-field production 
when using a cytoplasmic male-sterile breeding system.      
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CHAPTER 1: INTRODUCTION 
1.1. General Introduction 
1.1.1. Brief history of plant molecular farming 
Plants, ranging in size from several millimeters to more than one hundred meters, 
provide us with food, fuel, fiber, and the most important element required to sustain our 
life—oxygen. But, people have been trying to obtain more from plants. As a result of  
fast developing biotechnology during past few decades, nowadays plants can be used to 
produce various heterologous proteins, including pharmaceutical and industrial proteins, 
through recombinant DNA technology, often referred to as plant molecular farming (Faye 
and Gomord, 2010; Ma and Wang, 2012; Obembe et al., 2011; Wilken and Nikolov, 
2012). In 1970, the first isolation of a restriction endonuclease, Hind III, was reported 
(Smith and Wilcox, 1970). This study opened the door for recombinant DNA technology. 
The 1978 Nobel Prize for Physiology or Medicine was awarded for this discovery. The 
first recombinant DNA experiment was reported by Cohen and Boyer in 1973, twenty 
years after the discovery of the DNA structure by Watson and Crick (Cohen et al., 1973). 
They cut a fragment of DNA from the plasmid of one E. coli and transferred it into 
another E. coli DNA. Today, DNA is not only able to be transferred, but also can be 
artificially synthesized. Plus, with developing transformation techniques, the choice of 
the expression system is no longer restricted to bacteria. Yeast, mammalian cell culture, 
transgenic animals, plant cell cultures, and transgenic plants are common hosts used to 
produce foreign proteins. In this thesis, I present strategies for producing recombinant 
proteins in plants by using maize as a model system.  
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1.1.2. Advantages of plants over other recombinant expression systems 
Plants are chosen because they are ideally suitable for producing recombinant 
proteins with many advantages over other systems (Ma et al., 2003). First, compared to 
the traditional microbial fermentation, plants are able to perform post-translational 
modifications, such as glycosylation and hydroxylation, which are required for biological 
activity of numerous mammalian proteins (Hood et al., 1997; Tremblay et al., 2010; Xu 
et al., 2011b). Second, plants, especially crops, can produce exogenous proteins on large 
scale at very low cost, since plant growth, transport, and post-harvest process 
requirements are relatively inexpensive (Fischer and Emans, 2000; Giddings, 2001). 
Third, unlike animal or microorganism systems, plant-derived products reduce 
contamination risk due to human pathogens (Ma et al., 2003; Streatfield et al., 2001). 
There are also drawbacks for transgenic plant production; one of the concerns is that the 
timescale of production is relatively long compared with plant or animal cell cultures and 
microorganisms (Ma et al., 2003).        
 
1.1.3. Plant-derived products 
After the first recombinant protein, human insulin, was approved as a drug by the 
United States Food and Drug Administration (FDA) in the 1980s, the demand for 
recombinant proteins, especially pharmaceutical proteins, dramatically increased (Ma and 
Wang, 2012). Almost at the same time, improved plant transformation techniques and 
strategies made the plant capable of being a recombinant protein expression system 
(Bevan et al., 1983). The first plant-derived recombinant pharmaceutical protein, a 
human growth hormone, was produced in transgenic tobacco in 1986 (Barta et al., 1986). 
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Not long after, the first plant-derived antibody was reported in 1989 (Hiatt et al., 1989). 
Then, the first plant-derived vaccine, hepatitis B virus surface antigen, was expressed in 
transgenic tobacco in 1992 (Mason et al., 1992). In 1997, the maize-derived recombinant 
avidin, an egg protein, became the first plant-derived recombinant protein for commercial 
purposes (Hood et al., 1997). The plant-derived recombinant products have now been 
extended to a broader area, which can be generally categorized into three groups (Xu et 
al., 2011a): 1) therapeutic proteins, such as antibodies (Lai et al., 2010; Ma et al., 1998), 
blood proteins (Sijmons et al., 1990), cytokines (Liu et al., 2009), growth factors (Parsons 
et al., 2010), growth hormones (Staub et al., 2000), and vaccines (Chikwamba et al., 
2002a; Chikwamba et al., 2002b; Shoji et al., 2008; Shoji et al., 2011; Takaiwa, 2009); 2) 
industrial enzymes, such as avidins (Hood et al., 1997; Murray et al., 2002), α-amylase 
(Pen et al., 1992), β-glucuronidase (Kusnadi et al., 1998), cellulase (Hood et al., 2012; 
Hood et al., 2007), laccase (Hood et al., 2003), and trypsin (Woodard et al., 2003); and 3) 
biopolymers, such as collagens (Ruggiero et al., 2000; Xu et al., 2011b; Zhang et al., 
2009a; Zhang et al., 2009b), elastin-like polypeptides (Conley et al., 2009), plant gum 
(Xu et al., 2005), and spider silk proteins (Menassa et al., 2004; Scheller et al., 2001; 
Yang et al., 2005).  
  
1.1.4. Seed-based expression 
Recombinant proteins are commonly expressed in plant seeds, including many 
cereal grains like barley, maize, rice, soybean, and wheat (Ramessar et al., 2008). 
Compared with leaf tissue, seeds are better for protein accumulation and storage (Boothe 
et al., 2010; Lau and Sun, 2009; Ma et al., 2003). Seeds have advantages of in-field 
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process and long-term storage. High expression of recombinant proteins has been 
achieved by using seed-targeting strategies up to 10% of total seed proteins (Clough et al., 
2006; Hood et al., 2007; Hood et al., 1997; Horvath et al., 2000; Woodard et al., 2003; 
Xie et al., 2008; Xue et al., 2003; Yang et al., 2006; Yang et al., 2008).  
 
1.1.5. Maize seed as an ideal production platform   
Maize is one of the world’s major crops, domesticated from teosinte more than 
5,000 years ago (Gewin, 2003). The United States produces approximately 40% of the 
world's maize. In 2011, the production of maize in the U.S. was 12 billion bushels 
(http://www.nass.usda.gov/). Maize not only provides food and feed, but is also an 
important bio-fuel resource. Over 90% of fuel ethanol is produced from maize (Wolt and 
Karaman, 2007). The United States Department of Energy (DOE) and United States 
Department of Agriculture (USDA) estimated that more than 30% of the U.S. 
transportation fuel needs could be displaced by renewable bio-fuel from cellulosic 
resources (Perlack et al., 2005). To reduce the U.S. reliance on foreign oil, the need for 
maize continues to increase. Using the maize seed as a production platform has an 
advantage that the maize grain waste after recombinant protein recovery can be used to 
produce fuel ethanol (Johnson et al., 2003). Typically, 99% of the grain mass remains as 
waste after the recombinant protein recovery (Paraman et al., 2010). Thus, the maize seed 
is an ideal production platform for coproduction of recombinant proteins and fuel ethanol 
in the United States. Strategies for expressing recombinant proteins in maize seeds are 
presented in Chapters 3, 4, 5, and 6 of this thesis. In addition to the advantages of using 
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the seed-targeting method described above, the maize stalk after harvest can be 
renewable bio-fuel resource. 
 
1.1.6. Challenges  
Although numerous studies have been published about producing recombinant 
proteins in maize seeds, there are still two major remaining challenges: 1) open-field 
release regulation of pharmaceutical maize and 2) low expression of recombinant 
products. Maize is a wind-pollinated plant, which means the pollen drifts with the wind 
and pollinates another plant. A major concern has been raised that transgenic maize could 
contaminate surrounding non-transgenic maize by pollen drift (Andow et al., 2004; 
Commandeur et al., 2003; Gressel, 2010). Open-field release of pharmaceutical plants is 
regulated by the U.S. Animal and Plant Health Inspection Service (APHIS). To overcome 
limitations of maize pollen drift, two strategies for producing pharmaceutical maize for 
open-field release are described in Chapter 5: 1) establishing biolistic- or Agrobacterium-
mediated transformation methods of a tissue culture-amenable male-sterile line, and 2) 
conventional breeding strategies of introgressing of a transgene from male-fertile to male 
sterile transgenic maize.. 
The low expression of recombinant proteins in transgenic plants is the main 
challenge to plant molecular farming (Ma and Wang, 2012). To obtain high yield of 
plant-derived biogenic products, various approaches have been developed to enhance the 
expression or stability of recombinant proteins. These strategies include choosing suitable 
promoters, co-expressing with transcription factors, adding 5’ and 3’UTR, optimizing 
codon usage, replacing signal peptide or other targeting sequences, adding ER 
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(endoplasmic reticulum) retention sequence, avoiding mRNA destabilizing sequences, 
fusing with endogenous proteins or tags, rebalancing seed storage protein, etc. (Egelkrout 
et al., 2012; Hood and Vicuna Requesens, 2011; Kermode, 2006; Kermode, 2012; Ma 
and Wang, 2012; Obembe et al., 2011). In Chapters 3, 4, and 6 of this thesis, strategies 
for improving recombinant protein expression in transgenic maize seeds are presented, 
including tissue-specific expression, promoter selection, protein fusion, ER retention, 
seed storage protein rebalancing, and co-expression of transcription factors.            
1.1.7. Hypothesis and Objectives  
The purpose of this dissertation research was to evaluate strategies that can lead to 
safe production of high yield and adequately modified recombinant proteins in maize 
seeds. We hypothesize that 1) maize has potential to generate mammalian-like exogenous 
proteins by co-expressing a transgene with an enzyme with post-translational 
modification activity; 2) small peptides, such as peptide biosurfactants, can be produced 
and purified with simple steps from maize seeds by fusing to tag proteins or maize 
endogenous proteins; 3) pharma corn (transgenic maize expressing proteins with 
pharmaceutical activities) can be safely and effectively produced in open fields by using 
male-sterile maize lines; and 4) recombinant protein expression enhanced in maize lines 
in which either production of one of the major seed protein is reduced or one of the 
transcription factors for seed protein is increased. To examine our hypotheses, the 
following four objectives were conducted: 
1. Produce hydroxylated recombinant human collagen type I alpha 1 in maize 
seeds with co-expression of recombinant human prolyl 4-hydroxylase 
(Chapter 3) 
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2. Express the peptide biosurfactant GAM1 in maize seeds by fusing to the red 
fluorescent protein (RFP) or maize seed storage protein 22-kDa α-zein 
(Chapter 4) 
3. Develop transformation of the tissue culture-amenable male-sterile maize and 
transfer the E-coli heat-labile enterotoxin B subunit (LT-B), a vaccine gene, 
from male-fertile to sterile-maize lines for open-field release (Chapter 5) 
4. Evaluate the expression of green fluorescent protein (GFP) in maize lines in 
which either a 27 kDa γ-zein seed protein is silenced or a transcription factor 
prolamin box-binding factor (PBF) is overexpressed (Chapter 6) 
 
1.2. Dissertation organization  
This dissertation includes seven chapters. Chapter 1 is a general introduction. 
Chapter 2 is a literature review with a broad view of recombinant protein production in 
plants. The review includes: 1) a brief history of using plants to produce foreign proteins; 
2) strategies to enhance the expression of recombinant proteins in plants; and 3) examples 
of producing exogenous proteins in transgenic maize. Chapters 1and 2 focus and explain 
the benefits and challenges of using transgenic plants, what kinds of plants are suitable, 
advantages of selecting tissue-specific expression and strategies to enhance production. 
Chapters 3 through 6 are four independent, but related, studies in journal paper 
format. Chapter 3 presents the expression and characterization of recombinant human 
collagen type I α 1 (rCIα1) in transgenic maize. This work shows that rCIα1 not only can 
be produced in maize seed, but also can be post-translationally modified by co-expressing 
with a recombinant human prolyl 4-hydroxylase (rP4H). By taking advantage of high-
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resolution mass spectrometry (HRMS), the rCIα1was determined a high proline 
hydroxylation ratio. The present study indicates that maize is able to produce 
recombinant protein with mammalian-like post-translational modifications. This work 
has been published in the journal BMC Biotechnology. The gene construction work and 
maize transformation were completed by FibroGen Inc. and ProdiGene, Inc. We 
performed the protein and proteomics analyses on transgenic seeds that were transferred 
to Iowa State University, especially the hydroxylation analysis by using liquid 
chromatography tandem mass spectrometry (LC-MS/MS) on a Linear Ion Trap Orbitrap 
(LTQ Orbitrap) Mass Spectrometer. My major professor, Dr. Kan Wang, and Dr. Julio 
Baez from FibroGen. Inc, co-designed the experiments. 
Chapter 4 describes efforts to express the biosurfactant peptide GMA1 in maize. 
Transgenic plants were successfully generated. However, the GAM1 was unable to be 
detected, possibly due to the low expression. 
Chapter 5 is a paper about strategies to produce maize-derived pharmaceutical 
proteins by using male-sterile lines. This paper provides two strategies suitable for 
producing pharmaceutical proteins and avoiding cross-contamination by transgenic maize 
in open-field. This work has been published in the journal, Maydica. Dr. Kan Wang 
designed and guided the experiments. My contributions to this paper were designing the 
breeding strategies, breeding and selecting the desired maize line in the greenhouse, 
analyzing the pollen viability, and conducting most field-release work.     
Chapter 6 presents strategies to improve recombinant protein expression in maize 
by knocking down one major maize seed storage protein 27-kDa γ-zein and over 
expressing the maize seed protein transcription factor prolamin box-binding factor (PBF). 
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While some preliminary work is completed, this work is still in progress and will be 
submitted to a peer reviewed journal. 
Chapter 7 is a general conclusion, summarizing all work described above. All 
projects presented in this dissertation are under the instruction and supervision by my 
major professor, Dr. Kan Wang. My POS committee members, Drs. Charles E Glatz, 
Martha James, Lawrence Johnson, and Paul Scott not only provided suggestions, but also 
shared materials and methods. Staff of the Protein Facility and the W.M. Keck 
Metabolomics Research Laboratory at Iowa State University helped me with the protein 
analysis performed for Chapters 3, 4 and 6. Dr. Lorena Moeller, who was graduate 
student and postdoctoral research associate in the Plant Transformation Facility, provided 
green fluorescent protein (GFP) transgenic corn and GFP enzyme-linked immunosorbent 
assay (ELISA) protocols used in Chapter 6. Bronwyn Frame, Marcy Main, Katey 
Warnberg and Rose Schick of the Plant Transformation Facility at Iowa State University 
did the maize transformation and greenhouse care for the constructs described in 
Chapters 4,5, and 6.       
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CHAPTER 2: LITERATURE REVIEW  
 
2.1. Approaches for recombinant protein expression in plants 
2.1.1. Production platforms: Leaf- and seed-based systems   
Plants have been used as important sources for producing recombinant proteins 
due to the development of plant transformation technology. Various proteins have been 
produced in both public and private laboratories during the past decades, including 
therapeutics, nutraceuticals, vaccine antigens, antibodies, and polymers (Arntzen et al., 
2005; De Muynck et al., 2010; Giddings et al., 2000; Ling et al., 2010; Mooney, 2009; 
Sala et al., 2003; Sharma and Sharma, 2009; Stoger et al., 2005; Wilken and Nikolov, 
2012). Plant production platforms for foreign proteins have been mainly agricultural 
crops such as tobacco, rice, and maize (Basaran and Rodrıguez-Cerezo, 2008; Fox, 2006; 
Wilken and Nikolov, 2012). Tobacco is the leading leaf-based protein expression system 
for commercial products (Twyman et al., 2003; Wilken and Nikolov, 2012). The first 
tobacco-derived commercial product was immunoglobulin A (IgA) (Ma et al., 1998). As 
a leaf-based system, tobacco can achieve high biomass yield with less pollen 
contamination risk than other seed-based systems, since the plant can be harvested before 
flowering (Wilken and Nikolov, 2012). Also, unlike the seed-based system, the process 
of extracting recombinant proteins from leafy plants does not require additional 
operations, such as seed grinding, soaking, and de-oiling (Schillberg et al., 2005). 
However, major disadvantages are significant in leafy plants like tobacco—high water 
content and low storage stability (De Muynck et al., 2010; Doran, 2006; Wilken and 
Nikolov, 2012). Although leaf-based systems are able to produce a high yield of 
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recombinant proteins, this yield may be offset by an increased instability of expressed 
proteins in metabolically active tissues, such as leaves (De Muynck et al., 2010; Doran, 
2006).         
The seed-based recombinant production platform offers several advantages over 
the leaf-based platform. Seeds are naturally designed for protein storage for long periods 
of time without or with very little degradation (Fischer et al., 2009; Kusnadi et al., 1997; 
Nikolov and Hammes, 2002). Seeds can be stored after harvest without cooling or 
immediate isolation that are required for leafy tissues (Boothe et al., 2010; Fiedler and 
Conrad, 1995; Hood et al., 1997; Lorenz and Kulp, 1991). The seed-based recombinant 
production platform has been used to produce various pharmaceutical or industrial 
products, including cytokines, antibodies, vaccines, and enzymes (Chikwamba et al., 
2002a; Chikwamba et al., 2002b; Nochi et al., 2007; Stoger et al., 2000; Streatfield and 
Howard, 2003; Wu et al., 2007; Zhu et al., 1994). Compared to the leaf-based platform, 
seeds have a relatively lower biomass and higher cross-contamination risk by pollen drift 
for non-self-pollinated plants. However, considering the stability of foreign proteins, 
post-harvest processing, and overall cost, the seed-based platform is still more suitable 
for many recombinant proteins production on a large scale (Nikolov and Hammes, 2002; 
Schillberg et al., 2005). 
 
2.2.1. Cis-elements considerations 
2.2.1.1. Promoters  
Gene expression in plants is regulated at different levels. The selection of the 
promoter is the first thing to consider before making the construct. Promoter elements can 
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dramatically affect the level of messenger RNA and, thus, influence the accumulation of 
the protein (Ma and Wang, 2012). To obtain high transcription levels, many constitutive 
promoters have been used to drive the transgene. The most widely used promoter is the 
cauliflower mosaic virus (CaMV) 35S promoter (Odell et al., 1985). This viral promoter 
is strong in many dicotyledonous plant species and has been used to produce a number of 
pharmaceutical proteins with relatively high expression (Tremblay et al., 2010; Twyman 
et al., 2003). However, the 35S promoter is much weaker in monocotyledonous plants, 
although it is still often used to drive maker genes for selection (Hood and Vicuna 
Requesens, 2011; Ma and Wang, 2012). In dicotyledonous plants, strong constitutive 
promoters, such as rice actin-1 or maize ubiquitin-1, are more frequently used for 
expressing foreign proteins (Streatfield, 2007; Twyman et al., 2003). To avoid toxicity to 
host plants from the exogenous genes or to obtain expression in a particular tissue of the 
plant avoiding protein degradation, tissue-specific promoters should be considered for 
use. Examples of tissue-specific promoters include zein (from maize), glutenin (from rice 
and wheat), and legumin (from pea) promoters (Ma et al., 2003). Many pharmaceutical 
proteins have been expressed with tissue- or organ-specific promoters, such as vaccine 
antigen HBsAg M, murine single chain variable fragment G4, human interferon-α, and 
the heat labile enterotoxin (LT) B subunit of Escherichia coli (E. coli) (Chikwamba et al., 
2002a; Chikwamba et al., 2002b; De Jaeger et al., 2002; He et al., 2008). However, even 
the same promoter can result in different protein accumulation patterns within different 
species (Stoger et al., 2002). So, it is important to choose a suitable promoter for the 
specific system. 
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2.2.1.2. Codon usage 
Different species have different codon usage ratios for a specific amino acid, 
according to the supply of the tRNAs for that amino acid (Ikemura, 1985). Codon usage 
should be considered when a transgene is expressed in a host plant with different codon 
use frequency to achieve optimal expression levels. Nowadays, codon optimization is a 
standard practice for transgene expression. Many codon optimization programs are 
available on the Internet based on the analysis of sequences available for a given species 
(Liu and Xue, 2005; Streatfield et al., 2001b): 1) DNAWorks 
http://helixweb.nih.gov/dnaworks/ (Hoover and Lubkowski, 2002); 2) Gene Designer 
https://www.dna20.com/ (Villalobos et al., 2006), 3) GeneDesign 
http://genedesign.thruhere.net/gd (Richardson et al., 2006), and 4) OPTIMIZER 
http://genomes.urv.cat/OPTIMIZER/  (Puigbo et al., 2007).  
2.2.1.3. Subcellular targeting 
Subcellular targeting is an alternative strategy to enhance the expression of 
exogenous proteins by avoiding protein degradation caused by proteases in the host plant. 
Recombinant proteins can be targeted to the cell wall, the vacuole, the mitochondria, and 
the chloroplast by fusing with different targeting signal. If a targeting signal sequence is 
not designed, the recombinant protein may be released in the cytoplasm where the protein 
could be degraded by proteases (Hood and Vicuna Requesens, 2011). The endoplasmic 
reticulum (ER) is the entry point for the protein secretory pathway, where many 
endogenous proteins or even foreign proteins can assemble (Lau and Sun, 2009; Nuttall 
et al., 2002). The ER is also a protective environment for recombinant proteins, since 
fewer proteases are found there (Hood and Vicuna Requesens, 2011). Additionally, 
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recombinant proteins can be modified at the post-translational level such as glycosylation 
(Ma et al., 2003). All these benefits make the ER an ideal target compartment for 
recombinant proteins. The ER retention sequences, such as KDEL (Lys-Asp-Glu-Leu) or 
HDEL (His-Asp-Glu-Leu), are used to keep recombinant proteins within the ER. This 
strategy has significantly enhanced the expression of foreign proteins in transgenic plants 
(Ko et al., 2003; Ma et al., 2005; Vaquero et al., 2002). 
2.2.1.4. UTRs  
The 5’- and 3’-UTRs (untranslated region) are important to the stability of the 
mRNA. Replacing the 5’-UTR and signal peptide of the human α-iduronidase gene with 
the arcelin gene increases mRNA and protein levels of α-iduronidase, and results in 
increased α-iduronidase’s activity as well (Kermode, 2006). The extremely short 5’-
UTRs (< 20 nucleotides) may inhibit the formation of the ribosome complex or the 
recognition of the start codon (Kawaguchi and Bailey-Serres, 2005; Kozak, 1991). The 
GC content is another crucial factor of the 5’-UTR. A low GC content (< 33 %) of the 5’-
UTR is preferred while high GC content (> 50 %) inhibits ribosome loading (Kawaguchi 
and Bailey-Serres, 2005). Using the arcelin gene’s 3’UTR and flanking sequences 
increase the activity of the α-iduronidase, as well as adding the 5’-UTR (Kermode, 2006). 
The highest expression level of the α-iduronidase was achieved by using the 5’- and 3’-
UTRs, as well as the signal peptide sequence of the arcelin gene (Kermode, 2006). 
Although translation depends on the interaction between the 5’ cap and 3’ poly A, the 3’-
UTR region is very critical to controling the stability of the mRNA for some plant genes 
(Chan and Yu, 1998; Gil and Green, 1996). 
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2.2.1.5. Protein fusion and tags 
Protein fusion approaches are effective for boosting the expression, increasing 
solubility and stability, and facilitating isolation and purification of recombinant proteins 
(Hondred et al., 1999). Several fusion proteins have been developed and used to increase 
the production of recombinant proteins in plants. Zera is maize seed storage protein γ-
zein derived proline-rich N-terminus domain, which has self-assembling and protein 
body formation properties (Ma and Wang, 2012). The expression of F1-V hybrid vaccine 
antigens increased 3 times, when fused with Zera in N. benthamiana, Medicago sativa 
(alfalfa) and N. tabacum NT1 cells (Alvarez et al., 2010). Another successful fusion 
partner example is elastin-like polypeptides (ELPs), which are artificially-designed 
biopolymers (Urry, 1992). ELP fusion proteins increase the expression of recombinant 
proteins in plants, including human IL-10 and murine interleukin-4, the full-size anti-
human immunodeficiency virus type 1 antibody 2F5, and anti-foot and mouth disease 
virus single variable antibody fragments (Floss et al., 2008; Joensuu et al., 2009; Patel et 
al., 2007).  
Affinity tags are used to facilitate the purification and quantification of 
recombinant proteins, especially when there is no antibody for the target protein. An ideal 
affinity tag should be small to allow the high yield and purity of the target protein after 
purification (Terpe, 2003). A widely used affinity tag example is the poly-histidine tag or 
6XHis, since it usually consists of six consecutive histidines. The His-tagged proteins 
have inexpensively achieved high yield with large volume in bacterial systems, but are 
not very successful in plant systems due to the high background (Sharma and Sharma, 
2009). Another frequently used affinity tag example is StrepII, consisting of eight amino 
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acids (WSHPQFEK). It was used to purify membrane-anchored protein kinase, 
NtCDPK2 from N. benthamiana with high yield by one-step using StrepII-Tactin column 
(Witte et al., 2004). Although affinity tags are usually very small, they still could affect 
the target protein’s folding and normal functions. The FLAG tag system was designed to 
solve this problem. FLAG tag contains eight amino acids (DYKDDDDK) and can be 
released from the fusion protein by enterokinase treatment (Maroux et al., 1971). The 
purity of isolated FLAG-tagged protein was about 90% (Schuster et al., 2000). Other 
commonly used affinity tags include c-myc, glutathione S-transferase, calmodulin-
binding peptide, maltose-binding protein, and the cellulose-binding domain (Terpe, 2003). 
There are numerous purification and quantification kits commercially available for these 
tags, which facilitate the expression and down-stream characterization of recombinant 
proteins. 
     
2.2.2. Transcription factors 
2.2.2.1. Regulation in plants by transcription factors 
Plant genes are under the control of different factors like most eukaryotes. 
Transcription factors, known as a group of proteins recognizing particular DNA 
sequences in the promoter region of genes, usually affect the transcription of genes 
through protein-protein interaction activating RNA polymerase II (Grotewold, 2008). 
Based on the conserved folds in the DNA binding domains, transcription factors are 
categorized into more than fifty different families (Riechmann and Ratcliffe, 2000).   
The regulatory activity of most transcription factors are affected by histone 
modifications and the chromatin structure (Kouzarides, 2007). With increasing 
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knowledge, it has been realized the regulation of the transcription factors are complicated 
when associated with the plant metabolism network, especially related to chromatin 
functions (Hernandez et al., 2007).  
With the development of plant functional genomics, gene regulation by 
transcription factors has been discovered—especially in Arabidopsis thaliana, rice, and 
maize (Alonso and Ecker, 2006; Pastori and Foyer, 2002; Shinozaki and Yamaguchi-
Shinozaki, 2000). In Arabidopsis thaliana, many transcription factors, as well as their 
regulating metabolic pathways, have been identified, for instance, PAP1/PAP2 (R2R3-
MYB) regulate anthocyanin biosynthesis (Borevitz et al., 2000) and 
AtMYB12/AtMYB11/AtMYB111 regulate flavonol accumulation (Mehrtens et al., 2005; 
Stracke et al., 2007). TT2 (R2R3-MYB) and TT8 (bHLH) together are under the 
regulation of seed coat proanthocyanidins (Nesi et al., 2000; Nesi et al., 2001). In maize, 
it was determined P1 (R2R3-MYB) regulates phlobaphene accumulation (Grotewold et 
al., 1994), and C1/PL1 (R2R3-MYB) and R/B (bHLH) together are under the regulation 
of  anthocyanins (Hernandez et al., 2004).   
Since transcription factors are involved in many plant metabolic pathways, 
regulations, strategies, or technologies using transcription factor-based mechanisms will 
be part of the next generation of successful biotechnology-derived plants (Century et al., 
2008). The production of isoflavones was increased in tobacco, Arabidopsis thaliana, and 
maize by over-expression of PAP1 and anthocyanidin reductase (ANR) (Xie et al., 2006), 
and co-expression of the flavonoid regulators with isoflavone synthase (IFS) (Yu et al., 
2000). The expression of isoflavones was also successfully boosted in soybean by 
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expressing a synthetic regulator CRC (fused from maize C1 and R) and eliminating the 
endogenous F3H (Yu et al., 2003).  
To enhance the production of recombinant proteins in transgenic maize, using 
transcription factors is one of the strategies presented in this dissertation. Two maize seed 
protein transcription factors, O2 and PBF, are described in detail below. 
2.2.2.2. Transcription factors in maize: O2 
In the 1920s, a natural maize mutant opaque-2 (o2) was discovered with a seed 
phenotype change from glassy to opaque under light (Mertz et al., 1964). Major maize 
seed storage proteins, zeins, are reduced by 60 to 80% in o2 (Aukerman et al., 1991). In 
maize seed endosperm, about 60% of the total protein are zeins (Mertz et al., 1964). 
Zeins can be classified into four groups—α-, β-, γ, and δ-zeins. Zein reduction in o2 
resulted from the suppression of the 22-kDa α-zein, so it was hypothesized the 22-kDa α-
zein gene is regulated by O2, which may encode a transcription factor activating the 22-
kDa α-zein gene expression (Burr and Burr, 1982; Kodrzycki et al., 1989; Pedersen et al., 
1980; Soave et al., 1981).  
The O2 gene was identified and cloned (Motto et al., 1988; Schmidt et al., 1987). 
The cDNA of O2 was sequenced, indicating the O2 encoded protein consists of a leucine-
zipper DNA binding motif (Hartings et al., 1989; Landschulz et al., 1988; Schmidt et al., 
1990), which recognizes the specific sequence of the target DNA (Neuberg et al., 1989; 
Turner and Tjian, 1989). This domain with the leucine repeat has been named bZip 
domain (Vinson et al., 1989). O2 is able to bind with the promoter of the 22-kDa α-zein 
gene and the bZip domain in O2 is responsible for this binding (Aukerman et al., 1991; 
Schmidt et al., 1990). The O2 binding site in the 22-kDa α-zein DNA gene was identified 
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and only found in the 22-kDa α-zein gene and not other distantly related zein genes, 
which explains the specific effect on the expression of 22-kDa α-zein in the o2 mutant 
(Schmidt et al., 1992). Non-zein proteins increased in o2, which improved the nutrition of 
maize seeds, since zeins lack lysine, an essential amino acid (Coleman and Larkins, 1999; 
Osborne et al., 1914). However, the o2 mutant is more susceptible to diseases associated 
with low yield, which limit further applications.   
2.2.2.3. Transcription factors in maize: PBF 
Prolamins are the most abundant cereal storage proteins with high proline content 
and found in many grains, such as wheat (gliadin), barley (hordein), rye (secalin), 
sorghum (kafirin), and maize (zein) (Shewry and Halford, 2002). Prolamins are generally 
soluble only in strong alcohol solutions. The expression of prolamins appears to be highly 
regulated by both cis-elements and transcription factors (Marzabal et al., 2008). Several 
endosperm boxes are conserved in prolamin genes. In maize, a 7 bp prolamin box has 
been identified: p-box (5’-TG(T/C/A)AAAG-3’) (Boronat et al., 1986; Ottoboni et al., 
1993; Thompson and Larkins, 1989). The P-box motif is recognized by the Dof 
transcription factors so-called PBFs (prolamin-box binding factors) (Mena et al., 1998; 
VicenteCarbajosa et al., 1997; Yanagisawa, 2004).  
Dof (DNA binding with one finger) domain proteins are transcription factors 
specifically found in plants with highly conserved DNA-binding domains, including a 
single C2-C2 zinc finger (Umemura et al., 2004; Yanagisawa, 2002; Yanagisawa, 2004). 
The maize PBF interacts with prolamin box motifs in vitro with maize 22-kDa α-zein 
gene promoter (VicenteCarbajosa et al., 1997). The maize 27-kDa γ-zein promoter 
contains four prolamin boxes (Pb1, Pb2, Pb3, and Pb4) (Marzabal et al., 1998), which 
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could possibly be recognized by PBF. A recent study confirmed that only the 27-kDa γ- 
and 22-kDa α-zein gene expressions were affected when the PBF expression was 
knocked down by RNAi (RNA interference) (Wu and Messing, 2012a). By co-expression 
with PBF, the 27-kDa γ-zein promoter has been enhanced seven times stronger in tobacco 
(Marzabal et al., 2008). Thus, using transcription factors to enhance the target promoter 
can be a good strategy to increase the expression of recombinant proteins in plants.   
 
2.2.3. Major seed protein gene silencing  
Plant seeds have the ability to rebalance nutrition components after some major 
protein is eliminated. In the maize o2 mutant, non-zein proteins have increased, while 
zeins are reduced significantly, resulting in improved maize seed nutritional quality 
(Coleman and Larkins, 1999). In cotton, the RNAi mediated knock-down of two key fatty 
acid desaturase genes leads to the increase of high-oleic and high-stearic cotton seed oil, 
essential fatty acids for human heart health (Liu et al., 2002). In soybean, while the 
expression of α and α’ subunits of β-conglycinin is suppressed by sequence-mediated 
gene silencing in seeds, another soybean seed storage protein glycinin is increased to 
balance the total seed protein (Kinney et al., 2001), and the glycinin driven GFP 
expression was increased by 3.5-4.0 fold when introgressed into the β-conglycinin 
suppression line compared to the parent line (Schmidt and Herman, 2008).  
Therefore, a strategy is raised to improve the nutritional quality or to enhance the 
expression of recombinant proteins in seeds, using the gene silencing mechanism to 
reduce a major seed protein gene (Kermode, 2006). In Arabidopsis thaliana, a transgene 
arcelin5-I from Phaseolus vulgaris increased up to 15% of the total soluble protein of the 
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seed when the endogenous seed storage protein 2S albumin is silenced by antisense 
(Goossens et al., 1999). A similar approach was also achieved in rice suspension culture. 
The recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) 
increased by 1.9 fold with 22% reduction of α-amylase by RNAi (Kim et al., 2008).  
Two major maize seed storage proteins, α- and γ-zeins, have been silenced by 
antisense or RNAi methods (Huang et al., 2004; Segal et al., 2003; Wu et al., 2010; Wu 
and Messing, 2012b). Non-zein proteins increased in these transgenic maize lines and 
seed nutritional quality improved high-lysine maize (Houmard et al., 2007). However, 
although recombinant proteins are commonly produced in transgenic maize, the seed 
protein gene silencing strategy has yet to be been adopted to improve the expression of 
recombinant proteins in transgenic maize. Chapter 5 focuses on use of such a strategy.                
 
2.2. Case study: Recombinant protein expression in transgenic maize 
2.2.1. Human collagen type I α 1 
Collagens are the most abundant proteins in mammals and have been widely used 
in food and pharmaceutical industries (Olsen et al., 2003). More than one-half million 
metric tons of collagen and its denatured form, gelatin, are used in medical applications 
annually (Ritala et al., 2008). Current sources of collagen and gelatin are all animal 
collagen-rich tissues (Eskelin et al., 2009). With increasing public concerns for animal-
derived collagen and gelatin safety issues (Asher, 1999), alternative non-animal-derived 
recombinant collagen expression systems have been developed, such as mammalian cells 
(Geddis and Prockop, 1993), insect cell cultures (Myllyharju et al., 1997), yeast (Vuorela 
et al., 1997), and plant cell culture (Ritala et al., 2008).  
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With advantages of low cost, high capacity, low contamination risk, and 
inexpensive storage, the transgenic plant system would be suitable for producing 
recombinant collagens (Ma et al., 2003; Menkhaus et al., 2004). Human collagen type I is 
the most abundant collagen type in the human body, containing two α 1 (CIα1) and one α 
2 (CIα2) chains (Van der Rest and Garrone, 1991). The recombinant human collagen type 
I α 1 (rCIα1) has been expressed in tobacco (Ruggiero et al., 2000), barley (Eskelin et al., 
2009), and maize (Xu et al., 2011; Zhang et al., 2009a; Zhang et al., 2009b).  
The mature human CIα1 in human bodies is hydroxylated by human prolyl 4-
hydroxylase (Van der Rest and Garrone, 1991). Thus, it is a challenge to express rCIα1 in 
the non-mammalian expression system. Plants have no or very low hydroxylation activity 
on CIα1. In Chapter 2, we present work showing maize has the ability to hydroxylate 
rCIα1 if recombinant human prolyl 4-hydroxylase is co-expressed with collagen. 
 
2.2.2. GAM1 
Biosurfactants are bio-derived molecules that lower the surface tension between 
two liquids, or between a liquid and a solid (Das et al., 2008). Biosurfactants are 
sustainable alternatives to fossil fuel-based surfactants (Clapes and Infante, 2002; Kaar et 
al., 2009; Van Hamme et al., 2006). Petroleum-based surfactants are not environmentally 
friendly and their prices are directly affected by oil prices. Therefore, in recent decades 
biosurfactants have been developed and applied in biomedical, pharmaceutical, 
environmental, and food industries (Banat et al., 2010; Nitschke and Costa, 2007; Singh 
et al., 2007).  
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GAM1 is an interfacially active designed peptide biosurfactant. Such peptide 
biosurfactants have been recently reported to have advantages of lowering the interfacial 
tension and control of interfacial rheology (Dexter et al., 2006; Dexter and Middelberg, 
2007; Malcolm et al., 2006). GAM1 is a 22 amino acid peptide (sequence 
GMKQLADSLHQLARQVSRLEHA) modified from a previously reported stimuli-
responsive peptide biosurfactant AM1 (Dexter et al., 2006; Dexter and Middelberg, 2008; 
Kaar et al., 2009). GAM1 has been successfully expressed in E. coli as a fusion to a 
maltose-binding protein with surface activity and the ability to trigger a switch between 
form-stabilizing and form-destabilizing states (Kaar et al., 2009). In Chapter 3, attempts 
to produce GMA1 in transgenic maize via fusion of the red fluorescent protein (RFP) and 
maize seed endogenous protein 22-kDa α-zein are presented. 
 
2.2.3. Heat-labile enterotoxin B subunit (LT-B) 
Enterotoxigenic E. coli (ETEC) colonizes in the large intestine of human beings 
(Hudault et al., 2001) and can cause severe diarrhea (Williams et al., 1999). The heat-
labile enterotoxin from E. coli is about 84 kDa containing a 27 kDa toxic A subunit non-
covalently linked to a ring shaped pentamer composed by five identical non-toxic 11 kDa 
B subunits. Thus, the B subunit of the heat-labile enterotoxin (LT-B) is an excellent 
choice as a potential vaccine against the toxin causing diarrhea, since the B subunit can 
induce secretory IgA and serum IgG (Millar et al., 2001). The recombinant LT-B has 
been produced in a variety of plants, including transgenic maize, tobacco, potato, and 
ginseng plants (Chikwamba et al., 2002a; Chikwamba et al., 2002b; Kang et al., 2006; 
Kang et al., 2003; Mason et al., 1998; Streatfield et al., 2001a). Especially, the benefits of 
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producing antigens as edible vaccines have been shown (Ramessar et al., 2008; 
Streatfield, 2007). The feeding experiments with mice indicated diarrhea symptoms 
induced by E. coli toxins in mice could be reduced by feeding maize-derived LT-B 
(Chikwamba et al., 2002a).  
However, the open-field released transgenic plants producing pharmaceuticals, 
such as the LT-B, may meet challenges from potential health and environmental risks 
associated with its use. The major concern is whether maize-derived antigens will 
contaminate the food chain (Ripplinger et al., 2009). The pollen drift from maize could 
be considered a potential contamination source. Thus, in Chapter 4, we present strategies 
to overcome this challenge by using a tissue culture-amenable male-sterile maize line.  
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CHAPTER 3: HYDROXYLATION OF RECOMBINANT HUMAN COLLAGEN TYPE I 
ALPHA 1 IN TRANSGENIC MAIZE CO-EXPRESSED WITH A RECOMBINANT HUMAN 
PROLYL 4-HYDROXYLASE 
 
Modified from a paper published in BMC Biotechnology 2011, 11:69 
 
Xing Xu, Qinglei Gan, Richard C. Clough, Kameshwari M. Pappu, John A. Howard, 
Julio A. Baez, Kan Wang 
Abstract   
Background Collagens require the hydroxylation of proline (Pro) residues in their 
triple-helical domain repeating sequence Xaa-Pro-Gly to function properly as a main 
structural component of the extracellular matrix in animals at physiologically relevant 
conditions.  The regioselective proline hydroxylation is catalyzed by a specific prolyl 4-
hydroxylase (P4H) as a posttranslational processing step.   
Results A recombinant human collagen type I α-1 (rCIα1) with high percentage of 
hydroxylated prolines (Hyp) was produced in transgenic maize seeds when co-expressed 
with both the α- and β- subunits of a recombinant human P4H (rP4H).  Germ-specific 
expression of rCIα1 using maize globulin-1 gene promoter resulted in an average yield of 12 
mg/kg seed for the full-length rCIα1 in seeds without co-expression of rP4H and 4 mg/kg 
seed for the hydroxylated rCIα1 (rCIα1-OH) in seeds with co-expression of rP4H.  High-
resolution mass spectrometry (HRMS) analysis revealed that nearly half of the collagenous 
repeating triplets in rCIα1 isolated from rP4H co-expressing maize line had the Pro residues 
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changed to Hyp residues.  The HRMS analysis determined the Hyp content of maize-derived 
rCIα1-OH as 18.11%, which is comparable to the Hyp level of yeast-derived rCIα1-OH 
(17.47%) and the native human CIa1 (14.59%), respectively.  The increased Hyp percentage 
was correlated with a markedly enhanced thermal stability of maize-derived rCIα1-OH when 
compared to the non-hydroxylated rCIα1.   
Conclusions This work shows that maize seed has potential to produce adequately 
modified exogenous proteins with mammalian-like post-translational modifications that may 
be require for their use as pharmaceutical and industrial products. 
 
Background  
Collagen is the most abundant protein found in animals.  It has been used widely for 
industrial and medical applications such as drug delivery and tissue engineering [1, 2].  
Human type I collagen is the most abundant collagen type in the human body and is also one 
of the most studied collagen types.  It is a heterotrimer composed of two α1 (CIα1) and one 
α2 (CIα2) chains with the helical region composed by a repeating composition of Xaa-Yaa-
Gly, where X and Y are typically proline (Pro) and hydroxyproline (Hyp) [3].  Collagens 
used commercially are traditionally extracted from animal tissues.  These products contain 
different types of collagen and may be contaminated with potential immunogenic and 
infective agents considered hazardous to human health.  Thus, recombinant technology has 
been developed to produce high quality and animal derived contaminant-free collagens.  
Recombinant collagens have been produced in mammalian cells [4], insect cell cultures [5], 
yeast [6], and plant cell culture [2, 7].   
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Transgenic plant systems have advantages over other recombinant production 
systems in terms of lower cost, higher capacity, lower infective agents/toxins contamination 
risk, and inexpensive storage capability facilitating processing[8, 9].  The production of plant 
derived recombinant collagen I α-1 (rCIα1) was reported in 2000 using tobacco [10] and 
tobacco cell culture [2].  The rCIα1 was also expressed in transgenic maize seed [11, 12] and 
barley [13]. 
A challenge for producing rCIα1 in non-mammalian expression systems is the 
resulting low regioselective hydroxyproline content that makes the product unstable at 
physiologically relevant temperatures.  In humans the 4-hydroxyproline residues synthesized 
by prolyl 4-hydroxylases (P4Hs) increase the stability of the collagen triple helix structure 
[14].  The stability of the collagen is increased with the presence of the hydroxyproline 
primarily through stereoelectronic effects [15].  On the other hand, the hydroxyproline 
content for the rCIα1 is almost zero in transgenic tobacco[10], or very low in transgenic 
maize [11] when rCIα1 is not co-expressed with P4H.  Since the insect, microbial and plant 
endogenous P4Hs are not able to achieve the same level of hydroxylation of rCIα1 as present 
in the human CIα1 chain, the co-expression with collagen of a recombinant animal P4H 
(rP4H) is necessary to increase the hydroxyproline content of the rCIα1 to deliver a stable 
product.  In tobacco, co-expression of P4H with an α subunit from C. elegans and a β subunit 
from mouse [16] or a recombinant human P4H [17] led to increased hydroxyproline levels of 
the rCIα1.  Similar results were seen in tobacco cell culture [2].  However, the tobacco-
derived collagen still had lower Hyp content compared to native human CIα1 making this 
product unsuitable for use in many applications.  
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In this study, we generated transgenic maize lines expressing the human rCIα1 gene 
alone or lines co-expressing both rCIα1 and rP4H genes.  Using high-resolution mass 
spectrometry (HRMS) analysis, we measured the percentages of Hyp and Pro residues in the 
rCIα1 protein extracted from transgenic maize seeds as well as the actual positions of 
hydoxylated prolines.  We also performed in vitro pepsin treatment at different temperatures 
to compare the thermal stabilities of maize-derived hydroxylated or non-hydroxylated rCIα1 
proteins.  Here, we report for the first time that by co-expressing rP4H genes, maize can 
produce rCIα1 with a hydroxyproline content comparable to native human type I collagen.  
This achievement provides further confirmation that maize seeds can be used to produce 
exogenous proteins that require mammalian-like posttranslational modifications for use in 
specific applications.  
 
Results  
Generation of maize lines expressing rCIα1 with and without rP4H co-expression in 
seeds  
The constructs used in this study are shown in Figure 1.  The CGB construct carries a 
gene encoding a recombinant full-length human collagen type I, rCIα1, and the CGD 
construct carries the rCIα1 gene and both α and β subunits of recombinant human prolyl 4-
hydroxylase, rP4Hα and rP4Hβ.  The rCIα1 gene was partially maize codon-optimized and 
its expression was driven by a maize embryo specific globulin-1 promoter (Pglb, [18]).  A 
barley alpha amylase signal sequence (BAASS, [19]) was used as a substitute for the human 
CIα1 signal peptide (UniProtKB/Swiss-Prot: P02452[1-22],).  The combination of embryo 
specific promoter and the BAASS has demonstrated high expression of foreign proteins in 
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maize seed [20-22].  The rCIα1 gene lacks the N-propeptide but contains the telopeptide 
sequences both at the N and C terminal regions.  A 29 amino acid bacteriophage T4 fibritin 
foldon peptide sequence [23] was fused at the C-terminus to the rCIα1 replacing the C-
propeptide.  The foldon, as the native C-propeptide, facilitates the rCIα1 triple-helical 
assembly and enhances its stability [23].  To avoid undesired DNA rearrangement caused by 
using identical sequences (such as using same promoters for multiple gene expression in 
single construct), we chose to use the maize ubiquitin promoter (Pubi, [24]) to drive the 
expression of α and β subunits of rP4H.  It was shown previously that there is a preferential 
accumulation of recombinant protein in germ tissue using the ubiquitin promoter[25].   
Both constructs were introduced into maize Hi II germplasm using immature embryo 
via an Agrobacterium-based transformation system.  Twelve independent transgenic events 
for CGB and 21 events for CGD, respectively, were recovered and brought to maturity in the 
greenhouse using pollen donors from an elite inbred.  Initial transgene expression screens 
were conducted on both callus and T1 seeds using an enzyme-linked immunosorbent assay 
(ELISA) to detect the expression of rCIα1, and α and β subunits of rP4H.  T2 seeds from 
events with the highest transgene expressions were produced by self pollination.   
For T1 seed analysis, seeds from multiple plants derived from each event were 
analysed.  In depth molecular and biochemical characterizations of rCIα1 described in this 
study were performed on T2 seeds from one selected CGB and CGD event, respectively.  
Individual seeds of the transgenic events were analyzed by polymerase chain reaction (PCR) 
to separate transgene positive seeds from negative ones.  Positive seeds were pooled and 
analyzed by ELISA for the expression of the rCIα1.  Negative null segregant seeds were used 
as controls.  
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The average expression level of rCIα1 measured by ELISA in event CGB was 1.86 ± 
1.26 mg/g of total soluble protein (TSP) or 12.14 ± 8.06 mg/kg of dry seed weight (DSW).  
The highest rCIα1 content measured to date from a single CGB seed was 3.54 mg/g TSP or 
25.11 mg/kg DSW.  The average expression level of the rCIα1 in event CGD was about four 
times lower than that of in event CGB, which was 0.58 ± 0.26 mg/g TSP or 4.40 ± 2.09 
mg/kg DSW.  The highest rCIα1 expression in single CGD seed was 0.92 mg/g TSP or 7.54 
mg/kg DSW.  
Figure 2 shows the detection of rCIα1 in the total protein extracts from CGB and 
CGD seeds.  Because of the low expression level of rCIα1 in CGD seeds, we concentrated 
the extract using an Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-30 membrane (cat 
# UFC903008, Millipore) before loading on the gel.  Figure 2 shows that rCIα1 could be 
detected from both CGB and CGD protein samples using anti-foldon antibody.  No cross-
reacting band at a similar position could be detected in non-transgenic maize seeds (data not 
shown).  It was observed that the CGB rCIα1 migrated faster than its CGD counterpart 
(Figure 2, open arrow in Lane CGB vs solid arrow in Lane CGD), suggesting different 
electrophoretic mobility for these two proteins.  To exclude that the observed protein 
migration difference was due to lane shifts during electrophoresis, we mixed the TSPs from 
both CGB and CGD before loading on the gel.  Lane CGB+CGD of Figure 2 shows there are 
two distinct major bands that cross-reacted with anti-foldon antibody.  This result indicates 
that the rCIα1 proteins derived from maize CGB and CGD events have different 
electrophoretic mobility, with CGD rCIα1 moves slower than CGB rCIα1.  The altered 
electrophoretic mobility may reflect the increase in molecular weight of rCIα1 that due 
partially to increased numbers of hydroxylated proline in rCIα1 from CGD event, which is 
60 
 
 
also co-expressing the rP4H genes.  The difference in electrophoretic mobility can also been 
seen in Pichia-derived rCIα1 (Figure 2, FE291) and hydroxylated rCIα1 (Figure 2, FE285).  
The expression of the β subunit of rP4H in the CGD seeds was verified by Western 
Blotting with an anti P4Hβ monoclonal antibody (Figure 3).  A main band at ~60 kD (open 
triangle, Figure 3) was detected in CGD, but not in CGB and non-transgenic wild type maize 
control, as expected.  A weak secondary band detected in CGD is likely due to cross-
reactivity of other forms of rP4Hβ in maize.  The detection of α subunit of P4H was 
performed in transgenic callus but not in seeds (data not shown).  
To determine whether rCIα1 can also be detected in tissues other than seeds, we 
performed both protein and transcript analyses of rCIα1 in CGB and CGD plants.  Maize leaf 
samples from 5 different development stages were collected.  Total RNA and proteins were 
prepared from these tissues and subjected to Reverse Transcriptase PCR (RT-PCR) and 
ELISA, respectively.  No detectable rCIα1 transcript and protein could be observed in these 
samples (data not shown), suggesting that the rCIα1 is not expressed in leaf tissue in both 
lines as expected. 
Co-expression of rP4H increases the hydroxylation of rCIα1  
To examine the percentage and positions of the prolines that were hydroxylated by 
the co-expression of rP4H in the CGD event, we carried out proteomics analysis of gel 
purified rCIα1 using liquid chromatography tandem mass spectrometry (LC-MS/MS) on the 
Linear Ion Trap Orbitrap (LTQ Orbitrap) Mass Spectrometer, a high resolution mass 
spectrometry (HRMS).  The HRMS not only can verify the amino acid sequence of the rCIα1, 
but also can identify the positions of hydroxylated proline residues (Hyp).  In addition to 
maize-derived rCIα1 proteins from CGB and CGD, we also included three control samples: 
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gel isolated CIα1 fragment from human collagen (cat # 234138, CalBiochem Inc), Pichia-
derived rCIα1 (isolated from strain FE291 that does not co-express rP4H) and Pichia-derived 
hydroxylated rCIα1 (isolated from strain FE285 that co-express rP4H) (FibroGen).  
Results are summarized in Figure 4 and Table 1.  The protein sequence coverage by 
the HRMS (yellow highlighted sequences in Figure 4) on the five samples ranged from 58.66% 
(human CIα1) to 85.81% (Pichia CIα1-OH).  To compare the percentages and positions of 
Hyp in each sample, we chose the peptide regions in all five CIα1 proteins (475 AA) that 
were covered by the HRMS (red boxes in Figure 4).  The common peptide regions represent 
44.94% of the full-length CIα1 sequence (1057 AA).  A total of 114 Pro and Hyp out of 475 
total amino acids (24.00%) were identified by the HRMS in all samples (Figure 4).  
For two maize-derived CIα1 samples, a total of 28 and 86 Hyp were identified from 
CGB and CGD (green highlighted amino acids in Figure 4), respectively, representing a Hyp 
percentage of 5.89% and 18.11%, respectively, for these two lines (Table 1).  This result 
indicates that the co-expression of rP4H in maize can greatly enhance the hydroxylation of 
prolines on collagen molecules.  The increased number of Hyp in rCIα1 from CGD samples 
may partially contributed to the increased molecular weight and thereby decreased the 
migration rate (Figure 2).   
Because rP4H catalyzes hydroxylation of Pro residues in the Yaa position of the Xaa-
Yaa-Gly triplets within collagen strands [26], we further compared the Pro residues on all 
Xaa-Pro-Gly triplets in both maize CGB and CGD lines.  HRMS analysis identified 752 AA 
(71.14%) from maize- rCIα1 (CGB) and 818 AA (77.39%) from maize rCIα1-OH (CGD) as 
shown in Table 1 and Figure 4 (bold and yellow highlighted letters).  Among these HRMS 
identified AA, we chose 652 AA that were shared for both CGB and CGD.  We further 
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identified a total of 90 sets of collagenous triplets within the 652 AA.  Among the 90 sets of 
triplets, 44 sets (48.9%) have the Pro residues changed to Hyp (double underlined triplets in 
Figure 4) in both CGB and CGD lines; 5 sets (5.6%) have the Pro unchanged (single 
underlined triplets in Figure 4) in both lines.  On the other hand, 41 sets of triplets (45.6%) 
have the Pro residues changed to Hyp (black boxes in Figure 4) only in rCIα1 isolated from 
CGD, indicating that nearly half of the collagenous triplets were posttranslationally modified 
by the co-expression of rP4H genes in CGD maize line.   
Seventy-one Hyp residues out of 475 AA by HRMS (14.95%) were identified in 
human CIα1 control sample (Table 1).  For Pichia samples, while only two Hyp residues 
(0.42%) were found in non-hydroxylated CIα1 (FE291), 83 Hyp residues (17.47%) were 
found in hydroxylated CIα1 (FE285), indicating that the co-expression of P4H in Pichia had 
also dramatically increased proline hydroxylation in collagen (Table 1).  
Co-expression of rP4H enhances the thermal stability of rCIα1 
To further characterize the maize-derived rCIα1 and rCIα1-OH, we carried out 
thermal stability analysis using pepsin digestion at 10
o
C for 15 minutes after heat treatment 
of protein samples at 4
o
C or temperatures ranged from 29 to 38.6
o
C for 6 minutes.  The 
proteolytic resistance of maize-derived collagens were compared with that of the native 
human collagen and the recombinant collagen from Pichia pastoris.  Figure 5A is a Western 
Blot results showing the proteolytic resistance of the collagens after 4°C heat treatment using 
anti-foldon antibody.  Both non-hydroxylated rCIα1 from maize (CGB) and non-
hydroxylated rCIα1 from Pichia (FE291) were not detected after pepsin treatment.  By 
contrast, the hydroxylated rCIα1 could be detected from both maize (CGD) and 
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hydroxylated- CIα1 Pichia (FE285) samples, suggesting that the pepsin digestion resistance 
of these collagens was associated with the higher percentage of Hyp residues.   
The thermal stability of rCIα1 was further characterized by the determination of 
melting temperature (Tm) using Western analysis.  Two different antibodies, anti-foldon and 
anti-25kD collagen, were used.  In our hands, anti-foldon antibody gave results with less 
non-specific cross-reactive background bands, while anti-25kD antibody appeared to be more 
sensitive.  Because the native human CIα1 can only be detected with anti-25kD antibody, we 
used both antibodies in this study.  In the experiments shown in Figure 5B, maize seeds TSP 
from CGB and CGD were extracted and concentrated as described above.  The quantity of 
maize-derived rCIα1 was estimated by ELISA.  Approximately 50-100 ng/reaction of rCIα1 
from CGB and CGD were used for pepsin treatment.  As a control, commercial human 
collagen (2 µg/reaction) was spiked into TSP extracted from non-transgenic maize seed for 
pepsin treatment.  As can be seen in Figure 5B, both maize-derived rCIα1 (CGB) and rCIα1-
OH (CGD) were as stable as the human collagen control at all temperatures tested in the 
absence of pepsin.  When digested with pepsin, the maize-derived non-hydroxylated rCIα1 
(CGB) was degraded after the heat treatment at temperatures as low as 4°C.  On the other 
hand, the hydroxylated rCIα1-OH (CGD) could still be detected after temperature treatment 
as high as 35
o
C when using anti-foldon antibody, and 38.6°C when using anti-25kD antibody.  
The difference in Tm results was likely due to the sensitivity and epitope recognition sites of 
two types of antibodies.  Interestingly, the control native human collagen could only 
withstand the digestion up to temperature treatment around 31°C.  This observation is in fact 
in agreement with the HRMS analysis of the collagens described in Table 1 and Figure 4.  
Because the maize-derived rCIα1-OH has higher Hyp percentage (18.11%) than that from 
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human collagen control (14.95%), it is expected that the increased Hyp residues could help to 
increase the thermal stability of the collagen molecules.  
 
Discussion 
The production of plant-derived recombinant collagens have been reported in tobacco 
leaves, barley cell culture and seeds, as well as maize seeds as summarized in Table 2.  
Previous tobacco-derived rCIα1 studies showed that different combinations of recombinant 
human collagens (i.e. rCIα1, rCIα2, and N-propeptide free rCIα1) were used to improve the 
production of homotrimeric or heterotrimeric recombinant human type I collagen [10, 16, 17, 
27].  In a recent paper, Stein et al [17] achieved a high expression level of 200 mg/kg fresh 
leaves by expressing the collagens under a Chrysanthemum rbcS1 promoter and vacuolar-
targeting signal sequence.  Early work with tobacco-derived collagens had very low levels of 
Hyp (0.53%, [10]).  With co-expression of C. elegans P4Hα/Mouse P4Hβ [16] or the human 
rP4Hα/β [17], Hyp levels were increased to 8.41% and 7.55%, respectively.  However, this 
enhanced Hyp level in tobacco is still lower than that of native human collagen CIα1, which 
is reported as 10.8% by amino acid analysis [28] or around 15% by the HRMS analysis (this 
work).  
Both the full length and a smaller fragment (45 kD) of rCIα1 were produced in barley 
cell culture [7] and barley seeds [13].  The barley-derived 45 kD collagen has 2.8% of Hyp 
content when produced in seeds without co-expression of rP4H genes [13].   
Previous work on fractionation, purification and characterization of maize-derived 
full length and a smaller fragment (44 kD) of collagen suggested that an accumulation level 
of about 3 mg/kg (for the full length) and of 20 mg/kg (for the 44 kD) of DSW, respectively 
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[11, 29].  A similar maize line accumulating the full length rCIα1 producing maize line (CGB) 
was used in this study.  In our case, the collagen yield of the rCIα1 accumulating line without 
P4H co-expression averages 12 mg/kg DSW, while the rCIα1 accumulating line with P4H 
co-expression (CGD) is about 4 mg/kg.  The Hyp percentage in rCIα1 protein of CGB was 
reported as 1.23% using total amino acid composition (AAC) analysis [11]; however, it was 
measured at 5.89% by using HRMS analysis in our study.  Similarly, the Hyp percentage in 
human CIα1 was reported as 10.8% using AAC analysis [28].  In our HRMS analysis, the 
Hyp for human CIα1 measured around 15%.  It is not clear why Hyp percentages of C1α1 
proteins measured uniformly higher in HRMS analysis than that of in AAC analysis.  This 
discrepancy is likely due to the different degrees of resolution of these two very different 
methodologies.  Because the concentrations of rC1α1 and rC1α1-OH obtained from maize 
seeds were too low to be measured by AAC analysis in our study, we were not able to obtain 
AAC analysis results for comparison.   
P4H is an enzyme that regioselectively modifies the Pro residues in collagenous 
triplets Xaa-Pro-Gly [30, 31] in the ER as a posttranslational modification.  Compared to the 
Pichia recombinant protein production system, maize can produce hydroxylated rCIα1 with a 
comparable Hyp percentage (Table 1, 18.11% in maize CGD vs 17.47% in Pichia FE285).  
Interestingly, rCIα1 produced in maize seems to have a higher base-level Hyp percentage 
when compared to rCIα1 isolated from Pichia with no rP4H co-expression (Table 1, 5.89% 
in maize CGB vs 0.42% in Pichia FE291).  Small numbers of proline at both Xaa and Yaa 
positions got hydroxylated in CGB maize line without the co-expression of P4H (data not 
shown).  It is likely that the rCIα1 produced in maize is also a substrate for plant endogenous 
P4Hs with lower efficiency [30].   
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Conversely, the expression of human rP4H in maize may also catalyze hydroxylation 
of Pro residues in any plant endogenous proteins with collagenous domains.  We checked 
amino acid sequences of three abundant seed storage proteins (19 kD and 22 kD α-zein, and 
27 kD γ-zein) in maize and did not find any collagenous triplets (X. Xu, unpublished).  
Therefore we do not expect any Pro to Hyp modifications on these seed storage protein in the 
rP4H expressing CGD line.  In fact, the Hyp-only AAC analysis on both CGB and CGD 
seeds showed no differences in Hyp contents (X. Xu, unpublished).  However, because both 
α and β subunits of rP4H were under the control of the constitutive ubiquitin promoter, it is 
possible that any of the collagenous triplet domains on proteins in plant cells can be modified 
by rP4H in such transgenic lines.  It may be desirable in the future to restrict rP4H expression 
to seed tissue only using seed specific promoters.   
Using HRMS to analyze posttranslational modification has obvious advantages such 
as low protein quantity requirement, free of contaminating proteins in samples and reading 
accuracy.  However, it does not give 100% coverage.  In this study the peptide coverage 
ranged from 58.66% to 85.81%.   
Because posttranslational modification is a continuous process in the cells, the 
collagen isolated from the seeds represents a population of protein molecules, i.e., the proline 
hydroxylation may vary from one collagen molecule to another.  In fact, we have performed 
multiple HRMS measurements on samples extracted from same batch of seeds.  We found 
that while positions of Pro to Hyp modification may vary between measurements, the overall 
Hyp content remained constant between these samples.  
The thermal stability tests in this report showed that maize-derived rCIα1-OH could 
still be detected after pepsin digestion followed by heat treatment as high as 35
o
C (using anti-
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foldon antibody) and 38.6
o
C (using anti-25kD antibody).  Commercial human collagen 
control undergoing the same treatment could only withstand up to 31
o
C temperatures.  Stein 
et al [17] reported that the melting temperatures for their tobacco-derived collagen 
heterotrimer and human skin collagen samples were around 39
o
C.  High melting temperature 
of plant-derived collagen could potentially be useful for certain industrial application where 
higher melting temperature is desired, for example, biomaterials for tissue engineering [32, 
33]. 
We recovered the maize-derived rCIα1 from the seed total soluble proteins using a 
previously described protocol [11].  Because collagens are acid soluble proteins, the 
extraction buffer used had a pH of 1.7.  Unlike Zhang et al. [11], we did not perform 
extensive purification for rCIα1 before gel electrophoresis and Western blot analysis.  When 
treating such acidic rCIα1 solutions under high temperature as we normally do before loading 
protein gels, we were unable to detect them in Western blot, suggesting that the combination 
of acidic buffer and high temperature could be detrimental to collagen integrity.  Therefore in 
this study, all maize-derived rCIα1 samples in acidic solutions were not boiled prior to 
Western blot analysis to avoid collagen degradation.   
It is interesting to note that both maize- and Pichia- derived non-hydroxylated rCIα1 
were completely digested by pepsin at 10
o
C after the temperature treatment of samples at 4
o
C 
in our study (Figure 5A).  This result is different from what reported in barley [7] and maize 
[11], in which plant- and Pichia-derived rCIα1 were still detectable after the heat treatment 
around 26-27
o
C.  This could attribute to the different pepsin treatment protocols used in the 
experiments.  For example, the pepsin experiments reported by Zhang et al [11] were 
conducted under pH 7, 15 minutes heat treatment followed by 150 µg/mL pepsin digestion at 
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4
o
C for 16-18 hr.  Ritala et al [7] conducted heat treatment for 6 min before subjected the 
samples to 150 µg/mL pepsin digestion at 10
o
C for 30 min under an acidic condition.  Our 
conditions were similar to Ritala et al except that we used 200 µg/mL pepsin for 15 min 
under pH 1.7.  Because pepsin functions best in acidic environment, our pepsin digestion 
under low pH is likely leading to the degradation of non-hydroxylated rCIα1 even at 4oC.  
Another explanation could be the quantity of the collagen substrate used in different 
experiments.  We estimated that approximately 50-100 ng/reaction of unpurified rCIα1 from 
CGB seeds were subjected to pepsin digestion in our study.  However, Zhang et al used about 
600 – 700 ng purified rCIα1 per reaction in their study [11].  The quantity of collagen for 
pepsin digestion in Ritala et al [7] was not specified.  
We have demonstrated for the first time that mammalian-like hydroxylation of human 
rCIα1 can be achieved in transgenic maize co-expressed with a human rP4H.  The Hyp 
content in maize-derived hydroxylated rCIα1 is comparable to that of the native human 
version, leading to a similar thermal stability of the product.  The current expression levels of 
collagen reported here are too low for large scale production, as desired accumulation level 
of recombinant proteins for commercial production is estimated between 250 to 1000 mg/kg 
grain [34, 35].  Further improvement of recombinant protein production in plants can be 
achieved by optimization of gene expression including using more effective regulatory 
elements and protein targeting/retention sequences, as well as using conventional breeding 
program to select high expression lines over generations [34, 36].  
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Conclusions 
In this study we have shown that properly hydroxylated recombinant human collagen 
I alpha 1 (rCIα1) can be produced in maize seed.  By co-expressing recombinant human 
prolyl 4-hydroxylases (rP4Hs), we have successfully produced rCIα1 containing Hyp residue 
levels that are comparable to native human CIα1.  The increased Hyp content is associated 
with increased thermal stability in maize-derived rCIα1.  Application of high-resolution mass 
spectrometry (HRMS) allowed us to measure hydroxylated prolines at specific amino acid 
positions in different samples.  Our findings indicate that maize seed can be used as a system 
to produce recombinant proteins requiring mammalian-like posttranslational modifications.  
 
Methods  
Vector construction 
Human collagen type I α 1 (CIα1) coding sequence together with its original N- and 
C- telopeptides sequences (UniProtKB/Swiss-Prot: P02452) were optimized by Aptagen 
LLC (Jacobus, PA) for expression in maize.  The optimized CIα1 sequence was fused with a 
29 amino acids bacteriophage foldon peptide sequence [23] at the C-terminus to produce a 
protein with 1086 amino acids.  Two constructs (Figure 1) were made to produce either 
recombinant CIα1 (rCIα1) only (CGB), or both rCIα1 and recombinant human prolyl-4-
hydroxylase (rP4H, CGD).  The rCIα1 gene was regulated by a maize embryo-specific 
promoter, globulin-1 [18], with a 3’-terminator from potato protease inhibitor II (pin II) gene.  
Genes encoding two subunits of rP4H (rP4Hα and rP4Hβ) were regulated by a maize 
constitutive promoter (ubiquitin promoter) and the potato pin II gene terminator.  All three 
gene coding sequences (rCIα1, rP4Hα, and rP4Hβ) in the two constructs were translationally 
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fused with a barley alpha amylase signal sequence (BAASS, [19]) at the 5’ end.  The 
phosphinothricin acetyl transferase (bar) gene driven by the cauliflower mosaic virus (CaMV) 
35S promoter was adopted in both constructs to be a marker for the transgenic callus 
selection.  It confers resistance to the herbicide glufosinate ammonium (bialaphos) [37-39].  
Production of transgenic plants    
Constructs CGB and CGD were introduced into immature embryos of Hi II maize 
genotype [40] via an Agrobacterium-based transformation system [41].  Briefly, maize 
immature embryos were infected by Agrobacterium strain EHA101 [42] containing the 
above described vectors and selected on 3 mg/L bialaphos.  Regeneration of transgenic plants 
from the callus was as previously described [20].  Seedlings were transplanted into soil in the 
greenhouse and allowed to flower and produce seed through hand-pollinations.  Seed 
increases for multiple events from CGB and CGD were conducted in greenhouse and nursery 
trials.  T2 transgenic maize seeds were used for further analysis in this study. 
PCR analysis of transgenic plants 
Total genomic DNA was isolated by Cetyl Trimethyl Ammonium Bromide (CTAB) 
method [43] from maize leaf or seed.  The presence of transgenes rCIα1, rP4Hα and rP4Hβ 
were detected by polymerase chain reaction (PCR).  A typical PCR reaction consists 100 ng 
of genomic DNA, 0.8 mM of dNTPs, 2 mM of MgCl2, Taq DNA polymerase buffer and 0.5 
U Taq DNA polymerase (Bioline USA Inc, Taunton, MA) in a final volume of 25 µL.  PCR 
was performed at the following condition for 35 cycles: 30 s denaturation at 94°C, 30 s 
annealing at 60°C, and 45 s extension at 70°C.  Primers for amplifying rCIα1 are x7-05 (5’-
ACCAGATGGGCCGCTCTCACCTTT-3’) and x7-06 (5’-
TTCCCTGGTGCCGTTGGAGCTA-3’); for rP4Hα are x7-17 (5’- 
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ATCTCGGCGTCGCTGATGAT-3’) and x7-18 (5’- GTGGTCCGAGCTGGAGAACC -3’); 
and for rP4Hβ are x7-13 (5’-ATGAAGAACACCTCCTCCCTCTG-3’) and x7-14 (5’-
TCACAGCTCGTCCTTCACGG -3’).  PCR products were analyzed in 1% agarose gel.  The 
expected sizes of PCR products are 1308 bp (rCIα1), 745 bp (rP4Hα) and 1531 bp (rP4Hβ), 
respectively.  Gel was stained by ethidium bromide (0.5 µg/ml) for 20 min.  The products 
size was determined by 1 kb DNA Ladder (cat # N3232S, New England Biolabs). 
Protein extraction 
Total soluble protein (TSP) from maize seeds was extracted using an acidic buffer 
described by [11] for collagen preparation.  Maize seeds were ground in a coffee grinder (Mr. 
Coffee) for 1 min.  For rCIα1 extraction, extraction buffer (0.1 M phosphoric acid, 0.15 M 
sodium chloride, pH 1.7) was added in to the seed powder at the ratio of 1:10 (w/v).  For 
rP4H extraction, extraction buffer [25 mM sodium phosphate (pH 6.6), 100 mM sodium 
chloride, 0.1% Triton X-100 (v/v), 1 mM EDTA, 10 µg/mL leupeptin, and 0.1 mM serine 
protease inhibitor Perfabloc SC (Fluka)] was added into the seed powder at the ratio of 1:10 
(w/v).  The mixture was incubated in a shaker incubator (250 rpm, 37°C) for 0.5 hour for 
rCIα1 and one hour for rP4H.  The mixtures were then centrifuged at 13,000 rpm for 10 min 
at room temperature in a bench top centrifuge.  The supernatants were transferred to clean 
tubes for further analysis.  Some protein samples were concentrated by Amicon Ultra-15 
Centrifugal Filter Unit with Ultracel-30 membrane (cat # UFC903008, Millipore) followed 
the product instruction.  In short, 15 mL of total seed protein extraction was loaded into the 
filter device, centrifuged at 3000 x g for approximately 2-3 hours at 4°C.  Concentrated 
samples were recovered by withdrawing with a pipettor.  The concentration level was 
measured by the volume and could be adjusted by the control of the centrifugation time. 
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ELISA 
A competitive ELISA procedure developed by FibroGen and described by Zhang et 
al. [29] was used with minor modifications.  Briefly, ELISA plates (cat # 3590, Corning) 
were coated overnight at 4°C with 5 ng per well of heat-denatured (65 5C for 30 minutes) 
non-hydroxylated rCIα1 from Pichia pastoris (FE301,[7]) with phosphate buffer saline (PBS, 
cat # 21-040-CV, Mediatech).  After washing with washing buffer (10 mM PBS, 0.05% 
Tween 20, pH 7.0), the plates were blocked with 2% dry milk in 100 mM PBS for 1 hour at 
room temperature.  After 3X washings with washing buffer, heat-denatured samples and 
standard (FE301) in assay buffer (100 mM PBS, 0.05% Tween 20, 1% dry milk, pH 7.0) 
were added to the plates.  The primary antibody, rabbit polyclonal anti-25kDa CIα1 (CA725, 
FibroGen), was added immediately at a 1:4000 dilution in the assay buffer.  After 1 hour 
incubation at room temperature, plates were washed 3X with washing buffer.  The goat-anti-
rabbit IgG (H+L) HRP conjugate (cat # 81-6120, Zymed) was added at a 1:5000 dilution in 
the assay buffer followed by incubation at room temperature for 1 hour.  After 3X washings 
with washing buffer, 100 µL/well of Sure Blue TMB substrate solution (cat # 52-00-01, 
Kirkegarrd & Perry Laboratories) were added.  The plated were then read at 620 nm on a 
microplate reader (KC4, Biotek) after incubation at room temperature for 30 minutes. 
Western blotting  
Forty microliters of protein extract from maize seed were mixed with 8 µL of 
Laemmli sample buffer (cat # 161-0737, Bio-Rad) and then loaded onto a 4-15% 
polyacrylamide SDS-PAGE gel (cat # 161-1158, Bio-Rad).  To avoid protein degradation in 
the combination of acidic pH and high temperature (X. Xu, unpublished), the step of sample 
boiling prior to loading was omitted.  The proteins separated on the gel were transferred to a 
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0.45 µm nitrocellulose membrane using Bio-Rad Semidry Transblotting apparatus according 
to the manufacturer’s instructions.  Membranes were incubated in blocking buffer (138 mM 
sodium chloride, 2.7 mM potassium chloride, pH 7.4, 0.1% Tween-20, 5% dry milk powder) 
for 1 hour at room temperature on a rotary shaker.  The membrane was then incubated for 1 
hour in blocking buffer with 1:1000 dilution of anti-foldon antibody (rabbit anti-sera with 
0.01% sodium azide) for the rCIα1, and with 1:1000 dilution of anti-P4Hβ antibody (cat # 
63-164, ICN Biomedicals) for the rP4Hβ.  After washing with washing buffer (138 mM 
sodium chloride, 2.7 mM potassium chloride, pH 7.4, 0.05% Tween-20) 4 times (5 min each 
wash), the membrane was then incubated for 1 hour in blocking buffer with 1:5000 dilution 
of HRP-Goat anti-rabbit IgG (H+L) secondary antibody (cat # 62-6120, Zymed) for the 
rCIα1, and with1:5000 dilution of HRP-Goat anti-mouse IgG (H+L) secondary antibody (cat 
# 62-6520, Zymed) for the P4Hβ.  After washing the membrane with washing buffer 4 x 5 
min, the excess buffer was then drained off and the membrane transferred into a clean 
container.  Bands appeared after incubation with horseradish peroxidase substrate, 3,3’, 5,5’-
tetramethylbenzidine (cat # T0565, Sigma) within 10 minutes.   
High-resolution mass spectrometry (HRMS) analysis  
To prepare maize-derived rCIα1, 10 µg of total soluble proteins extracted from seeds 
was separated on the 4-15% polyacrylamide SDS-PAGE gel followed by Bio-Safe 
Coomassie Stain (cat # 161-0786, Bio-Rad).  For purified collagen control samples, three 
micrograms of each of Pichia-derived non-hydroxylated collagen (FE291), Pichia-derived 
hydroxylated collagen (FE285), and human collagen (cat # 234138, CalBiochem Inc.) were 
loaded on the gel.  After electrophoresis, collagen bands were excised from the gels and sent 
to the Proteomics & Mass Spectrometry Facility at Donald Danforth Plant Science Center, St. 
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Louis, MO for analysis.  The samples were automatically digested with trypsin performed by 
MultiProbe II protein digester (PerkinElmer) in a temperature-controlled enclosed 
environment.  After digestion, samples were run by LC-MS/MS on the Linear Ion Trap 
Orbitrap (LTQ-Velos Orbitrap, ThermoFisher Scientific).  For post-translational modification 
analysis, the numbers of Hyp and Pro from each sample were counted and compared.    
Thermal stability analysis  
The melting temperature (Tm) of C1α1 samples was determined by pepsin digestion 
after heat treatment [23].  Twenty-five microliters of total soluble protein extracted from 
CGB and CGD maize seed was subjected to heat treatment in a Thermocycler machine 
(Biometra GmbH, Germany) at 4
o
C, or at temperatures ranged from 29°C to 38.6°C for 6 
min.  For positive controls, 1.4 µg of Pichia-derived rCIα1 in hydroxylated (FE285) and non-
hydroxylated (FE291) forms, and human collagen were also treated.  After heat treatment, all 
protein samples were then incubated at 10°C with or without pepsin (0.2 mg/mL final 
concentration, cat # P6887, Sigma) for 15 min.  Digestion results were analyzed by western 
blotting using anti foldon and anti 25 kDa collagen antibodies. 
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Figure 1. A schematic representation of the two constructs used in this study. LB, left 
border of Agrobacterium T-DNA; T35S, CaMV 35S terminator; bar, bialaphos resistant 
coding sequence; P, CaMV 35S promoter; PIN II, potato protease inhibitor II gene terminator; 
CIα1, human collagen I α1 chain coding sequence; BAASS, barley alpha amylase signal 
sequence; P4Hα, prolyl 4-hydroxylase α subunit; P4Hβ, prolyl 4-hydroxylase β subunit; Pglb, 
maize globulin-1 promoter; Pubi, maize ubiquitin promoter; RB, right border of 
Agrobacterium T-DNA.  
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Figure 2. Electrophoretic mobility difference analysis of rCIα1 in the CGB and CGD 
line. Equal volumes of total protein extracts from seeds of CGB, CGD (10X concentrated by 
volume) and mixture of CGB+CGD extracts were loaded on the gel.  The rCIα1 from CGB 
and CGD lines were detected by western blot using anti-foldon antibody.  Pichia-derived 
rCIα1 (FE291) and rCIα1-OH (FE285) were included as controls and detected by Coomassie 
Brilliant Blue staining.  Open arrows, rCIα1 from CGB or FE291; solid arrows, OH-rCIα1 
from CGD or FE285.  M, molecular weight marker.  
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Figure 3. Western blot of the rP4Hβ using anti-P4Hβ antibody. Equal volume of total 
protein extraction from seeds of CGB, CGD and non-transgenic control maize (WT) extracts 
was loaded on the gel.  Open triangle, rP4Hβ.  M: molecular weight marker. 
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                                    20                  40                  60                  80                 100 
Pichia rCIα1      QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
Maize rCIα1       QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
Human CIα1        QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
Maize rCIα1-OH    QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
Pichia rCIα1-OH   QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGL 
 
                                   120                 140                 160                 180                 200 
Pichia rCIα1      PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
Maize rCIα1       PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
Human CIα1        PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
Maize rCIα1-OH    PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
Pichia rCIα1-OH   PGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPR 
 
                                   220                 240                 260                 280                 300 
Pichia rCIα1      GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
Maize rCIα1       GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
Human CIα1        GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
Maize rCIα1-OH    GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
Pichia rCIα1-OH   GSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPG 
 
                                   320                 340                 360                 380                 400 
Pichia rCIα1      PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
Maize rCIα1       PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
Human CIα1        PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
Maize rCIα1-OH    PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
Pichia rCIα1-OH   PAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQ 
 
                                   420                 440                 460                 480                 500 
Pichia rCIα1      DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
Maize rCIα1       DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
Human CIα1        DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
Maize rCIα1-OH    DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
Pichia rCIα1-OH   DGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQ 
 
                                   520                 540                 560                 580                 600 
Pichia rCIα1      GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
Maize rCIα1       GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
Human CIα1        GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
Maize rCIα1-OH    GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
Pichia rCIα1-OH   GVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDG 
 
                                   620                 640                 660                 680                 700 
Pichia rCIα1      VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
Maize rCIα1       VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
Human CIα1        VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
Maize rCIα1-OH    VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
Pichia rCIα1-OH   VRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGA 
 
                                   720                 740                 760                 780                 800 
Pichia rCIα1      KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
Maize rCIα1       KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
Human CIα1        KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
Maize rCIα1-OH    KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
Pichia rCIα1-OH   KGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVV 
 
                                   820                 840                 860                 880                 900 
Pichia rCIα1      GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
Maize rCIα1       GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
Human CIα1        GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
Maize rCIα1-OH    GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
Pichia rCIα1-OH   GLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAG 
 
                                   920                 940                 960                 980                1000 
Pichia rCIα1      KSGDRGETGPAGPAGPVGPAGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
Maize rCIα1       KSGDRGETGPAGPAGPVGPAGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
Human CIα1        KSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
Maize rCIα1-OH    KSGDRGETGPAGPAGPVGPAGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
Pichia rCIα1-OH   KSGDRGETGPAGPAGPVGPAGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGP 
 
                                  1020                1040                  
Pichia rCIα1      IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Maize rCIα1       IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Human CIα1        IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Maize rCIα1-OH    IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
Pichia rCIα1-OH   IGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA 
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Figure 4. LC-MS/MS analysis of the rCIα1.  Full length peptide sequences of 1057 amino 
acid are listed. Pichia rCIα1, Pichia-derived rCIα1 from strain FE291; Maize rCIα1, maize-
derived rCIα1 from line CGB; Human CIα1, gel-isolated CIα1 fragment from commercial 
collagen (CalBiochem Inc); Maize rCIα1-OH, maize-derived rCIα1 from line CGD; Pichia 
rCIα1-OH, Pichia-derived rCIα1 from strain FE285.  Yellow-highlighted letters: amino acid 
sequences identified by the Orbitrap; green-highlighted letters: Hyp residues identified by the 
Orbitrap; red boxes: peptide regions identified in all five samples by the Orbitrap.  Black 
boxes: collagenous triplets Xaa-Pro-Gly with Pro changed to Hyp in Maize rCIα1-OH but 
not in Maize rCIα1; single underlines: triplets with Pro unchanged in both maize lines; 
double underlines: triplets with Pro changed to Hyp in both maize lines.  
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Figure 5. Thermal stability analysis of the rCIα1 from maize, Pichia and human. (A) 
Western blot results of the maize-derived rCIα1 (CGB), rCIα1-OH (CGD), Pichia-derived 
rCIα1 (FE291), and rCIα1-OH (FE285) after 4°C incubation and pepsin treatment. (B) 
Western blot results of the maize-derived rCIα1 (CGB), rCIα1-OH (CGD), and human CIα1 
(HuC) after heat treatments under various temperatures and pepsin treatments as indicated.  
M: molecular weight marker. 
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CHAPTER 4: STRATEGIES AND METHODS OF PRODUCING A DESIGNED 
PEPTIDE SURFACTANT IN TRANSGENIC MAIZE     
 
Xing Xu, Yan Jin, and Kan Wang 
Abstract  
Designed peptide surfactants are sustainable, environmentally-friendly 
alternatives to petroleum-based products within a wide range of applications, including 
biomedical, pharmaceutical, environmental, and food industries. Currently, these peptide 
surfactants have been produced mainly in the microbial systems. Because maize seed has 
the potential to produce low-cost, high-capacity, and low-contamination-risk peptide 
biosurfactants, we designed strategies to express a designed 22-amino-acid peptide 
biosurfactant GAM1 in transgenic maize. Our strategy is to first recover the recombinant 
peptide GAM1 from the endosperm of seed, then use the seed remnant for production of 
fuel ethanol. GAM1 was translationally fused to the C-terminus of a red fluorescent 
protein (RFP) or 22-kDa maize α-zein protein. Transgenic maize lines were successfully 
produced. DNA sequence analysis on transgenic plants showed both translationally-fused 
genes were correctly assembled. Red fluorescence was detected from seeds expressing 
RFP::GAM1, suggesting RFP was folded properly in the tissue. However, the presence of 
GAM1 in RFP::GAM1 fusion could not be detected by using Western analysis and in-gel 
digestion/peptide mass fingerprinting. Similarly, high-performance liquid 
chromatography and mass spectrometry failed to detect the presence of GAM1 in 
Zein::GAM1 fusion. Further experiments are needed to determine whether the failure of 
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GAM1 detection was due to the low expression of the fusion proteins, degradation of 
fusion proteins in the process, or other unexpected causes.  
 
Introduction  
With the increased demand for fuels and environmental concerns regarding fossil 
fuels, bio-renewable resources, especially plant-based bio-refineries, are becoming an 
increasingly important research area. Bio-renewable chemicals target a slightly smaller 
market, but of higher value with less sensitivity to oil prices. Biosurfactants particularly 
have been utilized and explored in recent years as alternatives to petroleum-based 
surfactants (Banat et al., 2000; Clapes and Infante, 2002; Kaar et al., 2009; Sekhon, 2006; 
Van Hamme et al., 2006). Biosurfactants are bio-derived, surface-active substances with 
abilities to reduce surfaces and tension at interfaces between two liquids, or between a 
liquid and a solid (Banat et al., 2000). Biosurfactants have been applied widely on 
biomedical, pharmaceutical, environmental, and food industries (Banat et al., 2010; 
Nitschke and Costa, 2007; Singh et al., 2007). 
Interfacially-active designed peptide biosurfactants have been recently reported to 
have advantages of lowering interfacial tension and controling interfacial rheology 
(Dexter et al., 2006; Dexter and Middelberg, 2007; Malcolm et al., 2006). Bacterial 
derived lipopeptide biosurfactants (e.g. surfactin) have received much attention due to 
their high surface activities (Deleu et al., 1999; Grangemard et al., 1997). However, 
recombinant production of such lipopeptides is inefficient because multiple enzymes are 
needed in the process (Peypoux et al., 1999). Designed peptide biosurfactants are linear 
amino acid sequences without conjugated lipids and their production is simpler than for 
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bacterial lipopeptides (Kaar et al., 2009). The peptide sequences can be designed to 
provide reversible control of emulsions and foams (Dexter et al., 2006; Malcolm et al., 
2006). Peptide biosurfactants are not only designed for material properties, but also can 
be adopted as antimicrobials (Vogt and Bechinger, 1999), vaccines (Kanodia and Kast, 
2008), gene delivery vehicles (Kichler et al., 2003), and nutraceuticals (Mine and Shahidi, 
2006).   
In the present study, a “switchable” biosurfactant GAM1, slightly modified from 
a previously reported stimuli-responsive biosurfactant AM1, was chosen as a peptide 
model (Dexter et al., 2006; Dexter and Middelberg, 2008; Kaar et al., 2009). The AM1 is 
a 21- residue amphiphilic peptide, which switches the mechanical strength of an oil-water 
interface according to the aqueous solution composition (Dexter et al., 2006). The 
favored condition for the helical conformation of AM1 is neutral pH (Dexter et al., 2006). 
In the presence of zinc ions at neutral pH, the AM1 forms a strong interfacial film caused 
by the ion-mediated cross-linking between peptides, which stabilizes foams and 
emulsions (Dexter et al., 2006). At low pH or without metal ions, the surface activity of 
AM1 is lost; therefore, it is called “switchable” (Dexter et al., 2006). The AM1 is highly 
soluble in aqueous solution and has no critical micellar behavior (Dexter et al., 2006). 
The GAM1 has the same properties as the AM1, but with an extra amino acid, glycine, at 
the N-terminus (Kaar et al., 2009)—a 2489 Dalton, 22-residue amphiphilic peptide 
(sequence GMKQLADSLHQLARQVSRLEHA). 
The biological production of designed peptides are mainly reported for E. coli 
(Achmuller et al., 2007; Kaar et al., 2009; Lee et al., 2005; Morreale et al., 2004; Xu et 
al., 2006; Zhou et al., 2007), as fusion proteins because of the low expression, 
93 
 
 
degradation, (Itakura et al., 1977) or toxicity to the host (Ingham and Moore, 2007). 
Transgenic plants have advantages over other recombinant protein/peptide expression 
systems, including cost efficiency, higher capacity, lower toxic contamination risk, and 
inexpensive storage capability (Ma et al., 2003; Menkhaus et al., 2004). Maize seeds have 
been considered to be a suitable recombinant protein expression system (Azzoni et al., 
2002; Bailey et al., 2004; Ramessar et al., 2008; Woodard et al., 2003; Xu et al., 2011). 
After recovering recombinant proteins from seeds, typically 99% of the seed mass 
remains (Paraman et al., 2010). The seed remnant can be used for other purposes, such as 
producing ethanol (Johnson et al., 2003). Thus, the co-production strategy of expressing 
seed specific recombinant proteins and using the seed remnant after protein extraction for 
producing fuel ethanol would efficiently utilize the biomass of maize grains and reduce 
total costs. Additional benefits of using this strategy include improving the environment 
by reducing waste, lowering green house gas emissions and reducing the U.S. reliance on 
foreign fossil fuels.  
In the present study, we generated transgenic maize lines producing GAM1 by 
using a protein fusion strategy. GAM1 is a 22-amino acid long peptide. It is difficult to 
produce the small peptide in E. coli (Piers et al., 1993) because small peptides are 
susceptible to degradation (Li, 2009). The fusion protein strategy has been successfully 
developed to overcome this challenge. In E. coli, GAM1 was fused to the N-terminus of 
maltose binding protein (MBP), which enhanced its solubility (Kapust and Waugh, 1999) 
and expression level (Kaar et al., 2009). The high expression of small peptides in 
transgenic plants has been achieved by fusing to β-glucuronidase (GUS) or fusing two 
small peptides via a linker sequence (Francois et al., 2002; Okamoto et al., 1998).  
94 
 
 
The first strategy was to fuse the GAM1 at the C-terminus of the RFP, a 
commonly used fluorescent tag protein with various commercial purification kits. The 
second strategy was to fuse GAM1 at the C-terminus of a 22-kDa α-zein, one of the 
major maize seed storage proteins (Soave et al., 1981). We expected fusing to the 22-kDa 
α-zein and using the native 22-kDa α-zein promoter and terminator, the GAM1 would 
achieve high expression as it became a part of the major maize endogenous protein. This 
strategy has been demonstrated by Dr. David Jackson, Cold Spring Harbor Laboratory (D. 
Jackson, personal communication). The tobacco etch virus (TEV) protease recognition 
site was designed between GAM1 and the fusion protein partners, which facilitates the 
release of GAM1 by enzymatic digestion (Dougherty et al., 1988). Our hypothesis was, 
by fusing to a tag protein or a major seed protein, we will be able to produce the fusion 
proteins in seeds and extract GAM1 by using an affinity column (RFP::GAM1) or by size 
differentiation (zein::GAM1).      
 
Materials and Methods 
Vector construction 
Two constructs were designed to deliver GAM1 into maize—pYJ16 and pYJ15 
(Figure 1). The binary vector pTF101.1 (Paz et al., 2004) was used as a backbone for 
both constructs provided by the Plant Transformation Facility at Iowa State University. In 
pYJ16, the GAM1 was fused to the N-terminus of the RFP (RFP::GAM1) with an AG 
linker sequence (Ala-Gly-Ala-Gly-Ala-Gly) and TEV protease recognition site (Glu-Asn-
Leu-Tyr-Phe-Gln-Gly) in between. The AG linker connects two proteins with minimal 
effects on stability and folding rates of proteins (Ladurner and Fersht, 1997). The TEV 
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protease recognition site was cut by the TEV protease and the GMA1 was released from 
the fusion proteins (Dougherty et al., 1988). The signal peptide of a maize seed storage 
protein—27-kDa γ-zein was added at the N-terminus of the RFP to lead the fusion 
protein to the reticulum endoplasmic (ER). An ER retention sequence SEKDEL was 
added after the GAM1 to retain the protein in ER (Gomord et al., 1997). The 
RFP::GAM1 was driven by the promoter of 27-kDa γ-zein. The terminator in pYJ16 was 
a soybean vegetative storage protein gene terminator (Tvsp).  
In pYJ15, the GAM1 was fused to the C-terminus of another maize seed storage 
protein, 22-kDa α-zein (22-kDa α-zein::GAM1), also with the AG linker sequence and 
TEV protease recognition site in between. The promoter of 22-kDa α-zein was used to 
drive the α-zein::GAM1 in pYJ15. The native terminator of 22-kDa α-zein was also used 
for pYJ15. The phosphinothricin acetyl transferase (bar) gene driven by the cauliflower 
mosaic virus (CaMV) 35S promoter was used in both constructs as the marker for the 
transgenic callus selection (Anzai et al., 1989; Gordonkamm et al., 1990; Uchimiya et al., 
1993). Agrobacterium tumefaciens strain EHA101 was used to transform both constructs 
into maize (Hood et al., 1986), 
 
Production of transgenic plants  
The maize transformation was performed by the Plant Transformation Facility at 
Iowa State University as previously described (Frame et al., 2002). Briefly, constructs 
pYJ15 and pYJ16 were introduced into immature embryos of Hi II maize genotype via an 
Agrobacterium-based transformation system. Herbicide-resistant calli were analyzed by 
the polymerase chain reaction (PCR) for presence of intact transgenes. Selected calli 
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were regenerated. The plants were brought to maturity in the Plant Transformation 
Facility’s greenhouse. The transgenic lines were named A273 and A274 for constructs 
pYJ15 and pYJ16, respectively.  
 
PCR analysis of transgenic plants 
Total genomic DNA was isolated using the cetyl trimethyl ammonium bromide 
(CTAB) method (Murray and Thompson, 1980) from maize calli, leaves, or seed. The 
presence of the T-DNA was detected by PCR. A PCR reaction contains 100 ng of 
genomic DNA, 0.8 mM of dNTPs, 2 mM of MgCl2, 1 X Taq DNA polymerase buffer and 
0.5 U Taq DNA polymerase (Bioline USA Inc, Taunton, MA) in a final volume of 25 µL. 
PCR was performed utilizing the following conditions for analysis. For A274 
(transformed with pYJ16): 35 cycles by primers x10-09 (5'- CCTACAAGACCGACATC 
AAG-3') and x10-10 (5'- GTGCATATCAGCATACCTTA-3') (Figure 1): 30 s 
denaturation at 95°C, 30 s annealing at 56°C, and 20 s extension at 70°C. For A274 
(transformed with pYJ15), PCR was performed by utilizing the following conditions by 
primers x11-01 (5'-TTACAACAGTTGCTTCCATT-3') and x11-02 (5'- 
TCATTAGGCACCCCA-3') (Figure 1) for 35 cycles—30 s denaturation at 95°C, 30 s 
annealing at 58°C, and 40 s extension at 70°C. PCR products were analyzed in 1% 
agarose gel. The expected sizes of PCR products were 355 bp (pYJ16) and 1566 bp 
(pYJ15). The gel was stained with ethidium bromide (0.5 μg/ml) for 20 min. The 
product’s size was determined by 1 kb DNA Ladder (cat # N3232S, New England 
Biolabs). 
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Protein extraction 
Total zein proteins (water-insoluble) were extracted from maize seed by using an 
ethanol-based extraction buffer containing 70% ethanol, 61 mM sodium acetate, and 100 
nm DL-Dithiothreitol (DTT) (Flint-Garcia et al., 2009). Seeds were ground and 100 mg 
the powder was extracted with 1 mL of extraction buffer in a 1.5 mL Eppendorf tube. The 
tube was laid horizontally on a shaker at 225 rpm at 37
o
C for 1 hour. Then, the tube was 
spun 10 minutes at room temperature in a micro-centrifuge at 15,000 rpm. The 
supernatant was filtered for high-performance liquid chromatography (HPLC), by using 
Ultrafree centrifugal filter units (cat # UFC30HV00, Millipore) by following the 
manufacturer’s instructions. 
Total water soluble protein (TSP) from ground maize seeds was extracted, 
utilizing the following protein extraction buffer at a ratio of 10 µL buffer per milligram of 
seed powder for 2 hours at 37
o
C: 25 mM sodium phosphate (pH 6.6), 100 mM NaCl, 0.1% 
Triton X-100 (v/v), 1 mM EDTA, 10 µg/ml of leupeptin, and 0.1 mM serine protease 
inhibitor Perfabloc SC (Fluka). 
      
Fluorescence imaging  
The mature seeds of transgenic line A274 were visualized and imaged by utilizing 
an Olympus SHZ10 stereoscope (Leeds Precision Instruments, Inc., Minneapolis, MN, 
USA) coupled to a SPOT RT color CCD camera (Diagnostic Instrument Inc., Sterling 
Heights, MI). Images were taken under a bright or fluorescent field. A RFP filter (Cat # 
49008, ET - mCherry, Texas Red, Chroma Technology Corp) was utilized and λex=540-
580 nm and λem=600-660 nm were acquired by employing SPOT Advanced software. 
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Western Blot and Coomassie Brilliant Blue staining  
The Red Fluorescent Protein (RFP) from the total soluble protein extracted from 
A274 seed powder was purified by Anti-RFP magnetic beads (cat # M165-9, MBL 
International), following the manufacturer's protocol. After affinity column purification, 
30 µl of elutes in Laemmli sample buffer were obtained from the 500 µl of A274 raw 
protein extract. Fifteen micro liters of the A274 samples and 1 µg of the commercial RFP 
control (cat # 4997-100 BioVision) were loaded onto a 12% polyacrylamide SDS-PAGE 
gel (cat # 465-1043, Bio-Rad). Electrophoresis was performed at 200 V for 35 min. The 
gel was stained by Bio-Safe Coomassie Stain (cat # 161-0786, Bio-Rad) or transferred to 
a 0.45 µm nitrocellulose membrane for the Western Blot using a Bio-Rad Semidry Trans-
blotting apparatus, according to the manufacturer’s instructions. The membrane was 
incubated in the blocking buffer (138 mM sodium chloride, 2.7 mM potassium chloride, 
pH 7.4, 0.1% Tween-20, 5% dry milk powder) for 1 hour at room temperature on a rotary 
shaker. The membrane was then incubated for 1 hour in the blocking buffer with 1:1000 
dilution of rabbit anti-RFP antibody (cat # A00682 Genscript). After washing with the 
washing buffer (138 mM sodium chloride, 2.7 mM potassium chloride, pH 7.4, 0.05% 
Tween-20) 4 times (5 min each wash), the membrane was then incubated for 1 hour in 
the blocking buffer with 1:2000 dilution of HRPGoat anti-rabbit IgG (H+L) secondary 
antibody (cat # 62-6120, Zymed). The membrane was then washed with the washing 
buffer 4 × 5 min. The excess buffer was drained and the membrane transferred into a 
clean container. Bands appeared after incubation with horseradish peroxidase substrate, 
3,3’, 5,5’-tetramethylbenzidine (cat # T0565, Sigma) within 10 min. 
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The zein Western Blot procedure is similar to the RFP, except the first antibody 
was an anti-zein rabbit antibody (kindly offered by Dr. Paul Scott) with the dilution of 
1:50,000 instead. 
 
TEV treatment 
The TEV (tobacco etch virus) protease treatment is performed under the 
manufacturer’s instruction (cat # 12575-015, Invitrogen). In short, 50 µL of the RFP 
affinity column purified protein sample from seed for event A274-9-2 was digested in a 
solution containing 7.5 µL 20X TEV buffer (1 mM Tris-HCl pH 8.0, 10 mM EDTA), 0.1 
M DTT (dithiothreitol), 10 units (1 µL) AcTEV
TM
 Protease (cat # 12575-015, Invitrogen), 
and 90 µL water. The reaction was performed at 30 °C for 2 hours. The reaction can be 
terminated by adding Laemmli sample buffer and stored at -20 °C. 
 
High-performance liquid chromatography (HPLC) and mass spectrometry 
The HPLC method for α-zein::GAM1 was slightly modified from Flint-Garcia et 
al. (2009). In brief, the alcohol-soluble zein proteins were extracted as described in 
protein extraction. An aliquot (20 µL) of the extract was injected into a C18 column (5 
microns, 2.1 mm X 250 mm, Vydac Cat # 218TP52), and absorbance at 214 nm was 
measured. Separation of zein proteins was achieved by hydrophobicity with a gradient of 
water and acetonitrile. The water contained 0.1 % trifluoroacetic acid and the acetonitrile 
contained 0.08 % trifluoroacetic acid. The gradient of acetonitrile ranged as follows—0-
30 % from time 0 to 20 min, 30-60 % from time 20 to 28 min, 60-63 % from time 28 to 
40 min, and 63-100 % from time 40 to 45 min. The flow rate was 0.2 mL/min. All peaks 
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from the HPLC were collected individually and analyzed further by Matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI-MS). The Protein Facility at Iowa 
State University completed the HPLC and MS work.   
The HPLC method for RFP::GAM1 was provided by Dr. Charles E. Glatz 
(Department of Chemical and Biological Engineering, Iowa State University). An aliquot 
of 20 µL of the affinity-column-purified RFP was injected into a Phenomenex Jupiter C-5 
column (5 u particle size, 300 Angstrom Unit pore size, 4.6 mm x 150 mm). Mobile 
phases are: A) 0.1% trifluoroacetic acid and B) 90% acetonitrile. The flow rate was 1 
mL/min. and the gradient was 25 to 55% of mobile phase B. Elution was monitored at 
210, 214, and 280 nm. 
 
Antimicrobial activity analysis 
The methods for small peptide antimicrobial activity were modified from (Yang 
et al., 2007). Fifty micro liters of E. coli culture in Luria-Bertani (LB) liquid medium 
with OD values between 0.4 and 0.5 were spread evenly on the pre-warmed (37 °C) LB 
solid medium. After the culture was dry (around one-half hour), twenty micro litters of 4 
mM pure GAM1 (synthesized by Genscript) in PBS solution or double-distilled water (as 
negative control) was dropped on the LB medium. The plates were then incubated 
overnight at 37 °C.  
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Results and Discussion 
Generation of the transgenic maize  
Two proteins, the red fluorescent protein (RFP) and the maize endogenous seed 
storage protein 22-kDa α-zein, were selected for fusing to GAM1 in the present study. 
The constructs employed are shown in Figure 1. In the pYJ16 construct, GAM1 was 
fused to the C-terminus of RFP. RFP is a widely used reporter protein and the use of the 
RFP in maize cell biology has been developed (Shaner et al., 2004). Additionally, as a tag 
protein, there are various commercial purification kits available for purifying RFP tagged 
fusions. The pYJ15 construct carries a gene coding sequence for the maize native 22-kDa 
α-zein fused to the N-terminus of GAM1, driven by the 22-kDa α-zein promoter. The 22-
kDa α-zein terminator was used as well. The α-zeins were the most abundant zein 
proteins, accounting for 75-85% of total zeins (Tatham et al., 1993). This α-zein fusion 
strategy was successfully used (D. Jackson, Cold Spring Harbor Laboratories). By fusing 
to the 22-kDa α-zein and using its original promoter and terminator, we expected GAM1 
would achieve high expression via the native maize 22-kDa α-zein system.   
Both constructs were transformed into maize HiII germplasm by using immature 
embryos via Agrobacterium-based methods. Eleven independent events each for A274 
and A273 were recovered and brought to maturity in the greenhouse by crossing with 
pollen donors of an inbred maize line B73. Initial transgene expression screens were 
completed on both calli and T1 seeds using PCR. The PCR and the PCR products 
sequencing results in the calli and T1 seeds indicated the GAM1 DNA coding sequence 
was intact and the protein::GAM1 DNA coding sequence fusion was correctly made from 
transgenic lines carrying both constructs (data not shown).  
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Characterization of the RFP::GAM1 transgenic line A274  
Visualization of the RFP in the RFP::GAM1 transgenic line. The fluorescence 
imaging screen was conducted on the transgenic maize A274 line. The RFP was 
successfully expressed in the A274 line. As shown in Figure 2, the positive segregates of 
RFP positive kernels are red under the fluorescent field, while the RFP negative segregate 
are not. The red fluorescence suggested the RFP in this RFP::GAM1 fusion protein was 
correctly folded. A total of 633 kernels from a total of 2,071 kernels (30%) screened from 
11 events were red fluorescent (Table 1). Of 11 events, only two events—A274-9 and 
A274-11—showed 1:1 segregation as measured for RFP expression. These were also the 
lines in which red fluorescence was strongest. The remaining nine events had the RFP 
expression ranging from 15.8% (A274-6) to 38.7% (A274-8). We did not perform PCR 
analysis on the presence of transgenes. Therefore, it is unclear whether the lack of RFP 
expression was due to the lack of gene or gene silencing. Event A274-9 was chosen for 
further analyses described below, due to its strong RFP expression and abundance of 
seeds.  
Western Blot of the RFP in the RFP::GAM1 transgenic line. To confirm the 
red fluorescence in seed, indeed, was due to the expression of the RFP, we screened seeds 
selected from two events (A274-3-2 and A274-6-3) by using Western Blot analysis. Eight 
randomly selected seeds from each event were individually ground powder. The total 
aqueous soluble (TAS) protein was extracted from the seed powder at a ratio of 10 µL of 
extraction buffer per mg of seed powder. Equal volume (20 µL) from each seed sample 
was analyzed in Coomassie Brilliant Blue staining or Western Blot. As seen in Figure 3A, 
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TAS protein from eight seeds for each event and 1 µg of the commercial RFP were 
shown by Coomassie staining. A band around 28 kDa, close to the anticipated RFP size 
(27.6 kDa), could be detected in three seeds from A274-3-2 and one seed from A274-6-3 
by RFP antibody in the Western Blot (Figure 3A). One microgram of commercial RFP 
was loaded on to the gel as positive control. However, the smear RFP band is shown for 
all samples.  
Subsequently, we used a RFP affinity column to concentrate the RFP fusion 
protein from the A274 seeds. A274-9-2, an event with stronger red fluoresce in seeds, 
was selected for RFP purification. Due to product inconsistency of the RFP affinity 
columns purchased from MBL International, only the first lot of the Anti-RFP magnetic 
beads worked. The purified protein was split into two equal aliquots and 15 µl each were 
loaded on to two SDS-PAGE gels. One gel was for Coomassie Brilliant Blue staining and 
the other was for the Western Blot. One microgram of the commercial RFP was also 
loaded onto the gel as a positive control. As shown in Figure 3B, a band around 28 kDa 
could be detected from A274-9-2 by the RFP antibody in the Western Blot. A population 
of proteins smaller than the 28 kDa could also be detected from the same lane (observed 
as a smear). It is possible these RFP antibody cross-reacting proteins were the RFP 
degradation products.  
The molecular weight of the commercial RFP control was 27.6 kDa (cat # 4997-
100 BioVision). The molecular weight of the fusion protein RFP::GAM1 was 33.3 kDa, 
predicted from the protein sequence (the molecular weight of the RFP without fusion 
with GAM1 is 28.9 kDa). There may be a slight difference in molecular weight between 
the A274-9-2 sample and the positive control in the Western Blot. However, the 
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difference was not obvious, due to the unfocused band and the resolution limit of the gel. 
Further investigation is needed to ascertain the size of the maize-derived RFP fusion 
protein.  
In summary, the RFP Western Blot result indicated the red fluorescence in seed 
was correlated with the presence of RFP protein in seed protein extract, but the presence 
of GAM1 was undetermined.  
The in-gel digestion/peptide mass fingerprinting of the RFP::GAM1 fusion 
protein. To determine if GAM1 was also expressed with the fusion protein RFP, the 
band of A274-9-2 derived RFP in the Coomassie Brilliant Blue stained SDS-PAGE gel 
was cut out and collected. The gel piece was then digested with trypsin. After digestion, 
the peptides from the sample were released from the gel and analyzed by tandem mass 
spectrometry (MS/MS). The peptide sequence was identified by its pattern from the MS 
results. Thus, the target protein was determined by the sequenced peptides via a protein 
database search. The Protein Facility at Iowa State University completed this in-gel 
digestion/peptide mass fingerprinting method. By using this method, we expected to 
identify the GAM1 sequence. 
The GAM1 however was undetected on several attempts. The peptide sequences 
identified from the MS/MS are always from a common contamination source, Keratin. 
We speculate that the desired peptide sequences were not detected in our samples due to 
a low concentration of the fusion protein. In an attempt to achieve higher concentration 
and better purity of the RFP fusion protein from the seed extracts, we tested a number of 
RFP purification products, such as Protein A MagBeads (Cat # L00273, GenScript), 
RFP-tag Antibody (pAb, Rabbit Cat # A00682-40, GenScript), in addition to the 
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purification kit from MBL International Company described above. Nevertheless, we 
could not obtain a better yield for RFP fusion protein. After discussions with Dr. Charles 
E. Glatz (Department of Chemical and Biological Engineering, Iowa State University), 
we decided to use HPLC as an alternative method to detect GAM1. 
The HPLC of the RFP::GAM1 fusion protein. Dr. Glatz kindly allowed us use 
of the HPLC in his lab to detect the RFP::GAM1, since the E. coli derived GAM1 has 
been successfully identified by using HPLC. Two types of protein samples were used for 
this analysis. One sample type was protein purified by the RFP affinity column from 
A274-9-2. The other sample was the same purified sample, but treated with TEV protease. 
By using the TEV treatment, the GAM1 was expected to cleave from the fusion protein 
and be detected by HPLC. Because of the limited amount of protein, we did not measure 
the concentration prior to sample loading. Fifty microliters of each protein sample 
(treated with or without TEV) was subjected to HPLC analysis. We also included a 
synthetic GAM1 (synthesized by GenScript) as a positive control.  
Only the 1 µg synthesized GAM1 was detected from the HPLC analysis (Figure 
4). Neither the RFP::GAM1 fusion protein nor the GAM1 peptide (from TEV-treated 
protein sample) could be detected. It seemed the expression of the fusion protein was 
below the detection limit.  
Further research is needed to verify the expression of GAM1 in the A274 line. 
Not all RFP::GAM1 transgenic events were analyzed in this study. Only the A274-9-2 
was characterized because it had the most seeds with strong red fluorescence. More or 
even all events should be analyzed. Other commercially-available RFP purification kits 
should also be utilized. Some advanced instruments with higher detection capability, such 
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as High-Resolution Mass Spectrometry (HRMS), should be considered ($1,000 per 
sample) as well.  
 
Characterization of the α-zein::GAM1 transgenic line A273    
In this fusion protein strategy, GAM1 was fused to the C-terminus of maize native 
22-kDa α-zein, under the control of the 22-kDa α-zein promoter and terminator. By 
fusing to the 22-kDa α-zein and using its original promoter and terminator, GAM1 was 
expected to achieve high expression by using the machinery of the most abundant zein 
proteins.  
PCR-positive seeds from two events, A273-2-3 and A273-4-2, were selected for 
characterization because they had large, healthy looking seeds. There is no commercial 
purification kit or antibody available for 22-kDa α-zein. Dr. Paul Scott, USDA and 
Department of Agronomy, Iowa State University, kindly offered us an antibody for zeins. 
The Western Blot analysis was achieved by using this antibody, but multiple bands were 
shown and no difference could be determined between the transgenic positive and 
negative samples (Figure 5). We also checked to determine if the 22-kDa α-zein might 
switch from alcohol-soluble to aqueous-soluble, due to fusion with GAM1. Therefore, the 
TAS protein extracted from the A273 transgenic positive sample was also analyzed by 
Western Blot, however, no zein was detected.  
With help from the Protein Facility at Iowa State University, the band between 25 
to 37 kDa (the predicted 22-kDa α-zein::GAM1 fusion molecular weight is 30.6 kDa) 
from the Coomassie Brilliant Blue stained SDS-PAGE gel were collected and analyzed 
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using the in-gel digestion/peptide mass fingerprinting method. Nevertheless, GAM1 
could not be detected.  
HPLC was conducted to analyze the 22-kDa α-zein fused GAM1 in the A273-2-3 
line. The total zein proteins were extracted from PCR positive A273-2-3 mature seeds 
and analyzed by HPLC (Figure 6). If the α-zein::GAM1 was successfully produced in 
detectable quantity, one additional peak was expected in the A273-2-3 sample when 
compared to its negative segregants. However, no difference was determined between the 
PCR positive and negative samples by comparison of the HPLC results. To perform more 
detailed analysis, each peak from HPLC was collected and further analyzed individually 
by using the mass spectrometer (MS) in the Protein Facility at Iowa State University. 
Nevertheless, the expected fusion protein still could not be identified from a high 
background, possiblly due to a limitation of the MS (Figure 6B). All 22 peaks were 
analyzed and an example of a peak at 37 min is shown in Figure 6B.   
 So far, all methods attempted failed to verify the expression of the α-zein::GAM1 
fusion protein in the A273 line. The α-zein fusion strategy might be reconsidered. It has 
been reported that a 30-amino-acid long peptide hormone GLP-1 was successfully 
expressed in rice when fused to the C-terminus of GFP (green fluorescent protein) 
(Yasuda et al., 2005). The fusion protein was under the control of the rice storage protein 
glutelin GluB-1 promoter, and the glutelin GluB-1 terminator was also used. The signal 
peptide derived from glutelin GluB-1 and the ER retention sequence KDEL were 
included in the construct to lead the fusion protein and accumulate in the ER. The 
accumulation of GFP::GLP-1was detected at the RNA level by Northern Blot in 
immature seeds and at the protein level by Western Blot (anti GLP-1 or anti-GFP) in 
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mature seeds (Yasuda et al., 2005). Another successful example was reported by 
expressing a 39-amino-acid-long antimicrobial peptide sarcotoxin IA (ST) in tobacco by 
fused to the β-glucuronidase (GUS) (Okamoto et al., 1998). The high expression of the 
fusion protein was achieved by either a ST::GUS or GUS::ST fusion strategy and with or 
without a signal peptide of PRla gene of Nicotiana tabacum. All constructs were under 
the control of the 35S promoter and the nos terminator. The expression of the fusion 
protein was analyzed by both GUS assay and anti-ST Western Blot (Okamoto et al., 
1998). These studies suggested that either using an endogenous gene promoter or a strong 
constitutive promoter leads to high expression of fusion proteins. Adding a signal peptide 
and KDEL is also a good strategy. The C- or N- terminus fusion did affect the expression. 
In addition, using an exogenous fusion to partner with the effective detection methods 
available (e.g. GFP or GUS) may facilitate identification and purification.  
In theory, the two strategies designed in the present study should work. However, 
using an endogenous fusion partner (i.e. α-zein) may not be effective because the 
endogenous zein protein was abundant and no effective method exists for detecting or 
purifying either α-zein or GAM1. Future work should verify the RNA expression of the 
α-zein::GAM1 by using Northern Blot or RT-PCR in immature A773 seeds. 
Antimicrobial function  
Peptides with antimicrobial properties are found in all kingdoms of life as part of 
the defense system against microbial invasion (Uzarski and Mello, 2012). Many 
recombinant antimicrobial peptides also have been successfully produced from various 
heterologous hosts (Ingham and Moore, 2007). The synthesized GAM1 (by GenScript 
USA, Inc.) was tested for its antimicrobial ability, according to the methods previously 
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described in (Yang et al., 2007). In short, 20 µL of 4 mM pure GAM1 in PBS solution 
was dropped on the center of a LB plate with E. coli spread evenly. If GAM1 had 
antimicrobial activity, the area GAM1 covered on the medium showed less or no bacteria 
colonies after overnight incubation at 37
o
C. No bacterial growth inhibition was observed 
on the GAM1 plates when compared with water control plates. This preliminary 
experiment suggested the GAM1 peptide had no antimicrobial function against laboratory 
strain E. coli DH5α used for recombinant DNA work. Future experiments including other 
gram positive or negative bacterial strains or fungi should be conducted.  
 
Summary        
GAM1 was reported through production in recombinant E. coli fused with the 
maltose binding protein (MBP) tag (Kaar et al., 2009). The bioactivity test of the E. coli 
expressed GMA1 indicated this biosurfactant peptide was surface active and able to 
induce switching between foam-stabilizing and foam-destabilizing states (Kaar et al., 
2009). Due to the contamination risk and low product quality of recombinant bacteria 
expression system, the transgenic plants have been considered as alternative production 
systems. Here, we report on an attempt to express GAM1 in maize seeds by using a 
fusion protein strategy. The ultimate goal was to recover the fusion proteins from maize 
seeds and utilize the seed remnant for fuel ethanol production.  
Two fusion partners, the RFP and 22-kDa α-zein, were utilized to facilitate 
purification and enhance expression of GMA1. Transgenic maize lines carrying 
RFP::GAM1 and α-zein::GAM1 were successfully generated, and the correct fusion 
sequences were confirmed by DNA sequence analysis and PCR. Seeds in RFP::GAM1 
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transgenic maize lines (A274) displaying red fluorescence were positive for RFP in 
Western Blot analysis, suggesting the RFP in these seeds were produced and correctly 
folded. However, we could not verify the presence of the GAM1 in both RFP::GAM1 
and Zein::GAM1 fusion lines, despite efforts to use various analytical methods, including 
in-gel digestion/peptide mass fingerprinting, HPLC, and MS.  
It is unclear why we were not able to detect GAM1 in both fusion proteins. First, 
we confirmed the fusion sequences were correctly assembled in the vector and intact 
transgenes were present in transgenic seeds. However, we did not check the transgene 
transcripts in seeds. We need to perform reverse transcription PCR (RT-PCR) to 
determine if the entire fusion transcripts can be detected in seeds, even though seeds 
possess a low quantity of RNA. Second, we detected red fluorescence in seeds carrying 
RFP::GAM1 fusion protein. We know at least the RFP was produced and correctly folded. 
Because we could not detect the presence of GAM1, it was possible the fusion protein did 
not become fully processed in the plant seeds due to unknown reasons; only the N-
terminal part of fusion protein, RFP, was produced. It was also possible the overall low 
expression level of RFP::GAM1 fusion protein was below the detection levels of the 
methods used.  
Future work should include RT-PCR screening on all transgenic maize seeds to 
determine whether the full length fusion transcripts are present in seed. If they can be 
detected, one can proceed with protein/peptide detection by using an instrument with 
higher detection capabilities. If no full-length fusion transcripts are detected, one will 
need to redesign the production strategy for this small peptide. Maize seeds may not be 
the best system for small peptide production.   
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Event Plant
# total 
seed
*# red 
fluorescent seed 
% red 
fluorescent
**Fluorescent 
intensity
1 2 16 2 12.5%
1 3 47 14 29.8%
63 16 25.4%
3 1 109 30 27.5%
3 2 126 44 34.9% strong
3 3 1 1 100.0%
3 4 174 53 30.5% strong
410 128 31.2%
5 1 21 10 47.6%
5 2 32 9 28.1%
5 3 2 0 0.0%
55 19 34.5%
6 1 109 0 0.0%
6 2 125 28 22.4%
6 3 117 25 21.4%
6 4 3 3 100.0%
354 56 15.8%
7 1 113 18 15.9%
7 2 2 2 100.0%
7 3 23 2 8.7%
7 4 36 9 25.0%
174 31 17.8%
8 1 20 5 25.0%
8 2 1 0 0.0%
8 3 3 2 66.7%
8 4 7 5 71.4%
31 12 38.7%
9 1 116 44 37.9% strong
9 2 67 51 76.1% very strong
9 3 82 47 57.3% strong
9 4 116 49 42.2% strong
381 191 50.1%
10 2 31 8 25.8%
10 3 53 15 28.3%
84 23 27.4%
11 1 45 20 44.4% very strong
11 2 29 13 44.8% very strong
11 3 26 14 53.8% very strong
11 4 33 13 39.4% very strong
133 60 45.1%
12 1 86 21 24.4% strong
12 2 78 30 38.5%
12 3 89 17 19.1%
12 4 97 29 29.9% strong
350 97 27.7%
11 13 1 36 0 0.0%
2071 633 30.6%
* determined by using a stereoscope coupled with RFP filter 
** intensity roughly determined by naked eyes
8
9
10
3
4
5
6
7
subtotal
subtotal
subtotal
subtotal
subtotal
subtotal
subtotal
subtotal
subtotal
A274
A274
A274
A274
A274
A274
A274
A274
A274
A274
A274
Table 1 Generation of transgenic maize line A274 (RFP::GMA1)
PTF ID
A274
A274
A274
subtotal
1
2
A274
A274
A274
A274
A274
A274
A274
A274
A274
A274
A274
A274
total
A274
A274
A274
A274
A274
A274
A274
A274
A274
A274
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Figure 1. Constructs used in this study. pYJ16, construct for generating transgenic 
maize line A274. Pγzein, 27-kDa γ-zein promoter; γzeinSP, 27-kDa γ-zein signal peptide; 
RFP, the red fluorescent protein; TEV, tobacco etch virus protease recognition site; 
GAM1, the biosurfactant peptide; SEKDEL, endoplasmic reticulum retention sequence; 
x10-09 and x10-10, primers for verifying the presence of RFP::GAM1 in pYJ16; pYJ15, 
construct for generating transgenic maize line A273. Pαzein, 22-kDa α-zein promoter; 
αzein, 22-kDa α-zein gene coding region; Tαzein, 22-kDa α-zein gene terminator; x11-01 
and x11-02, primers for verifying the presence of α-zein::GAM1 in pYJ15; Tvsp, 
soybean vegetative storage protein gene terminator; P35S, 35S promoter; bar, bar gene 
coding region;  LB, left border of Agrobacterium T-DNA; RB, right border of 
Agrobacterium T-DNA  
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Figure 2. Bright field and fluorescent imaging of A274-9-2 (RFP::GAM1) kernels. 
White arrows indicate the segregate of two RFP positive kernels. The other two are the 
segregate of RFP negative kernels  
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Figure 3. Coomassie Brilliant Blue staining and Western blot of A274 (RFP::GAM1) 
line. (A) Coomassie Brilliant Blue staining and Western blot of total aqueous soluble 
protein extracted from seed powders of eight kernels from each —274-3-2 and A274-6-3. 
(B) Coomassie Brilliant Blue staining and Western blot of RFP affinity column purified 
total aqueous soluble protein from A274-9-2 (denoted as A274 on the top of both 
Coomassie and Western lanes). RFP, 1 µg of the commercial RFP control; M, the 
molecular weight standard. Anti-RFP antibody was used to detect the RFP in Western 
blot.   
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Figure 4. GAM1 HPLC. 1 µg synthesized GAM1 was detected by HPLC around 28 min. 
The wavelength was 210 nm.  
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Figure 5. Western Blot of α-zein::GAM1.  Anti-zein rabbit polyclonal antibody (from 
Dr. Paul Scott) is used to detect zeins from A273-2-3 and A273-4-2. WT, wild type 
control B73 line.  
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Figure 6. Transgenic maize line A273-2-3 zein Liquid Chromatography Mass 
Spectrometry (LCMS). Total zein proteins were extracted from A273-2-3 PCR-positive 
seed and analyzed by LCMS. (A) Zeins separated by the C18 column (5 microns, 2.1 mm 
X 250 mm). The wavelength for detecting zeins is 214 nm. (B) One MS result of the peak 
appears around 37 min from liquid chromatography. No significant protein was identified 
from the background in this peak. All other individual peaks were also analyzed by MS, 
but not shown here, due to the length of the figure. No significant proteins were identified 
from all peaks.    
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Abstract  
Plant-made pharmaceuticals (PMPs) offer promise as efficient and cost-effective 
products for the treatment of human and animal diseases.  An advantage of producing 
pharmaceuticals in maize is the large storage capacity and stability for proteins and starch in 
seed, allowing for manufacturing recombinant proteins such as antigens and antibodies.  
Other advantages of the maize system include safety, high yields, and scalability of 
production and processing.  However, the benefits of this technology must be balanced 
against potential health and environmental risks that may be associated with its use.  Because 
PMPs presently have no provision for regulatory tolerance, their inadvertent occurrence in 
foods and feeds remains an important economic consideration, even when the health and 
environmental risks are low.  Pollen drift is considered a source of potential contamination of 
maize-made pharmaceuticals in the food chain.  In addition to physical and temporal 
isolation requirements, open field pharmaceutical maize production also calls for controlled 
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pollen release.  Here, we describe two strategies to address the issue of transgenic pollen drift.  
First, we describe the development and genetic transformation of a tissue culture-amenable 
male-sterile line using biolistic- or Agrobacterium-mediated transformation methods.  
Secondly, we describe the introgression of a transgene from male-fertile transgenic maize to 
male-sterile germplasm by conventional breeding.  After six seasons of breeding, this second 
strategy allows us to obtain 100% transgenic seeds from an open-field production using a 
non-transgenic line as the pollinator.   
 
Introduction 
Maize grain is used as feedstock for many large volume industrial products (e.g. 
ethanol, biodiesel, poly-lactic acid, sweeteners) and has been demonstrated to be an effective 
expression system for functional proteins of prokaryotic (Bailey et al., 2004; Chikwamba et 
al., 2002a; Streatfield et al., 2001; Witcher et al., 1998;); viral (Streatfield et al., 2001) and 
eukaryotic (Hood et al., 1997; Yang et al., 2002; Zhong et al., 1999) origins.  Previously we 
have successfully produced a transgenic maize line expressing a B-subunit protein of 
Escherichia coli heat labile enterotoxin (LT-B) (Chikwamba et al., 2002a).  Mice fed with 
maize-derived LT-B were protected against diarrhea-inducing E coli toxins and showed 
reduced symptoms compared to control mice fed with non-transgenic maize meal 
(Chikwamba et al., 2002a).   
There are several benefits of producing antigens for use as edible vaccines in maize 
(Streatfield, 2007; Ramessar et al., 2008).  Maize is a major crop world wide used for food, 
feed and fuel.  As food and feed, maize is well tolerated by both humans and animals since it 
is non-toxic and non-allergenic.  Compared to bacterial and mammalian systems, the use of 
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maize for producing recombinant proteins greatly reduces the possibility of contamination 
with mammalian pathogens.  Maize yields are high and its seed is a natural protein storage 
site that can be harnessed as an efficient protein production factory.  According to Hood and 
coworkers (Hood et al., 1999), maize can be used to produce foreign proteins at rates that are 
in excess of 2 kilograms per acre at a cost of a few cents per milligram.  Breeding techniques 
can be used in this crop to enhance foreign protein expression (Chikwamba et al., 2002b; 
Hood et al., 1997; Streatfield et al., 2001; Witcher et al., 1998).  Moreover, the infrastructure 
for large scale grain production and seed processing are well established for the crop in the 
United States.   
Since maize is one of the most important crops globally, there are many issues that 
arise regarding its use as a source of biopharmaceuticals.  Major concerns, especially in the 
case of vaccine-producing maize plants, are whether the antigens will inadvertently enter the 
food chain and what measures are in place to prevent this (Ripplinger et al., 2009).  There are 
three broad categories of grain handling systems used in the U.S.: commodity, identity-
preserved, and seed (Strayer, 2004).  These systems vary in their purity standards, which are 
primarily based on end-user requirements.  The commodity system is used when there are no 
requirements for differentiation by end users and the identity-preserved system is used when 
end-users require specific grain characteristics.  The seed system is used specifically for 
producing the seed to be planted for commodity and identity-preservation systems (Strayer, 
2002; 2004).  
One major concern with regard to cross-contamination in these systems is the 
potential for transgenic maize pollen to drift to surrounding non-transgenic maize fields.  
Several measures can be taken to prevent pollen contamination from a vaccine-producing 
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maize plant.  First, any APHIS (Animal and Plant Health Inspection Service, USA) approved 
pharmaceutical maize field release currently requires a separation distance of 1 mile (5280 
feet or 1609 km) from the nearest maize plant (BRS, 2006).  This physical isolation is eight 
times greater than the distance required for production of foundation maize seed or identity 
preservation.  Second, confinement strategies for transgenic maize produced under permit 
include conditions that prevent transgenic maize pollen from pollinating surrounding fields.  
Current APHIS rules stipulate that non-pharmaceutical maize may be grown within one half 
mile (2640 feet) of the test site if the regulated pharma-maize is control-pollinated by 
detasseling or bagging procedures.  For temporal isolation, pharma-maize must be planted no 
less than 28 days before or after the surrounding non-pharma maize is planted (APHIS, 2008).   
In addition to spatial and temporal isolation, it is also possible to prevent 
contamination from transgenic pollen drift by producing vaccines in maize varieties that are 
male-sterile.  A number of cytoplasmic male-sterile varieties producing near 0% viable 
pollen can be used for this purpose (Levings III, 1993; Gabay-Laughnan and Laughnan, 
1994).  Because transgenic male-sterile maize does not produce viable pollen, its female 
flowers can be pollinated by non-transgenic maize pollen to set seed.  According to 
Ripplinger et al (2009), if pollen produced from pharmaceutical maize is controlled, the risk 
of accidental release and food supply contamination is very close to the target tolerance level 
of zero.   
Here we describe two strategies that can be used to produce male-sterile transgenic 
maize lines suitable for open-field pharmaceutical production.  One strategy is to directly 
introduce the transgenes into transformable male-sterile germplasm.  A fertile and 
transformation-amenable Hi II genotype (Armstrong et al., 1991) was converted into a male-
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sterile, transformation-amenable group of lines by crossing to cytoplasmic male sterile 
(CMS)-T (Texas) maize.  This is the first report of successful transformation of such male-
sterile lines using the biolistic-(gene gun) or Agrobacterium-mediated methods.   
The second strategy involves transfer of the subunit vaccine gene from a fertile 
transgenic line to a cms-T B37 background.  After six seasons of breeding, male-sterile 
transgenic maize seed can be used for open-field production using a non-transgenic pollen 
donor to produce seeds for large scale recombinant protein recovery, 100% of which contain 
the subunit vaccine gene. 
 
Materials and Methods 
Germplasm 
Development of the tissue culture amenable (T) germplasm used in this study was 
previously described (Wise et al., 1999b).  Briefly, T-cytoplasm A188 [(T) A188] was 
pollinated by N-cytoplasm Hi II (high Type II, or HT), the standard germplasm for maize 
transformation (Armstrong and Green, 1985; Armstrong et al. 1991).  (N) HT is originally a 
tissue-culture line derived from A188 and B73, hence the selection of (T) A188 as the T-
cytoplasm female.  Immature embryos were excised from the resulting F1 seed, cultured on 
N6E30 medium (Frame et al., 2000), and selected based on Type II callus response.  Callus 
was then transferred to regeneration medium (Frame et al., 2000), and T cytoplasm plantlets 
were grown to maturity.  Since the resulting ears were T cytoplasm, they were pollinated by 
(N) HT.  Male-sterile, (T) HT plants were maintained by pollinating with the (N) HT stock 
(Pei, 2000).  Genotype nomenclature and crosses made for seed increase and embryo 
production for transformation purposes are detailed in Table 1.  For introgression 
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experiments, cms-T B37 seed was increased via isolation plot in our 2000 Ames, IA summer 
nursery.   
Plant materials 
For genetic transformation: Immature embryos (1.5-2.0 mm) were aseptically 
dissected from 10-13 day old field or green house-grown ears of male-sterile (T) and male-
fertile (N) germplasm.  Male-sterile phenotypes were assessed for each donor plant used or 
transgenic R0 and R1 plant produced in this study by monitoring the presence or absence of 
pollen shed from mature plants.  Structural anatomy of (T) and (N) cytoplasm transgenic 
plants (Figure 1) was compared and imaged using an Olympus SZ stereo-microscope (Leeds 
Precision Instruments, Minneapolis).  
DNA plasmid constructs and Agrobacterium strain for plant transformation 
Construct pAHC25 (Christensen and Quail, 1996), containing the maize ubiquitin 
promoter driving both bar and gus-intron gene cassettes (Pubi-bar/Pubi-gus intron), was used 
for all biolistic gun-mediated transformation experiments.   
Agrobacterium tumefaciens strain EHA101 (Hood et al., 1986) harboring the standard 
binary vector pTF102 (Frame et al., 2002), was used in all Agrobacterium-mediated 
transformation experiments.  This vector carries a P35S-bar/P35S gus-intron cassette.  A 
fresh bacteria culture was initiated from -80°C every four weeks on solid YEP (An et al., 
1988) containing antibiotics (100 mg/L spectinomycin, 50 mg/L kanamycin, 25 mg/L 
chloramphenicol) and stored at 4°C.  Cultures for weekly experiments were initiated from 
this 4°C “mother” plate and grown at 19°C for 3 days before use.  Final OD550 in all 
experiments ranged from 0.3-0.4.  All other bacteria manipulations, maintenance and pre-
infection preparation steps were identical to the protocol detailed in Frame et al. (2002).  
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Culture media 
Biolistic transformation: All media components and preparation steps were detailed in 
Frame et al. (2000) as adapted from Songstad et al. (1996).  Petri plates (100x15 mm) were 
used for all bombardment and selection media.  
Agrobacterium-mediated transformation: All N6 media (Chu et al 1975) components 
were described in Frame et al. (2002).  Co-cultivation media was modified from Zhao et al. 
(2001) to contain 300 mg/L cysteine; resting and selection media contained a combination of 
cefotaxime (100 mg/L) and vancomycin (100 mg/L) for counter selection.  All solid media 
tissue culture steps used 100x25 mm Petri-plates and all stocks were prepared as described in 
Frame et al. (2002).   
Regeneration Media: Independent, bialaphos resistant Type II callus events generated 
from either transformation protocol were sub-cultured to a Petri-plate (100x25 mm) 
containing MS salts (Murashige and Skoog, 1962) and modified MS vitamins (Frame et al 
2006), 6% sucrose, 100 mg/L myo-inositol, no hormones (Armstrong and Green, 1985), 0.3% 
gelrite, pH 5.8 and supplemented with 4 mg/L glufosinate (Sigma, St. Louis).  Cefotaxime 
(250 mg/L), added to this media after autoclaving, was included for Agrobacterium-derived 
putative events.  Three weeks later, mature somatic embryos were germinated in the light on 
MS Salts and modified MS vitamins, 3% sucrose, 100 mg/L myo-inositol and 0.3% gelrite 
(pH 5.8) without glufosinate or cefotaxime.  Petri-plates were wrapped with vent tape. 
Transformation protocols 
Biolistic-gun mediated: Transformation and selection procedures were as previously 
described for immature zygotic embryo transformation (Frame et al., 2000) except that DNA 
quantity per bombardment was reduced and embryos were bombarded 3 rather than 4 days 
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after dissection in the present study.  This protocol is used for routine production of 
transgenic (N) HT maize in our laboratory.  Briefly, 30 zygotic embryos per plate were 
dissected, scutellum side up, in a 2 cm
2
 grid on the middle of a Whatman No 5 filter paper 
laying on the surface of callus initiation medium.  These plates were incubated at 28°C (dark) 
for 3 days.  The morning of bombardment, an osmotic pretreatment of targeted embryos was 
begun by carefully transferring each grid of embryos (still on the filter paper) to the center of 
a Petri plate (100x15 mm) containing maintenance media supplemented with 0.2 M sorbitol 
and 0.2 M mannitol (Vain et al 1993).  Four hours later, each plate of embryos on osmotic 
medium was bombarded once at 650, 6 cm target, ¼ inch gap.  For bombardment, 10 macro-
projectiles (10 µl each) were prepared from one tube of 0.6 micron gold particles (3 mg) 
coated with 0.075 µg plasmid pAHC25.  The following morning, embryos were transferred, 
scutellum side up, to the surface of maintenance medium (28°C, dark) and 10 days later sub-
cultured to selection medium (28°C, dark) containing 2 mg/L bialaphos.  Embryos were 
subcultured to this medium a second time three weeks later.  Six to 10 weeks after 
bombardment, each bialaphos resistant putative transgenic callus event was harvested to its 
own plate of selection medium for bulking up and regeneration as described above.  
Agrobacterium-mediated: Infection, co-cultivation and selection procedures were all 
according to Frame et al. (2002).  This protocol is used routinely in our laboratory for 
production of transgenic maize using an Agrobacterium standard binary vector to transform 
(N) HTF2 germplasm.  Briefly, embryos from a single ear were dissected to an eppendorf 
tube (2 ml) filled with bacteria-free infection medium and washed once with the same before 
infecting with diluted, pre-cultured (2-5 hours) Agrobacterium suspension.  After 5 minutes 
infection (without vortexing), embryos were plated scutellum side up on 4-day old co-
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cultivation media containing 300 mg/L cysteine, and cultured at 20°C (dark).  After 3 days 
co-cultivation, all embryos were transferred to resting media containing cefotaxime (100 
mg/L) and vancomycin (100 mg/L) but no bialaphos and incubated at 28°C (dark) for 7 days 
after which all embryos were transferred to selection medium containing 1.5 mg/L bialaphos 
and antibiotics.  Selection was enhanced to 3 mg/L bialaphos for 2 two-week intervals after 
which individual, transgenic events could be seen emerging as actively growing Type II 
callus lobes on otherwise brown and dying zygotic embryo explants (Figure 2c).  At this time, 
each putative event was sub-cultured to its own plate of selection medium.  Putative events 
that continued to produce vigorous, embryogenic callus on selection medium containing 3 
mg/L bialaphos were regenerated for 3 weeks (25°C, dark) on media containing 4 mg/L 
glufosinate, germinated in the light, and grown to maturity in the green house as previously 
described (Frame et al., 2002). 
Histochemical GUS assays of callus and leaves from R1 progeny  
GUS histochemical assays (Jefferson et al, 1987) were carried out on all bialaphos-
resistant putative transgenic calli recovered from selection, and on leaf pieces of male-sterile 
and control R1 progeny plants to confirm expression of the gus transgene in segregating 
offspring of these germplasms. A single, 2 cm leaf piece was cut from each progeny plant, 
grouped by event in 60x20 mm Petri plates, and submerged in 4 ml X-Gluc solution.  Plates 
were vacuum-infiltrated for 10 minutes at 15 in Hg then wrapped with parafilm and 
incubated at 28°C for 20 hours.  Chlorophyll de-staining was done using a 6 hour 70% 
ethanol wash followed by an overnight 95% ethanol wash.  A stereo-microscope was used to 
identify the number of blue and non-blue staining leaves for each segregating event. 
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R1 progeny screening for bar gene expression 
After sampling progeny for GUS assays, R1 progeny of male-sterile and control 
germplasm were screened for bar gene expression by spraying 9 day old seedlings with a 250 
mg/L solution of glufosinate prepared from the herbicide Liberty® (Bayer, Research 
Triangle Park, NC).  The herbicide resistant/sensitive scores were recorded 4 days after the 
spray.   
 
Results and Discussion 
Biolistic gun transformation of male-sterile germplasm 
Field and green house derived immature embryos of (N) HTF2 and (T) male-sterile 
germplasms were targeted for biolistic transformation in 2003 and 2004 (field only).  Non-
transgenic (T) F2, and (T) B(BCn) embryo donor ear phenotypes were similar, with up to 200 
zygotic embryos per ear (Figure 2a), however (T) A(BCn) embryo donor ears were 
consistently small with poor seed set (not shown).  Transient GUS expression in (T) 
germplasm embryos was observed (Figure 2b), and the average transformation frequency (TF) 
for the (T) germplasms was equal to or higher than for the (N) HTF2 control material (Table 
2).  Across the 2003 and 2004 field seasons, the highest average TF was achieved for (T) 
B(BC0) material (19%) compared with the (N) HTF2 control (12%).  Histochemical GUS 
expression was observed in 62% of the bialaphos resistant callus events assayed in this study 
and expression of the unselected gene did not appear to depend on germplasm (Table 2).  
Except for the male-sterile tassel phenotype, all (T) germplasm transgenic plants 
resembled those of (N) germplasm control plants and transgenic ear sizes were similar 
(Figure 2e).  Average female fertility (events with > 50 kernels) for transgenic events derived 
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from (T) germplasm was higher (71%) than for (N) HTF2 control events (52%, Table 2).  
Finally, none of the 97 (T) cytoplasm transgenic plants (representing 67 independent 
transgenic events) taken to maturity shed pollen, while an average of 78% of the 35 (N) 
HTF2 transgenic events in this study shed pollen at maturity (Table 2, Figure 1).  
Furthermore, all 32 R1 progeny plants (representing 16 gun-derived events) taken to maturity 
after progeny tests were male sterile (not shown). 
Agrobacterium-mediated transformation of male-sterile germplasm 
Greenhouse and field immature embryos of (N) HTF2 and (T) germplasms were 
transformed with the Agrobacterium standard binary vector pTF102 (EHA101) (Frame et al., 
2002) in the spring and summer, respectively, of 2004.  On average, the three (T) male-sterile 
lines transformed at higher frequencies than did the (N) HTF2 male-fertile control, 
demonstrating that this T-cytoplasm material is readily transformable using the 
Agrobacterium-mediated method described (Table 3).  In field 2004 experiments, a TF of 22% 
was achieved using (T) A(BC1) germplasm compared with 7% for the (N) HTF2 control.  (N) 
HTF2, (T) F2 and BC0 of (T) A and (T) B were all targeted in both the greenhouse and field 
experiments in 2004 and the average TF for field-derived embryos (6%) was higher than that 
for the greenhouse study (2%).  In histochemical GUS assays carried out on all bialaphos 
resistant callus events recovered from Agrobacterium-mediated experiments, 90% of events 
also expressed the gus gene (Table 3, Figure 2d).  An average of 72% of the 56 (T) male-
sterile transgenic plants (representing 41 independent transgenic events) grown to maturity in 
the green house were female-fertile and none shed pollen.  In contrast, the five (N) HTF2 
control events (1 plant/event) in this study shed pollen at maturity and all were female-fertile 
(Table 3). 
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Progeny analysis in biolistic of transgenic events 
Analysis for expression of the bar and gus trangenes in gun-derived R1 progeny 
plants demonstrated Mendelian inheritance of the bar gene in 14 of 15 (T) germplasm 
derived events and 2 of 3 (N) HTF2 events (Table 4).  In contrast, gus marker gene 
expression in segregating progeny did not follow the predicted pattern for Mendelian 
inheritance at a single locus in almost half of the events (8 of the 18 events).  These abnormal 
segregation ratios were observed in both male-sterile and male-fertile genetic backgrounds 
(Table 4).  Expected segregation ratios were observed for bar gene expression in all R1 
progeny plants derived from Agrobacterium-mediated transformation events (Table 4), and 
only 2 of these 12 events segregated abnormally for the gus gene. 
Introgressing of transgenic maize expressing subunit vaccine into male-sterile 
germplasm via breeding 
One strategy proposed for the safe production of pharmaceutical maize seed is to 
express the pharmaceutical proteins in a male sterile genetic background (Lamkey, 2004).  A 
breeding scheme using 3 genotypes was designed for transferring the transgene into a T-
cytoplasm male-sterile (CMS) background.  In order for a T-cytoplasm line to produce pollen, 
it must carry dominant alleles of two nuclear genes, Rf1 and Rf2 (Schnable and Wise, 1998; 
Wise et al., 1999).  Plants with the genotype Rf1/rf1, Rf2/rf2 can also be fertile as they carry 
the required copy of the dominant Rf1 allele plus 1 copy of the dominant Rf2 allele. 
The first line, designated (T) B37 rf1/rf1, Rf2/Rf2, b/b, was inbred B37 that contained 
male-sterile cytoplasm, was male-sterile, and did not contain the LT-B gene (designated by 
b/b).  The second line, designated (N) B37 rf1/rf1, Rf2/Rf2, b/b, contained normal cytoplasm, 
was male-fertile, and did not contain the LT-B gene.  This line is referred to as a maintainer 
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line because it is needed to produce seed from the male-sterile line.  The third line, 
designated (N) HT rf1/rf1, Rf2/Rf2, B/B, carried the transgene, and was male-fertile.  In this 
line, the transgene cassette contains a gene encoding the B-subunit of the E. coli heat labile 
enterotoxin (LT-B) under control of the 27 kD gamma zein promoter (an endosperm-specific 
promoter).  The transgene was introduced into (N) HT germplasm (Chikwamba et al., 2002a) 
and the LT-B expressing homozygous line was generated after several generations of self 
pollination.  B is the transgene we wanted to transfer to T cytoplasm, and throughout this 
study, we assumed that HT germplasm was a non-restoring genotype   
Figure 3 illustrates the breeding strategy used for transferring the LT-B gene into 
male-sterile (T) B37.  Note that females are always listed first in a cross.  In Steps 1 and 2, 
we generated a BC1 population that contained 50% heterozygous transgenic seeds (N) B37
2
 
rf1/rf1, Rf2/Rf2, B/b and 50% non-transgenic segregants (N) B37
2
 rf1/rf1, Rf2/Rf2, b/b, by 
crossing the male-fertile restorer line (N) B37 rf1/rf1, Rf2/Rf2, b/b and transgenic heterozygous 
line (N) HT rf1/rf1, Rf2/Rf2, B/b (produced in Step 1).   
In Step 3, any non-transgenic segregants were effectively eliminated at the seedling 
stage by spraying with herbicide Liberty®.  Pollen from herbicide resistant heterozygous 
transgenic seeds (N) B37
2
 rf1/rf1, Rf2/Rf2, B/b was used to cross with the male-sterile (T) B37 
rf1/rf1, Rf2/Rf2, b/b.  This step resulted in a male-sterile population containing 50% 
heterozygous transgenic seeds, (T) B37
3
 rf1/rf1, Rf2/Rf2, B/b, and 50% non-transgenic 
segregants, (T) B37
3
 rf1/rf1, Rf2/Rf2, b/b.   
Step 4 (a, b and c) demonstrates how we selected and bred a homozygous transgenic 
maintainer line (N) B37
2
 rf1/rf1, Rf2/Rf2, B/B from the BC1 maintainer line harvested in Step 2.  
Once the homozygous transgenic maintainer line was achieved, it was used in Step 5 to 
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pollinate the heterozygous sterile BC2 generated from Step 3.  Seeds from Step 5 were male-
sterile and all carried the LT-B transgene, 50% (T) B37
4
 rf1/rf1, Rf2/Rf2, B/B and 50% (T) 
B37
4
 rf1/rf1, Rf2/Rf2, B/b.  This seed was then used in field production (Production 1) for LT-
B maize, in which a non-transgenic line was used as the pollen donor.  After this four-season 
breeding cycle, 75% of the seeds harvested were expected to express the LT-B protein.  To 
achieve 100% LT-B seed from field production (Production 2), the homozygous transgenic 
sterile line (T) B37
5
 rf1/rf1, Rf2/Rf2, B/B) was generated over an additional two growing 
seasons (Step 6).   
This breeding strategy was accomplished using both greenhouse facilities and field 
nurseries.  Open-field containment procedures followed strict USDA-APHIS regulations.  
Transgenic pollen remained contained at all times by bagging tassels, or by using male sterile 
material.  Tassel production and pollen viability in field conditions were monitored after the 
transgene was transferred into the male-sterile line.  All of these plants produced tassels, 75% 
of which did not shed pollen.  In the 25% of transgenic male-sterile plants that did shed 
pollen, no viable pollen was detected (X. Xu, unpublished), indicating that no fertility was 
restored in these plants. 
 
Conclusions 
We describe possible strategies for using cytoplasmic male sterile (cms-T) germplasm 
in open-field production of transgenic maize producing a pharmaceutical product.  In the first 
approach, a male-sterile germplasm amenable for tissue culture and transformation was 
developed from the widely used Hi Type II genotype.  Male-sterile transgenic events (non-
pharmaceutical) were generated using the biolistic gun and Agrobacterium-mediated 
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transformation methods and grown to maturity in the greenhouse.  While in vitro culture 
induced variation did not alter the male sterile phenotype in this study, the possibility that 
this could occur cannot be ruled out.      
Secondly, a pharmaceutical transgene introduced into (N) cytoplasm using the 
biolistic gun was transferred into a male-sterile genotype via conventional breeding.  Our 
transgene or the transgene insertion site did not restore male fertility in transgenic maize 
plants (although a non viable pollen was shed in 25% of plants), thereby affirming the 
applicability of this technology.  However, it is prudent to state that any potential restoration 
or reversion should be examined on a gene-by-gene basis.   
There may be a third strategy that could accelerate production of male-sterile 
homozygous pharmaceutical maize seed.  Both male-fertile and male-sterile genotypes can 
be directly transformed with the transgene of interest.  The male-fertile transgenic maize that 
serves as the maintainer line could be made homozygous and its pollen could then be used to 
cross to the male-sterile transgenic female.  Progeny would then carry two copies of the 
transgene at different loci.  While this practice may save 2-3 seasons of breeding, the 
presence of multiple transgene copies may cause transgene silencing (Meng et al., 2003; 
Shou et al., 2004).   
The outcome of using cms-T maize for large scale open-field release of a 
pharmaceutical product is untested.  T-cytoplasm maize is highly sensitive to the host 
selective pathotoxin HmT, produced by Cochlobolus heterostrophus Drechsler race T (Wise 
et al. 1999a).  While no obvious pathogen damage was observed in the small field 
experiments carried out in our study, it is important to bear in mind that recurrent large scale 
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field release of cms-T genotype may encourage reappearance of Southern maize leaf blight, 
which could lead to yield loss in Texas male-sterile, pharmaceutical maize.      
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Table 1. Description of germplasm used for genetic transformation * 
Pedigree
Femal
e
Male
(T) pA (T) A188/(N) HT pA x (N) HT pA BC6 fertile sterile (T) pA x (N) HTpA none NT
(T) F1 (T) A188/(N) HT pA x (N) HT pB BC0 fertile sterile (T) pA x (N) HTpB (T) F1 x (N) HTF1 (T) F2
(T) PeiA(BC0) [F98 (T) A188/HT A/B x (N) A188/HT 
A/B] x (N) HT pA 
Tissue culture regenerated plants from 
the greenhouse
fertile sterile (T) PeiA x (N) HTpA (T) PeiA(BCn) 
x 
(N) HTF1 
(T) A(BC0) in 
2003/4
(T) A(BC1) in 2004
(T) PeiB(BC0) [F98 (T) A188/HT A/B x (N) A188/HT 
A/B] x (N) HT pB 
Tissue culture regenerated plants from 
the greenhouse
fertile sterile (T) PeiB x (N) HTpB (T) PeiB(BCn) 
x 
(N) HTF1
(T) B(BC0) in 2003/4 
(T) B(BC1) in 2004
(N) HTpA HT parent A fertile fertile (N) HTpA x (N) HTpA none NT
(N) HTpB HT parent B fertile fertile (N) HTpB x (N) HTpB none NT
(N) HTF1 HT pA x HT pB fertile fertile (N) HTpA x (N) HTpB (N) HTF1 x (N) 
HTF1
(N) HTF2
(T): Texas male sterile cytoplasm
(N): Normal male fertile cytoplasm
NT: not tested
Transformation 
genotype 
nomenclature **
* Male-sterile (T) pA, (T) PeiA or (T) PeiB seed w as increased in 2003 by pollinating w ith the male-fertile (N) HTpA or (N) HTpB or to make
the F1 hybrid cross (T) pA x (N) HTpB. Embryo production for transformation purposes w as achieved by crossing these stock plants w ith
(N) HT F1 pollen in all cases. In 2003 and 2004, pollinations w ere carried out on plants grow n from the original pedigree [(T) BC0 x (N) HTF1 ].  
As w ell, in 2004 pollen from (N) HTF1 w as taken to one generation advanced (T) A(BC1) and (T) B(BC1) plants to produce (T) A or (T)
B(BC1) immature embryos for transformation experiments. (N) HTF1 plants w ere sib or self pollinated to produce (N) HTF2 embryos for
transformation of control material in this study.
** Nomenclature of immature zygotic embryo donor plant for genetic transformation.
PhenotypeBase 
germplasm 
ID
Cross for seed 
increase
Cross for 
transformation
150 
 
 
 
  
Source Donor 
plant
genotype
# Ears # Emb 
bba 
# Bialaphos 
resist 
events
% 
TFb
% Stable 
events GUS 
positivec
% Events 
with >50Kd 
% Events 
with pollen 
shede
2003 gh (N) HTF2 15 945 93 10 65 50 87
(T) F2 19 1400 232 17 60 82 0
2003 field (N) HTF2 16 1110 136 12 61 55 70
(T) F2 11 600 87 15 46 58 0
(T) A(BC0) 13 881 116 13 54 75 0
(T) B(BC0) 15 930 228 25 58 70 0
2004 field (N) HTF2 9 800 101 13 74 NT NT
(T) A(BC0) 2 272 48 18 69 NT NT
(T) A(BC1) 2 138 7 5 57 NT NT
(T) B(BC0) 6 382 50 13 80 NT NT
(T) B(BC1) 3 81 23 28 65 NT NT
a all embryos bombarded (bb) w ith pAHC25
b # independent bialaphos (2 mg/L) resistant events / total # embryos bombarded (X100)
c all callus events w ere assayed for histochemical GUS expression
de # independent events to seed (1 or 2 plants per event) ranged from 8 -30 events
NT (not tested)
Table 2. Biolistic gun transformation frenquency (TF), seed set, and pollen shed for Hi II (N) and (T)
germplasms
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Resb Senc Posd Nege
Biolistic eventsg
HTF2 187 7 8 0.1 6 9 1
(T) F2 753 13 12 0.0 0 25 25
(T) F2 771 4 21 11.6 3 22 14
(T) F2 777 11 18 1.7 13 16 0
(T) F2 760 12 17 0.9 0 29 29
(T) F2 752 11 18 1.7  15 14 0
HTF2 193 8 20 5.1 0 28 28
(T) A(BC0) 1057 17 13 0.5 0 30 30
(T) A(BC0) 1066 13 15 0.1 5 23 12
(T) A(BC0) 1028 15 14 0.0 15 14 0
(T) A(BC0) 1024 8 12 0.8 9 11 0
(T) A(BC0) 1018 12 16 0.6 0 28 28
HTF2 186 12 18 1.2 0 30 30
(T) B(BC0) 1252 14 11 0.4 17 8 3
(T) B(BC0) 1108 16 14 0.1 15 15 0
(T) B(BC0) 1207 10 15 1.0 16 9 2
(T) B(BC0) 1176 9 15 1.5 13 12 0
(T) B(BC0) 1204 18 11 1.7 19 10 3
Agro eventsg
HTF2 63 12 15 0.3 16 11 1
(T) F2 468 16 14 0.1 15 15 0
(T) F2 465 13 12 0.0 12 13 0
(T) F2 405 15 12 0.3 0 27 27
HTF2 72 14 15 0.0 15 14 0
(T) A(BC0) 453 16 11 0.9 14 13 0
(T) A(BC0) 446 10 16 1.4 9 17 3
(T) A(BC0) 426 17 12 0.9 15 14 0
HTF2 64 20 10 3.3 15 15 0
(T) B(BC0) 429 14 16 0.1 18 12 1
(T) B(BC0) 444 12 15 0.3 5 22 11
(T) B(BC0) 445 13 17 0.5 16 11 1
c Sen, sensitive to glufosinate spray (bar  non-expresser)
Event ID
g biolistic events  transformed w ith pAHC25 and Agro events w ith 
pTF102 (EHA101)
a Transgenic plants w ere crossed as the female parent w ith pollen 
from non-transformed B73 plants or Hi II (Agro event #'s 64, 72, 444) 
d Pos, GUS assay positive (gus -expresser)
e Neg, GUS assay negative (gus  non-expresser)
Table 4. Segregation analysis for gus and bar  gene 
expression in R1 generation progeny plants
a 
f X2=3.8 (0.05, 1 df)
Herbicide Gus
b Res, resistant to glufosinate spray (bar -expresser)
Genotype
Segregation Ratio
X2f X2f
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Figure 1. Tassels of gun-derived pAHC25 transgenic (T) F2 (left) and (N) HTF2 (right) 
plants at anthesis in greenhouse.  No anther extrusion is visible on tassel of (T) F2 transgenic 
event (b) while (N) HTF2 event (c) is undergoing anthesis.  Florets of transgenic (T) F2 plants 
contain degenerated anthers (d and f) while those of (N) HTF2 transgenic plants are filled (e) 
with pollen grains (h, bottom).  No pollen grains are visible in (T) germplasm transgenic 
anthers (h, top).  GUS expressing, viable pollen grains are visible in X-Gluc stained anthers 
of (N) transgenic germplasm (i, bottom) but not (T) transgenic germplasm (i, top) 
transformed with pAHC25 using the biolistic gun.   
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Figure 2. (N) HTF1 (right) and (T) F1 (left) greenhouse grown donor ears (a).  (T) F2 
immature embryo stained for transient GUS expression 5 days after Agro-infection with 
pTF102 (b). Putative transgenic events (arrows) emerging from 3 mg/L bialaphos selection 
of Agro-infected (T) A(BC1) field 2004 embryo infections (c).  Stable GUS expression in 
putative callus events from field 2004 Agrobacterium-derived (N) and (T) events (d).  Seed 
set on 3 (T) F2 (top) and 3 (N) Hi II F2 (bottom) pAHC25 gun-derived transgenic events (e).   
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Figure 3. Breeding schemes for achieving (a) 75% and (b) 100% LT-B maize seed 
production in the field.  T, male sterile, N, male fertile, rf1/rf1, Rf2/Rf2, nuclear restorer gene 
genotype, B, dominant transgene LT-B.  Genotype with letter strikethrough represents non-
transgenic segregants eliminated by herbicide spraying at plantlet stage. 
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CHAPTER 6: EVALUATION OF GFP EXPRESSION LEVELS IN TRANSGENIC 
MAIZE LINES WITH DECREASED SEED PROTEIN -ZEIN OR OVER-EXPRESSING 
A ZEIN TRANSCRIPTION FACTOR PBF  
 
Xing Xu, Liyan Yang and Kan Wang 
 
Abstract  
Maize is an important crop worldwide and has been used to produce recombinant 
proteins as a safe and cost effective source. However, the low levels of recombinant 
protein expression challenge the application of plant-based systems. In the present study, 
we present two strategies for improving the recombinant protein expression in maize 
seeds. The first strategy is to knock down the major seed storage protein γ-zein. The 16- 
and 27-kDa γ-zeins were knocked down by RNA interference (γRNAi) and crossed with 
a 27-kDa γ-zein promoter-driving green fluorescent protein (γGFP) line. The GFP 
expression in F1 progeny was decreased in the γGFP/γRNAi seeds, which is opposite to 
what was expected. Because the γ-zeins are essential for correct protein body formation 
where all zeins are stored, the irregular and disrupted protein body in γRNAi seeds might 
have negative effects on the GFP expression driven by the 27-kDa γ-zein promoter. The 
second strategy was to over-express a 27-kDa γ-zein transcription factor prolamin-box 
binding factor (PBF) under the control of the maize ubiquitin promoter. By crossing the 
PBF over-expressing maize line (oxPBF) with the 27-kDa γ-zein promoter driving 
recombinant protein transgenic maize line, the recombinant protein expression was 
expected to enhance. Data collected from this work sheds light on seed protein regulation 
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mechanisms, which, in turn, provides information for further improvement of 
recombinant protein expression in seed.   
 
Introduction  
The use of plants for recombinant protein expression has many advantages over 
animal and microbial systems, including high yield, low cost, low contamination risk, and 
post-translational modification ability (Fischer and Emans, 2000; Giddings, 2001; Ma et 
al., 2003; Ramessar et al., 2008). Seeds have been used to produce recombinant protein, 
since plant seed is a natural organ for protein synthesis and storage with low protease 
activities (Muntz, 1998; Stoger et al., 2005). Maize is one of the major crops with high 
yields, not only providing nutrients to humans and livestock, but also to producing fuel 
ethanol. More than 90% of fuel ethanol is maize-derived (Wolt and Karaman, 2007). 
Thus, maize seed is an ideal system for co-production of recombinant proteins and fuel 
ethanol. Usually, 99% of the seed mass remains after recombinant protein recovery 
(Paraman et al., 2010) which can be used for ethanol production (Johnson et al., 2003). 
The co-production strategy not only increases the profitability of maize-derived products, 
but also reduces the U.S. dependence on foreign fuel and lowers green gas emissions. 
Many pharmaceutical and industrial proteins have been successfully produced in 
transgenic maize, like aprotinin (Zhong et al., 2007), the B subunit of the heat labile 
enterotoxin (LT-B) (Chikwamba et al., 2002), collagen (Xu et al., 2011b), 
gastrogenterities virus (TGEV) capsid protein (Basaran and Rodrıguez-Cerezo, 2008), 
and immunoglobulin G (IgG) (Lee and Forciniti, 2010).  
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There is a major challenge however when maize is used to produce these 
exogenous proteins—low expression. The first plant-derived recombinant protein was 
reported in 1986, which was a human growth hormone produced in transgenic tobacco 
(Barta et al., 1986). The first plant-derived recombinant protein for commercial purposes 
was reported in 1997, a maize-derived recombinant avidin—an egg protein (Hood et al., 
1997). There are many factors limiting the commercialization of plant-derived 
recombinant protein, but low expression is a major issue both in academic and industrial 
areas. Numerous studies about how to enhance foreign protein production in plants have 
been published, including multiple strategies, such as tissue-specific expression, 
subcellular targeting, enhancing mRNA stability, and post-translational modification 
(Egelkrout et al., 2012; Hood and Vicuna Requesens, 2011; Kermode, 2006; Obembe et 
al., 2011; Xu et al., 2011a). Here, we evaluate two strategies for enhancing the expression 
of recombinant proteins in maize seed.   
The first strategy is to knock out the maize seed storage proteins. Previous studies 
have shown plant seeds have the ability to rebalance their content after singular major 
proteins is silenced. In the natural maize o2 mutant, non-zein proteins have increased, 
while zeins are significantly suppressed (Coleman and Larkins, 1999). High-oleic and 
high-stearic oil content cottonseed have been produced by the RNAi mediated knock-
down of two key fatty acid desaturase genes in cottonseed (Liu et al., 2002). By 
suppressing β-conglycinin in soybean via sequence-mediated gene silencing (Kinney et 
al., 2001), the glycinin promoter-driven green fluorescent protein (GFP) expression was 
increased four-fold when introgressed into the β-conglycinin suppression line compared 
to the parent line (Schmidt and Herman, 2008).  
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In maize, the major seed storage proteins, zeins, make up about 70% of the total 
endosperm content in maize seeds (Zarkadas et al., 2000). Zeins are a mixture of alcohol-
soluble proteins classified into four sub-families by their structure—α-, β-, γ-, and δ-zeins 
(Esen, 1987). These four subfamilies can be further classified as: 1) 19- and 22-kDa α-
zeins; 2) 50-, 16-, and 27-kDa γ-zeins; 3) 15-kDa β-zein; and 4) 10- and 18-kDa δ-zeins 
(Sodek and Wilson, 1971; Xu and Messing, 2008). In the present study, the γ-zein protein 
was selected to be silenced by RNAi, since the promoter for the 27-kDa γ-zein is one of 
the strongest promoters among zeins (Ueda and Messing, 1991) and is one of the most 
popular seed specific promoters used for recombinant production in maize. A transgenic 
maize line expressing GFP under the control of 27-kDa γ-zein promoter (γGFP) was also 
generated and crossed with the γ-zein knock-down line (γRNAi). Here, we hypothesize 
the GFP expression may be enhanced in the γ-zein knock-down background due to maize 
seed protein rebalancing.  
The second strategy was to enhance the expression of recombinant proteins by co-
expressing of a transcription factor. In plants, 5-7% of protein encoding genes are 
regulated by transcription factors (Shiu et al., 2005). For example, in Arabidopsis 
thaliana, PAP1/PAP2 (R2R3-MYB) regulate anthocyanin biosynthesis (Borevitz et al., 
2000) and AtMYB12/AtMYB11/AtMYB111 regulate flavonol accumulation (Mehrtens 
et al., 2005; Stracke et al., 2007). In maize, the prolamin-box binding factor (PBF) has a 
trans-activation on grain storage protein genes (Mena et al., 1998; VicenteCarbajosa et 
al., 1997). The expression of GUS (beta-glucuronidase, a reporter gene) was increased by 
seven-fold with co-transfection of a PBF over-expression vector 24 hours after 
bombardment in developing maize seeds (from 8 to 30 days after pollination (DAP)) 
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(Marzabal et al., 2008). GUS is driven by the γ-zein promoter and PBF is driven by the 
35S promoter, which indicated the PBF activated the expression of a recombinant gene 
under the control of the γ-zein promoter. A recent study (Wu and Messing, 2012a) also 
showed a similar result—the expression of the 27-kDa γ-zein promoter driving GFP was 
enhanced by co-expressed with the 35S promoter driving PBF. The enhanced GDP 
expression was observed in 10 DAP embryos 24 hours after infection or calli and root 
tissues after regenerated on regeneration medium. However, no report on the effects of 
over-expression of PBF on recombinant protein expression in stably transformed maize 
lines is available. In the present study, PBF was over-expressed in maize and to be 
crossed with a γ-zein promoter driven recombinant protein (GFP or collagen). We 
hypothesize the expression of recombinant proteins driven by the γ-zein promoter may be 
increased because of the up-regulation of PBF. The objective of this study is to evaluate 
whether any changes in endogenous protein contents or alteration of endogenous seed 
protein gene expression may enhance expression of recombinant proteins in maize seeds. 
 
Materials and Methods 
Vector construction 
Two constructs were designed (Figure 1): 1) pX006 generating a double-stranded 
RNA to knock down the native γ-zeins in maize seeds and 2) pX012 over expressing the 
prolamin-box binding factor (PBF) in maize. The construct, pX006, consists of a 478 bp 
fragment of the 672 bp 27-kDa γ-zein full coding sequence (NCBI GI#: 16305108) 
amplified with Gateway primers Gat8-07 (5’-
GGGGACCACTTTGTACAAGAAAGCTGGGTACC-GGTTCATCTACCGCCG-3’) 
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and Gat8-08 (5’-GGGGACAAGTTTGTACAAAAAAGCA-
GGCTTACCTGGCCGCTTTGCGGCT-3’) by polymerase chain reaction (PCR). The 
PCR was performed using the following conditions for 25 cycles—30 s denaturation at 
95°C, 30 s annealing at 72°C, and 3 min extension at 68°C. A typical PCR reaction 
consists of 100 ng of template DNA, 0.8 mM of dNTPs, 2 mM of MgCl2, Taq DNA 
polymerase buffer, and 0.5 U Taq DNA polymerase (Bioline USA Inc, Taunton, MA) in 
a final volume of 25 µL. The amplified 27-kDa γ-zein fragment was cloned into the 
pB7GWIWG2II0 (Karimi et al., 2002) backbone vector via DNA recombination using 
MultiSite Gateway® Three-Fragment Vector Construction Kit (cat # 12537-023, Life 
Technologies, USA). The 27-kDa γ-zein fragment was inserted into two positions on the 
vector with one in a reverse direction and the other in a forward direction, separated by a 
1355 bp intron containing a 703 bp chloramphenicol resistance gene (Cm
R
) (Figure 1, 
pX006) (Close and Rodriguez, 1982; Karimi et al., 2002). The reverse-intron-forward 
DNA structure driven by a promoter of a maize seed storage protein 27-kDa γ-zein 
should form a double-stranded RNA after transcribed, and trigger the RNA interference 
(RNAi) process for both 27 and 16-kDa γ-zeins in maize, since these two genes are 
highly conserved in DNA sequence. The pX012 construct consists of the full length of 
the PBF coding sequence (NCBI GI#: 162458993), including the 5’ and 3’ UTR 
(untranslated region) driven by a constitutive promoter from the maize ubiquitin gene 
(Figure 1, pX012). Both pX006 and pX012 are binary vectors in which transgenes can be 
delivered into plant cells with a bar gene cassette as a selection marker via the 
Agrobacterium-mediated transformation method.    
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Production of transgenic plants  
The maize transformation work was completed by the Plant Transformation 
Facility at Iowa State University as described (Frame et al., 2002). In short, constructs, 
pX006 and pX012, were introduced into immature embryos of HiII maize genotype by 
using an Agrobacterium-based transformation method. Herbicide-resistant calli were 
selected and analyzed by PCR for the presence of the transgene. PCR-positive calli were 
regenerated into seedlings. The plants were brought to maturity in the greenhouse at the 
Plant Transformation Facility. The transgenic lines were named as A222 and A339 for 
constructs pX006 and pX012, respectively.   
Two events selected from a total of fourteen events of A222 (γRNAi) line were 
crossed with one transgenic maize line (P309) carrying green fluorescent protein (GFP) 
under the 27-kDa γ-zein promoter (γGFP) previously generated (Moeller et al., 2009). 
The T2 seeds of γGFP/γRNAi were harvested, analyzed, and advanced to T3 by self- 
pollination. The A222 (γRNAi) line was also crossed with the A339 (oxPBF) line. Four 
genotypes of the seed were generated in the T2 progeny—+/+; +/+, oxPBF/+; γRNAi/+, 
oxPBF/+; +/+, and +/+; +/γRNAi.   
 
PCR analysis of transgenic plants 
Total genomic DNA was extracted by using the cetyl trimethyl ammonium 
bromide (CTAB) method (Murray and Thompson, 1980) from maize calli or seeds. The 
presence of the transgene was verified by PCR. To detect pX006, PCR was performed 
under the following conditions for 35 cycles by primers x8-15 (5'- 
GCAAGATGTGGCGTGTTACG -3') and x8-16 (5'- GGTGGCACTTG-
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TTGGTATGAGACT -3') designed for amplifying a fragment of the intron: 30 s 
denaturation at 95°C, 15 s annealing at 55°C, 30 s, and extension at 70°C. To detect 
pX012, PCR was performed under the following conditions by primers x11-03 (5'- 
GAGTTTAAGATGGATGGAA-3'), within the region of the ubiquitin promoter,  and 
x11-04 (5'- GTAGCGTGGTT-GTGACA -3'), within the region of the PBF coding 
sequence, for 30 cycles: 30 s denaturation at 95°C, 30 s annealing at 55°C, and 20 s 
extension at 70°C. PCR products were analyzed on 1% agarose gel. The expected sizes of 
PCR products are 332 bp (pX006) and 610 bp (pX012). The gel was stained with 
ethidium bromide (0.5 μg/ml) for 20 min. The product sizes were determined by using 1 
kb DNA Ladder (cat # N3232S, New England Biolabs). 
 
Seeds imaging  
The opaque phenotype was observed in the transgenic line A222. The mature 
seeds from the A222 line and wide type B73 were imaged with a digital camera on the 
top of a white light transilluminator (cat # TW-43, UVP LLC.).  
 
Protein extraction and Coomassie Brilliant Blue staining 
Total zein proteins (alcohol-soluble) from maize seed were extracted by using 
ethanol-based extraction buffer consisting of 70% ethanol, 61 mM sodium acetate, and 
100 nm DL-Dithiothreitol (DTT). Seeds were ground and 100 mg powder was added to 
1.0 mL of extraction buffer in a 1.5 mL Eppendorf tube. The tube was laid horizontally 
on a shaker at 225 rpm at 37
o
C for 1 hour. Then, the tube was spun 10 minutes in a 
micro-centrifuge.  
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Two micro liters of the total zein proteins extracted from the A222 seed powder 
were lyophilized overnight and re-dissolved in 30 µL Laemmli sample buffer (cat # 161-
0737, Bio-Rad). The sample was loaded onto a 12 % polyacrylamide SDS-PAGE gel (cat 
# 465-1043, Bio-Rad). Electrophoresis was performed at 200 V for 35 min. The gel was 
stained with a Bio-Safe Coomassie Stain (cat # 161-0786, Bio-Rad) for 20 min and de-
stained overnight in deionized water. 
The total water-soluble protein (TSP) from maize seeds was extracted by using 
the following protein extraction buffer at a ratio of 10 µL buffer per milligram of seed 
powder for 2 hours at 37 
o
C: 25 mM sodium phosphate (pH 6.6), 100 mM NaCl, 0.1% 
Triton X-100 (v/v), 1 mM EDTA, 10 µg/ml of leupeptin, and 0.1 mM serine protease 
inhibitor Perfabloc SC (Fluka). 
The method for extracting proteins from maize seeds for two-dimensional gel 
electrophoresis (2-D electrophoresis) was slightly modified from Consoli and Damerval 
(2001). Total proteins were extracted from 1 mg of seed powder by 75 µL of buffer 
containing 9.5 M urea, 2% v/v Triton X-100, 2% of IPG buffer pH range 3–10 (cat # 17-
6000-87, GE), and 100 mM dithiothreitol (DTT). After incubating in a shaker at room 
temperature for 60 min, the sample was centrifuged for 10 min at 12,000 g in a bench-top 
micro-centrifuge, and the supernatant was carefully removed for the 2-D electrophoresis.      
 
GFP detection by GFP antibody capture ELISA 
The GFP content in maize seeds was quantified by using the enzyme-linked 
immunosorbent assay (ELISA). Goat anti-GFP antibody (Cat # 600-101-215, Rockland) 
was used at 2.5 µg/mL concentration, 50 µL per well. The ELISA plate (cat # 3590, 
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Corning, Inc.) was incubated for 1 hour at 37°C. The plate was then washed with 1 X 
with phosphate buffered saline with tween-20 or PBST [PBS: 0.01 M Na2HPO4, 0.003 M 
KH2PO4, 0.1 M NaCl (pH 7.2)]. The plate was then blocked with 5% dry milk in PBS for 
1 hour at room temperature. After 1 X wash by PBST, 50 µL of the standard GFP (Cat # 
4999-1000, BioVision) or the total water-soluble protein (TSP) from samples was added 
to the well and the plate was incubated at room temperature for 1 hour. After 3 X wash 
using PBST, 50 µL of chicken anti-GFP antibody (Cat # 600-901-215, Rockland) were 
diluted at 1:1000 with 1% dry milk in PBS and added to the well. The plate was 
incubated at 37°C for 1 hour. After 3 X wash by PBST, peroxidase conjugated rabbit 
anti-chicken antibody (Cat # 603-4302, Rockland) was diluted at 1:1000 with 1% dry 
milk in PBS and added to the well. After 3 X wash by PBST, 100 μL per well of 
peroxidase substrate (Cat # 52-00-02, KPL) was added. The plate was then read at 635 
nm in a microplate reader (KC4, Biotek) after incubating at room temperature for 20 min.      
 
Two-dimensional gel electrophoresis 
Isoelectric focusing (IEF) was performed in a 7 cm long IPG ReadyStrip, pH 3-10 
(cat # 163-2000, Bio-Rad). A sample of 125 µL was loaded onto the strip. Focusing was 
completed using the following steps—50 V for 12 hours, 500 V for 1 hour, 1000 V for 1 
hour, and 8000 V for 8 hours at room temperature. The IEF was completed in the Protein 
Facility at Iowa State University. The second dimension and the Coomassie blue staining 
procedures were the same as described in Protein extraction and Coomassie Brilliant 
Blue staining in materials and methods, except the IPG well 12 % polyacrylamide SDS-
PAGE gel (cat # 161-1391, Bio-Rad) was used instead of the regular well size gel. The 
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molecular weight marker was the Precision Plus Protein Standard Plugs (cat # 161-0378, 
Bio-Rad).  
 
Statistical analysis 
Statistical analyses of GFP expressions in T3 transgenic maize were performed by 
utilizing the SAS v9.2 program (SAS Institute Inc., Cary, NC, USA). The general linear 
model (GLM) procedure was used. The whole data was considered as a randomized 
complete block design (RCBD).  
 
Results and Discussion 
Generation of transgenic maize line A222 (γRNAi)  
The pX006 (Figure 1) is an RNAi (RNA interference) construct containing two 
identical copies of the gene coding sequence for the 27-kDa γ-zein—one in reverse 
direction and the other in forward direction. The two 27-kDa γ-zein coding sequences 
were separated by an intron 1355 bp long, containing a 703 bp chloramphenicol 
resistance gene (Cm
R
) (Close and Rodriguez, 1982; Karimi et al., 2002) to facilitate the 
transcription forming a hairpin structure. The maize seed-specific promoter 27-kDa γ-
zein promoter is used to drive the transgene cassette. The construct was introduced into 
the maize HiII germplasm by using an immature embryo via Agrobacterium-based 
methods (Frame et al., 2002). 
The transgenic plants were brought to maturity in the greenhouse and crossed 
with the pollen donor of the inbred maize line B73. Initial transgene screens were 
performed on both calli and T1 seeds by PCR. PCR indicated that all events were positive 
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for the transgenes of interest (data not shown). No significant difference was observed 
between the A222 line and wild-type maize during growth process. Fourteen independent 
events of transgenic maize line carrying pX006 (γ-zein down-regulation, designated as 
A222 or γRNAi) were generated, and a total of 3,403 kernels from 31 plants were 
harvested (Table 1). 
 
Characterization of the γRNAi transgenic maize line A222  
The opaque phenotype was observed from the mature seeds of the A222 line by 
using a white light transilluminator (Figure 2, Table 1). All 3,403 kernels from 31 plants 
representing 14 events were examined (Table 1). Opaque phenotype kernels were found 
in all events, except for A222-15. Some events, such as A222-1, A222-5, and A222-12, 
had low percentages of opaque seeds.  
The opaque phenotype usually occurs when the zein content is reduced and the 
non-zein protein content is increased compensatorily or under stress (Crow and Kermicle, 
2002; Lyznik and Tsai, 1989; Neuffer et al., 1997). To further confirm that the opaque 
phenotype of seeds resulted from the γ-zeins knock-down in these seeds, the total zein 
proteins were extracted from the A222 mature seeds and analyzed on the SDS-PAGE gel 
followed by Coomassie blue staining. Seeds from plants A222-2-1, A222-7-1, A222-10-2, 
and A222-13-1 were chosen for this analysis, since these four have many opaque 
phenotype kernels with bigger seed size. In Figure 3, the zein accumulation pattern is 
shown from six kernels randomly selected for each of the four events. The segregants 
with 27-kDa γ-zein and 16-kDa γ-zein knock-down pattern were observed for all four 
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events indicating the γ-zein RNAi construct (pX006) worked efficiently in transgenic 
maize line A222.             
The γ-zein was knocked-down by RNAi in previous studies (Wu and Messing, 
2010). The RNAi constructs used in Wu and Messing and our study were very similar. 
Both vectors contain a “reverse 27-kDa γ-zein – intron – forward 27-kDa γ-zein” RNAi 
structure and both are driven by the 27-kDa γ-zein promoter. The pattern for 27-kDa and 
16-kDa γ-zein knock-down showed, by seed zein SDS-PAGE analysis in our study, was 
constant with observations with previous studies (Wu et al., 2010; Wu and Messing, 
2010). The reduction of 22-kDa and 19-kDa α-zein was also observed from the seed zein 
SDS-PAGE analysis in the γRNAi QPM (quality protein maize) background (Wu et al., 
2010), but not observed in our experiments.   
The use of the γRNAi background maize to enhance the recombinant production 
under the control of the 27-kDa γ-zein promoter has not been addressed, yet. In the 
present study, we crossed the γRNAi line with the γGFP line and evaluated the 
recombinant protein (i.e. GFP) expression level in transgenic maize seeds.    
 
Generation of hybrid γGFP/γRNAi 
Two A222 (γRNAi) events (A222-2-1 and A222-13-1) were selected to cross 
with the P309 (γGFP, (Moeller et al., 2009)) line after zein characterization, since these 
two events have more bigger kernels and more healthy looking seeds than the others. The 
breeding strategy is shown in Figure 4. The A222 and P309 lines were crossed 
reciprocally. The T2 generation was further advanced to T3 by self-pollination. Only the 
double transgenic genotype (i.e., consisting of both γRNAi and γGFP) in T2 was selected 
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for the parents of T3. According to Mendel's genetic laws, 9 genotypes and 4 phenotypes 
should be generated in the T3 generation. Two phenotypes (i.e., γRNAi with GFP and 
γRNAi without GFP) were further analyzed, and compared on the zein profiling and GFP 
expression levels.         
 
GFP expression decreased in seeds with γRNAi background 
To measure the GFP expression level in γGFP/γRNAi progenies, at least eight 
kernels were selected from each individual T2 and T3 progenies. First, genomic DNA was 
extracted from individually ground seed and PCR was performed to verify the genotype 
for each seed. GFP expression was quantified by ELISA for each individual GFP PCR 
positive seed. In addition, zein profiling was also completed on these seeds as shown in 
Figure 3. The seeds from the same plant were grouped into two phenotypes—GFP with 
γRNAi (G/Z) and GFP without γRNAi (G/z). The GFP expressions were compared 
between the G/Z and G/z kernels from the same plant.  
In total, 40 T2 progenies were generated from P309xA222-2-1 and P309xA222-
13-1 crosses and analyzed by GFP ELISA and zein profiling. No significant difference of 
GFP level was observed between G/Z and G/z plants. The double transgenic plants were 
advanced to T3 by self-pollination. A total of 43 T3 progenies were generated from 
P309xA222-2-1. Of these, 20 progenies were verified as GFP positive by both PCR and 
ELISA. Among these 20 progenies, six were verified for γRNAi segregation (G/Z or G/z) 
by both PCR and zein profiling. The GFP-positive seeds were grouped by with or without 
γRNAi within each of the six progenies. The GFP expression data collected from 
individual kernel by ELISA are shown in Table 2. The mean GFP expression was 
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calculated by groups for each progeny. As can be seen in Table 3, five out of six 
progenies have higher mean GFP expression levels in seeds without γRNAi than in seeds 
with γRNAi. The GFP expression is significantly higher without γRNAi (G/z) than with 
γRNAi (G/z) in three T3 progenies T3-1, T3-2, and T3-3, examined by the two-tail t-test 
(Table 3). The other three T3 progenies show no significant difference between G/Z and 
G/z when using the t-test. 
To further determine if the difference of the GFP expression level was significant, 
the statistical program SAS was used to analyze all samples. The data were analyzed by 
using the Randomized Complete Block Design (RCBD). Data obtained from all six 
progenies (Table 2) were considered as a block and the γRNAi was considered a 
treatment. The generalized linear model (GLM) procedure performed with SAS indicates 
the GFP expression difference between GFP lines without γRNAi and with γRNAi was 
significant (P <0.01). The two kernel types (i.e. G/Z and G/z) were the segragants from 
the same ear. Therefore, factors that cause the GFP expression difference in these two 
types of kernels, such as genetic background, growth and environmental conditions, and 
plants’ individual differences, can be excluded. The only difference between G/Z and G/z 
kernels was the γRNAi. This result suggested the GFP expression under the control the 
27-kDa γ-zein promoter decreased in maize lines when endogenous γ-zein genes were 
silenced.   
This observation was opposite to what we originally anticipated. We hypothesized 
any recombinant and exogenous protein under γ-zein promoter would be enhanced in the 
γ-zein knock-down background, because reduced γ-zein content in total seed proteins 
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might generate a positive feedback to the γ-zein production mechanism; hence, promote 
the production of recombinant protein under the γ-zein promoter.  
Recent studies about γ-zeins knock-down showed γRNAi slightly alters the 
protein body in morphology in which the zeins are stored, and the 19- and 22-kDa α-
zeins are also reduced (Wu et al., 2010; Wu and Messing, 2010). The protein body is 
formed from the disulfide bonds cross-linked with β- and γ-zeins matrix first (Lending 
and Larkins, 1989; Lopes and Larkins, 1991). Then, the α- and δ-zeins are transferred 
into the β- and γ-zeins matrix during synthesis (Holding and Larkins, 2009; Kim et al., 
2002; Lending and Larkins, 1989; Woo et al., 2001). The α-zeins are found in the protein 
body’s core and the 27-kDa γ-zein is rich in the peripheral region (Holding et al., 2007). 
The γ and β-zeins coordinate the α- and δ-zeins and retain them in the ER (endoplasmic 
reticulum) for protein body formation (Bagga et al., 1997; Geli et al., 1994; Holding and 
Larkins, 2009; Kim et al., 2002). Previous studies also indicated both proteins would be 
secreted and degraded when α- and δ-zeins were expressed in petunia and tobacco 
(Bagga et al., 1997; Coleman et al., 1996; Williamson et al., 1988). Thus, the normal 
protein body structure relies on the organized accumulations of γ-, β-, α-, and δ-zeins, and 
the γ-zein plays a key role during protein body formation. When the γ-zein is knocked 
down, the protein body does not properly form, and the 19- and 22-kDa α-zeins are 
reduced (Wu et al., 2010; Wu and Messing, 2010).  
In our study, the co-expressed γGFP levels in the γRNAi background were lower 
than their non-γRNAi segragants. Because limited cross events were evaluated, it is 
premature to conclude that recombinant protein expression driven by the γ-zein promoter 
will decrease in the γRNAi background. Research has shown the suppression of γ-zeins 
172 
 
 
leads to abnormal protein body formation.  It is possible such disruption triggers a 
negative feedback (instead of a positive feedback hypothesized originally) to reduce any 
gene expression regulated by the γ-zein promoter (in our case, it is GFP). For plants, 
energy is wasted if production of a storage protein continues that cannot be stored in the 
proper place. On the other hand, when a major storage protein is reduced, other proteins 
compensatorily increase, as found in maize natural zein mutants o2 and fl2 (Coleman and 
Larkins, 1999), maize α-zein RNAi line (Wu and Messing, 2012b), and soybean β-
conglycinin suppression line (Kinney et al., 2001). This makes sense that plants rebalance 
their protein content in seeds by producing more other proteins rather than enhancing the 
promoter for which the gene has been silenced. 
One successful example of enhancing the foreign protein expression in crops by 
using a seed major protein silencing strategy has been completed in soybean; whereas, 
the GFP expression under glycinin promoter control was increased in the β-conglycinin 
silenced background (Schmidt and Herman, 2008). Since increased non-zein proteins 
were found in zein mutants and knock-down lines (Coleman and Larkins, 1999; Osborne 
et al., 1914; Wu and Messing, 2012b), it will be interesting to evaluate the GFP 
expression levels when GFP is driven by non-zein gene promoters in γRNAi maize 
background.      
 
Generation of PBF overexpressing transgenic maize line A339 (oxPBF)  
The pX012 construct carries a gene coding sequence for the native maize PBF 
(prolamin-box binding factor) driven by the maize ubiquitin promoter—a constitutive 
promoter. The construct was delivered into the maize HiII germplasm by using an 
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immature embryo via Agrobacterium-based methods. Sixteen transgenic lines carrying 
pX012 (oxPBF, designated as A339) were generated. 
PBF is a transcription factor that regulates both 22-kDa α-zein and 27-kDa γ-zein 
(VicenteCarbajosa et al., 1997; Wu and Messing, 2012a). When PBF was suppressed by 
the PBF RNAi vector under the control of the 27-kDa γ-zein promoter, both 22-kDa α-
zein and 27-kDa γ-zein were reduced, but other zeins were unaffected (Wu and Messing, 
2012a). When PBF was over expressed, the expression of reporter genes (GUS or GFP) 
driven by the 27-Da γ-zein promoter was increased in immature maize seeds, embryos, 
calli and regenerated root tissues (Marzabal et al., 2008; Wu and Messing, 2012a).  
Our intention is to co-express a recombinant protein (collagen) or marker protein 
(GFP) driven by the 27-Da γ-zein promoter in oxPBF background. Their expression 
levels will be compared with that in regular PBF background. We do not have these 
maize seeds available at this time. However, we have generated an oxPBF/γRNAi hybrid. 
The progenies of this hybrid have four genotypes——+/+; +/+, oxPBF/+; γRNAi/+, 
oxPBF/+; +/+, and +/+; +/γRNAi. The quantitative 2-D gel electrophoresis analysis was 
used to quantify the differences between proteins in the same position by measuring the 
density of the spot on the gel. Preliminary data indicated both 16- and 27-kDa γ-zeins 
disappeared in γRNAi genotypes (see black and white arrows in Figure 5). Our future 
plan is to quantify seed protein contents in the oxPBF background. If the up-regulated 
gene is discovered from these genotypes, the promoter can be used to enhance the 
recombinant protein expression in such backgrounds.  
 
174 
 
 
Summary and Future Work 
In the present study, the γ-zeins (16- and 27-kDa γ-zein) in maize seed were 
successfully knocked down (Figure 3). The typical opaque phenotype was observed and 
correlated with the disappearance of 16- and 27-kDa γ-zeins. The γRNAi line was 
crossed with the 27-kDa γ-zein promoter-driving GFP (γGFP) line. Interestingly, the GFP 
levels in γGFP/γRNAi seeds appeared to be significantly lower than those for the non-
γRNAi segregants. Because the suppression of γ-zeins production disrupts of protein 
body formation in seed, this, in turn, may impact negatively transgene expression under 
the control of the same γ-zein promoter. It is likely the plant chooses a more economical 
and energy savings way to have other proteins compensatorily increase rather than 
continue to produce a protein constantly suppressed. Therefore, it may be desirable to 
generate a GFP expressing maize line under a non-zein seed specific promoter (nzGFP). 
This nzGFP will be introduced into the γRNAi background. The nzGFP levels will then 
be compared with that of a non-γRNAi segregants.  
A transcription factor for the 27-kDa γ-zein, PBF, was constitutively over-
expressed in maize. We crossed the oxPBF line with the γRNAi line and generated 
progenies with four oxPBF and γRNAi genotype combinations. The next step is to 
examine how seed proteins change within these four different backgrounds by various 
quantitative proteomics. Difference gel electrophoresis (DIGE) will be used first. Seed 
proteins from different backgrounds would be labeled with different colors and then 
loaded on the same SDS-PAGE gel for electrophoresis. The protein content difference 
would be identified via the different intensity of the color from the same gel. Protein 
bands showing different intensities could be cut, collected, and further identified by MS. 
175 
 
 
We expect to evaluate the maize seed protein changes affected by either oxPBF or γRNAi, 
which could provide further information for maize seed nutrition improvement or 
enhancing the recombinant protein expression (i.e. use the increased protein promoter for 
expressing recombinant proteins in such background).      
We also plan to cross the oxPBF line with the 27-kDa γ-zein promoter driving 
GFP line. Using this cross, we expect to achieve a higher GFP expression with over-
expression of GFP. The GFP expression would be quantified by ELISA as described in 
the present study. That study should show whether it is worth using a co-expression of 
PBF strategy for expressing recombinant proteins driven by the 27-kDa γ-zein promoter.  
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Table 1 Generation of transgenic maize line A222 (γRNAi) 
PTF ID Event Plant
# total 
seed
*# opaque 
seed
% op/total
**Zein 
Coomassie
A222 1 2 141 5 3.5%
A222 1 3 184 0 0.0%
A222 1 4 247 5 2.0%
572 10 1.7%
A222 2 1 81 70 86.4% See Figure3
A222 2 3 38 33 86.8%
A222 2 4 44 10 22.7%
163 113 69.3%
3 A222 5 1 238 5 2.1%
A222 6 1 28 13 46.4%
A222 6 3 39 8 20.5%
A222 6 4 103 10 9.7%
408 36 8.8%
5 A222 7 1 25 22 88.0% See Figure3
A222 10 2 62 60 96.8% See Figure3
A222 10 3 56 52 92.9%
A222 10 4 6 6 100.0%
149 140 94.0%
A222 12 1 222 0 0.0%
A222 12 3 202 2 1.0%
A222 12 4 229 0 0.0%
653 2 0.3%
8 A222 13 1 205 59 28.8% See Figure3
9 A222 15 2 271 0 0.0%
A222 17 2 153 0 0.0%
A222 17 3 62 0 0.0%
A222 17 4 220 2 0.9%
911 61 6.7%
11 A222 18 4 3 3 100.0%
A222 19 1 43 39 90.7%
A222 19 2 6 6 100.0%
A222 19 4 9 9 100.0%
61 57 93.4%
A222 20 1 93 79 84.9%
A222 20 2 159 10 6.3%
252 89 35.3%
A222 22 1 2 2 100.0%
A222 22 3 29 29 100.0%
A222 22 4 203 24 11.8%
234 55 23.5%
3403 563 16.5%
*Determined by using a white light transilluminator.
**Coomassie Brilliant Blue staining of total zein extraction from seeds.
subtotal
total 
subtotal
1
subtotal
2
subtotal
subtotal
subtotal
14
subtotal
subtotal
4
6
7
10
12
13
subtotal
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Table 2. T3 seed ^GFP expression with (G/Z) or without γ-zein knock-down (G/z)
G/Z G/z G/Z G/z G/Z G/z G/Z G/z G/Z G/z G/Z G/z
0.05 0.49 0.10 0.22 0.21 0.66 0.14 0.09 0.17 0.70 0.16 0.63
0.09 0.84 0.10 0.74 0.26 0.85 0.21 0.40 0.18 0.94 0.19 0.90
0.10 0.90 0.28 0.97 0.35 3.39 0.30 0.44 0.19 0.97 0.23 0.95
0.11 1.03 0.39 1.20 0.38 4.05 0.30 0.49 0.19 1.12 0.43 3.60
0.12 1.20 0.43 1.26 0.38 4.58 0.36 0.58 0.20 1.17 0.43 6.62
0.28 0.89 0.46 0.88 0.40 0.44 1.13 0.23 1.37 0.44
0.33 0.27 0.47 0.42 0.41 0.45 1.23 0.28 1.49 0.58
0.34 0.48 0.43 0.55 0.29 3.07 0.84
0.49 0.34 0.50 0.61 0.30 3.63 0.99
0.58 0.16 0.56 0.64 0.32 1.08
0.82 0.58 0.79 0.40 1.50
0.30 0.58 1.04 0.42 1.59
0.24 0.65 1.32 0.44 1.77
0.67 1.37 0.48 2.88
0.68 2.33 0.48 3.23
0.82 2.38 0.50 3.80
0.84 2.54 0.56 3.86
0.86 0.56 4.33
0.92 0.59 4.66
0.99 0.77
1.02 0.78
1.03 1.01
1.11 1.13
1.15 1.76
1.24 1.83
1.39 3.25
1.47 3.38
1.57 4.96
1.70
2.14
2.30
2.92
3.49
4.92
5.76
T3-6
^GFP expression levels are ug per mg of total protein
T3-1 T3-2 T3-3 T3-4 T3-5
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Table 3. GFP expression in T3 maize seed (P309xA222-2-1) with or without γ-zein knock-down
two-tail t-test
Events
Total kernel 
# analyzed
kernel # 
^Mean GFP 
expression 
kernel # 
*Mean GFP 
expression 
P-value
T3-1 20 13 0.30 7 0.80 *0.000611
T3-2 17 10 0.32 7 0.81 *0.002094
T3-3 40 35 1.28 5 2.71 *0.030800
T3-4 24 17 0.93 7 0.62 0.351047
T3-5 37 28 0.92 9 1.61 0.119340
T3-6 24 19 1.74 5 2.54 0.379165
*Signif icance in t-test, P-value < 0.05.
^GFP expression levels are ug per mg of total protein.
GFP with γRNAi (G/Z) GFP w/o γRNAi (G/z)
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Figure 1. Two constructs used in this study. In construct pX006: Pγ, 27-kDa γ-zein 
promoter; attB1 and attBt,  recombination sites for Gateway cloning; Cγ, 27-kDa γ-zein 
gene coding sequence; T, 35S terminator; ; x8-15 and x8-16, primers for verifying the 
presence of γRNAi transgene cassette in pX006. In construct pX012: Pubi,  maize 
ubiquitin promoter; PBF, maize prolamin-box binding factor coding sequence; PBF 
5’UTR, PBF 5’ untranslated region; PBF 3’UTR, PBF 3’ untranslated region; Tvsp, the 
soybean vegetative storage protein gene terminator; x11-03 and x11-04, primers for 
verifying the presence of PBF transgene cassette in pX012.  
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Figure 2. Opaque phenotype of maize seeds. Opaque phenotype is observed in γ-zein 
reduced transgenic maize seed A222-9-2. WT is wild type.  Photographs were taken with 
transmitted light.    
 
  
A222 WT 
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Figure 3. Maize seed zein accumulation pattern of four events from T1 A222 (γRNAi). 
Total zein proteins were extracted from six seeds from each event and detected by SDS-
PAGE followed by the Coomassie staining. Segregants with 27-kDa γ-zein and 16-kDa 
γ-zein knock-down pattern are observed in all four events and labeled as “+” on the top of 
the lane. The negative segregants are labeled as “-”. The WT is wild type B73.  
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Figure 4. Breeding schemes of double transgenic plants. The T1 GFP was crossed 
with γRNAi. Four genotypes were generated in T2 and only one (G/g Z/z) was selected to 
advance to T3 by self- pollination. γRNAi, γ-zein knock-down; GFP, green fluorescent 
protein over expression; Z, dominant transgene of γ-zein RNAi; G, dominant transgene of 
GFP.  
 
  
T1 X
↓
T2 G/g Z/z g/g Z/z G/g z/z g/g z/z 
U - - -
↓
T3 G/G Z/Z G/G Z/z G/g Z/Z G/g Z/z G/G z/z G/g z/z g/g Z/Z g/g Z/z g/g z/z 
          P309 GFP line (G/g)    A222  γRNAi line (Z/z) 
GFP with γRNAi GFP w/o γRNAi
191 
 
 
 
Figure 5. Two-D patterns of 4 genotypes T1 of A339 (PBF) X A222 (γRNAi). γRNAi, 
γ-zein knock-down; PBF, prolamin-box-binding factor over expression. Dark arrows 
indicate the 16-kDa γ-zein, and white arrows indicate the 27-kDa γ-zein, which are all 
absent in γRNAi segregates.   
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CHAPTER 7: GENERAL CONCLUSIONS 
In this dissertation, we proposed that maize can be used to safely produce high 
yielding and adequately modified recombinant proteins in seeds. Through Chapters 3-6, I 
presented research activities aimed at demonstrating this proposed approach: 1) produce 
hydroxylated recombinant human collagen type I α 1 (rCIα1) by co-expression of 
recombinant human prolyl 4-hydroxylase in maize seeds (Chapter 3); 2) generate a small 
biosurfactant peptide GAM1 in maize seeds with fusion to the red fluorescent protein (RFP) 
or a maize seed storage protein 22-kDa α-zein (Chapter 4); 3) establish transformation of the 
tissue culture-amenable male-sterile maize and transfer a vaccine gene, the E-coli heat-labile 
enterotoxin B subunit (LT-B), from male-fertile to sterile maize lines for open-field release 
(Chapter 5); and 4) evaluate the green fluorescent protein (GFP) expression in maize seeds 
with either silencing of a seed storage protein, the 27 kDa γ-zein or overexpression of a 
transcription factor prolamin box-binding factor (PBF) (Chapter 6). 
In Chapter 3, the rCIα1 was successfully expressed in high percentages of 
hydroxylated proline (Hyp) in maize seeds under the control of the seed-specific promoter 
maize globulin-1, when co-expressed with a recombinant human prolyl 4-hydroxylase 
(rP4H). High-resolution mass spectrometry (HRMS) analysis revealed that the Hyp ratio of 
maize-derived rCIα1with co-expression of rP4H (rCIα1-OH) is 18.11%, higher than the 
rCIα1 without co-expression of the rP4H (5.89%) and even higher than the native human 
CIα1 (14.95%). The increased Hyp content was correlated with distinctly enhanced thermal 
stability of rCIα1 compared to the non-hydroxylated rCIα1. We concluded maize is able to 
produce recombinant proteins with mammalian-like post-translational modifications, which 
may be necessary for their use as pharmaceutical and industrial productions. 
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In Chapter 4 the protein fusion strategy was presented to produce a 22-amino acid 
biosurfactant peptide GAM1 in maize seeds by fusing to the RFP or the 22-kDa α-zein. 
Maize endogenous seed-specific promoters of 27-kDa γ-zein and 22-kDa α-zein were used to 
lead the expression of RFP::GAM1 and α-zein::GAM1, respectively. Correctly fused 
sequences were confirmed by PCR and DNA sequencing for both constructs. Transgenic 
maize seeds carrying RFP::GAM1 displayed red fluorescence and were further confirmed as 
RFP positive in Western Blot analysis. Various analysis methods including in-gel 
digestion/peptide mass fingerprinting, high-performance liquid chromatography (HPLC), and 
MS have been used to detect the presence of the GAM1 in both RFP::GAM1 and 
Zein::GAM1 fusion lines. Due to low levels of fusion protein production and ineffective 
protein concentration methods, the verification of GAM1 was not successful. Future work 
should include reverse transcription PCR (RT-PCR) to determine the presence of the full 
length of fusion transcripts in seeds. The fusion and gene construction strategies will also 
need to be reevaluated.  
In Chapter 5, two strategies were described for the safe production of maize-derived 
pharmaceutical proteins in open field by using a male-sterile transgenic maize line to avoid 
pollen contamination. The first strategy was to directly introduce the transgene into 
transformable male-sterile maize. Transgene cassette maize ubiquitin promoter driving both 
bar and gus-intron was used for biolistic-mediated (gene-gun) transformation method, and 
35S promoter driving both bar and gus-intron cassette was used for Agrobacterium-based 
transformation methods. GUS assay was performed to verify the expression of gus gene in 
transgenic maize callus and leaves in the R1 progeny. This is the first report of successful 
transformation of male-sterile maize by biolistic- or Agrobacterium-based methods. The 
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second strategy was to introduce the transgene from a male-fertile transgenic line to the 
male-sterile maize line via conventional breeding. The B-subunit protein of Escherichia coli 
heat labile enterotoxin (LT-B), a vaccine gene, was used as a pharmaceutical product model 
in this strategy. After six seasons of breeding, we were able to obtain 100% transgenic male-
sterile maize seeds by using non-transgenic pollen donor in an open field. We concluded that 
maize-derived pharmaceutical proteins can be produced in the open field using male-sterile 
maize lines. 
In Chapter 6, maize seed protein γ-zeins (16- and 27-kDa γ-zein) were successfully 
knocked down via RNAi (RNA interference). By introgression of the 27-kDa γ-zein 
promoter driving GFP (γGFP) into the γ-zeins knock-down (γRNAi) maize line, we 
examined whether the GFP expression could be enhanced in γ-zein reduced maize 
background. The GFP expression in γGFP/γRNAi seeds was significantly lower than that of 
in the non-γRNAi segregants. This unexpected observation may have been due to the fact 
that both γ-zein knock-down and GFP expression were controlled by the same 27-kDa γ-zein 
promoter. Since the reduction of γ-zeins disrupts protein body formation in maize seeds, it 
may in turn negatively regulate the foreign gene expression driven by the same γ-zein 
promoter. It may be an energy-saving strategy for plants so other proteins compensatorily 
increased instead of continuing to produce a protein that is constantly suppressed. Thus, it 
would be desirable to use a non-zein seed specific promoter to lead the expression of the GFP 
(nzGFP) in the γRNAi background. The expression levels will then be compared between the 
γRNAi and non-γRNAi segregants.     
Another attempt described in Chapter 6 was to enhance the expression of recombinant 
proteins in transgenic maize by overexpressing a transcription factor for the 27-kDa γ-zein, 
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prolamin-box binding factor (PBF). We hypothesized that the expression of the 27-kDa γ-
zein promoter driving recombinant protein is enhanced by over-expressing PBF in maize 
seeds. The PBF over-expression transgenic maize line (oxPBF) was successfully generated. 
Future work should include crossing the oxPBF line with the 27-kDa γ-zein promoter driving 
GFP line. GFP expression should be quantified by ELISA as described in this study. This 
study would provide further information of whether it is a good strategy to co-express the 
PBF to enhance recombinant proteins driven by the 27-kDa γ-zein promoter in maize seeds.  
The studies presented in this dissertation demonstrate strategies to overcome 
challenges encountered in using transgenic maize to produce recombinant proteins. While 
maize has the potential to produce recombinant proteins with mammalian-like post-
translation modifications and can be produced safely in an open field, it remains challenging 
to produce a high quantity in seeds for industrial purposes. The materials and preliminary 
data related to the regulatory mechanism of maize seed protein generated from this work can 
be used to further improve recombinant protein expression in seeds.   
   
 
